
<html lang="en"     class="pb-page"  data-request-id="4b68f8ab-a236-43a6-af74-2cd46a6a5848"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-6;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm401536b;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold" /></meta><meta name="dc.Creator" content="Maurizio  Taddei" /></meta><meta name="dc.Creator" content="Serena  Ferrini" /></meta><meta name="dc.Creator" content="Luca  Giannotti" /></meta><meta name="dc.Creator" content="Massimo  Corsi" /></meta><meta name="dc.Creator" content="Fabrizio  Manetti" /></meta><meta name="dc.Creator" content="Giuseppe  Giannini" /></meta><meta name="dc.Creator" content="Loredana  Vesci" /></meta><meta name="dc.Creator" content="Ferdinando M.  Milazzo" /></meta><meta name="dc.Creator" content="Domenico  Alloatti" /></meta><meta name="dc.Creator" content="Mario B.  Guglielmi" /></meta><meta name="dc.Creator" content="Massimo  Castorina" /></meta><meta name="dc.Creator" content="Maria L.  Cervoni" /></meta><meta name="dc.Creator" content="Marcella  Barbarino" /></meta><meta name="dc.Creator" content="Rosanna  Foderà" /></meta><meta name="dc.Creator" content="Valeria  Carollo" /></meta><meta name="dc.Creator" content="Claudio  Pisano" /></meta><meta name="dc.Creator" content="Silvia  Armaroli" /></meta><meta name="dc.Creator" content="Walter  Cabri" /></meta><meta name="dc.Description" content="Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycumene scaffold with differently substituted aryl propiolates gave a new family of 1,4,5-trisubstitu..." /></meta><meta name="Description" content="Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycumene scaffold with differently substituted aryl propiolates gave a new family of 1,4,5-trisubstitu..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 17, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401536b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401536b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401536b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401536b" /></link>
        
    
    

<title>Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401536b" /></meta><meta property="og:title" content="Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0017.jpeg" /></meta><meta property="og:description" content="Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycumene scaffold with differently substituted aryl propiolates gave a new family of 1,4,5-trisubstituted triazole carboxylic acid derivatives that showed high affinity toward Hsp90 associated with cell proliferation inhibition, both in nanomolar range. The 1,5 arrangement of the resorcinol, the aryl moieties, and the presence of an alkyl (secondary) amide in position 4 of the triazole ring were essential to get high activity. Docking simulations suggested that the triazoles penetrate the Hsp90 ATP binding site. Some 1,4,5-trisubstituted triazole carboxamides induced dramatic depletion of the examined client proteins and a very strong increase in the expression levels of the chaperone Hsp70. In vitro metabolic stability and in vivo preliminary studies on selected compounds have shown promising results comparable to the potent Hsp90 inhibitor NVP-AUY922. One of them, (compound 18, SST0287CL1) was selected for further investigation as the most promising drug candidate." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401536b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401536b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401536b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401536b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401536b&amp;href=/doi/10.1021/jm401536b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2258-2274</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500089r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4019614" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maurizio++Taddei">Maurizio Taddei</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Serena++Ferrini">Serena Ferrini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Giannotti">Luca Giannotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Massimo++Corsi">Massimo Corsi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabrizio++Manetti">Fabrizio Manetti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Giannini">Giuseppe Giannini</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Loredana++Vesci">Loredana Vesci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ferdinando+M.++Milazzo">Ferdinando M. Milazzo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Domenico++Alloatti">Domenico Alloatti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mario+B.++Guglielmi">Mario B. Guglielmi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Massimo++Castorina">Massimo Castorina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+L.++Cervoni">Maria L. Cervoni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marcella++Barbarino">Marcella Barbarino</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosanna++Foder%C3%A0">Rosanna Foderà</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valeria++Carollo">Valeria Carollo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudio++Pisano">Claudio Pisano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Armaroli">Silvia Armaroli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Walter++Cabri">Walter Cabri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dipartimento di Biotecnologie, Chimica e Farmacia, Università degli Studi di Siena, Via A. Moro 2, I-53100 Siena, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">R&D Sigma-Tau Industrie Farmaceutiche Riunite S.p.A., Via Pontina Km 30,400, I-00040, Pomezia, Roma, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Sigma-Tau Research Switzerland S.A., Via Motta, 2a, CH-6850 Mendrisio-Stazione, Switzerland</span></div><div class="corresp-info"><strong>*</strong>M.T.: phone, +39-0577234275; fax, +39-0577234333; e-mail, <a href="/cdn-cgi/l/email-protection#94f9f5e1e6fdeefdfbbae0f5f0f0f1fdd4e1fafde7fdbafde0"><span class="__cf_email__" data-cfemail="204d415552495a494f0e54414444454960554e4953490e4954">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>G.G.: phone, +39-0691394441; fax, +39-0691393638; e-mail, <a href="/cdn-cgi/l/email-protection#4e29273b3d2b3e3e2b6029272f20202720270e3d2729232f633a2f3b60273a"><span class="__cf_email__" data-cfemail="2d4a44585e485d5d48034a444c43434443446d5e444a404c00594c58034459">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401536b&amp;href=/doi/10.1021%2Fjm401536b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2258–2274</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 3, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 October 2013</li><li><span class="item_label"><b>Published</b> online</span>17 March 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401536b" title="DOI URL">https://doi.org/10.1021/jm401536b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2258%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaurizio%2BTaddei%252C%2BSerena%2BFerrini%252C%2BLuca%2BGiannotti%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D6%26contentID%3Djm401536b%26title%3DSynthesis%2Band%2BEvaluation%2Bof%2BNew%2BHsp90%2BInhibitors%2BBased%2Bon%2Ba%2B1%252C4%252C5-Trisubstituted%2B1%252C2%252C3-Triazole%2BScaffold%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2274%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401536b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2584</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401536b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maurizio&quot;,&quot;last_name&quot;:&quot;Taddei&quot;},{&quot;first_name&quot;:&quot;Serena&quot;,&quot;last_name&quot;:&quot;Ferrini&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Giannotti&quot;},{&quot;first_name&quot;:&quot;Massimo&quot;,&quot;last_name&quot;:&quot;Corsi&quot;},{&quot;first_name&quot;:&quot;Fabrizio&quot;,&quot;last_name&quot;:&quot;Manetti&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Giannini&quot;},{&quot;first_name&quot;:&quot;Loredana&quot;,&quot;last_name&quot;:&quot;Vesci&quot;},{&quot;first_name&quot;:&quot;Ferdinando&quot;,&quot;last_name&quot;:&quot;M. Milazzo&quot;},{&quot;first_name&quot;:&quot;Domenico&quot;,&quot;last_name&quot;:&quot;Alloatti&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;B. Guglielmi&quot;},{&quot;first_name&quot;:&quot;Massimo&quot;,&quot;last_name&quot;:&quot;Castorina&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;L. Cervoni&quot;},{&quot;first_name&quot;:&quot;Marcella&quot;,&quot;last_name&quot;:&quot;Barbarino&quot;},{&quot;first_name&quot;:&quot;Rosanna&quot;,&quot;last_name&quot;:&quot;Foderà&quot;},{&quot;first_name&quot;:&quot;Valeria&quot;,&quot;last_name&quot;:&quot;Carollo&quot;},{&quot;first_name&quot;:&quot;Claudio&quot;,&quot;last_name&quot;:&quot;Pisano&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Armaroli&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;Cabri&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;2258-2274&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401536b&quot;},&quot;abstract&quot;:&quot;Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycumene scaffold with differently substituted aryl propiolates gave a new family of 1,4,5-trisubstituted triazole carboxylic acid derivatives that showed high affinity toward Hsp90 associated with cell proliferation inhibition, both in nanomolar range. The 1,5 arrangement of the resorcinol, the aryl moieties, and the presence of an alkyl (secondary) amide in position 4 of the triazole ring were essential to get high activity. Docking simulations suggested that the triazoles penetrate the Hsp90 ATP binding site. Some 1,4,5-trisubstituted triazole carboxamides induced dramatic depletion of the examined client proteins and a very strong increase in the expression levels of the chaperone Hsp70. In vitro metabolic stability and in vivo preliminary studies on selected compounds have shown promising results comparable to the potent Hsp90 inhibitor NVP-AUY922. One of them, (compound 18, SST0287CL1) was selected for further&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401536b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401536b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401536b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401536b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401536b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401536b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401536b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401536b&amp;href=/doi/10.1021/jm401536b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401536b" /></input><a href="/doi/pdf/10.1021/jm401536b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401536b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401536b%26sid%3Dliteratum%253Aachs%26pmid%3D24588105%26genre%3Darticle%26aulast%3DTaddei%26date%3D2014%26atitle%3DSynthesis%2Band%2BEvaluation%2Bof%2BNew%2BHsp90%2BInhibitors%2BBased%2Bon%2Ba%2B1%252C4%252C5-Trisubstituted%2B1%252C2%252C3-Triazole%2BScaffold%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D6%26spage%3D2258%26epage%3D2274%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291235" title="Column chromatography">Column chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jmcmar.2014.57.issue-6/production/jmcmar.2014.57.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Ruthenium catalyzed 1,3-cycloaddition (click chemistry) of an azido moiety installed on dihydroxycumene scaffold with differently substituted aryl propiolates gave a new family of 1,4,5-trisubstituted triazole carboxylic acid derivatives that showed high affinity toward Hsp90 associated with cell proliferation inhibition, both in nanomolar range. The 1,5 arrangement of the resorcinol, the aryl moieties, and the presence of an alkyl (secondary) amide in position 4 of the triazole ring were essential to get high activity. Docking simulations suggested that the triazoles penetrate the Hsp90 ATP binding site. Some 1,4,5-trisubstituted triazole carboxamides induced dramatic depletion of the examined client proteins and a very strong increase in the expression levels of the chaperone Hsp70. In vitro metabolic stability and in vivo preliminary studies on selected compounds have shown promising results comparable to the potent Hsp90 inhibitor NVP-AUY922. One of them, (compound <b>18</b>, SST0287CL1) was selected for further investigation as the most promising drug candidate.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24527" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24527" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Heat shock protein 90 (Hsp90) is a ubiquitous and abundant ATP-dependent molecular chaperone representing about 1–2% of the whole cytosolic proteomic load,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> increasing up to ∼4–6% under stress conditions.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Hsp90 is a protein highly conserved from bacteria to mammals, and it is documented to interact with more than 200 different “client” proteins involved in signal transduction, protein trafficking, receptor maturation, and innate and adaptive immunity.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> The main Hsp90 role is to promote the protein folding and the late-stage of maturation. Most of the so-called oncoproteins are Hsp90 clients.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Consequently, Hsp90 has emerged as an interesting molecular target for developing new anticancer agents against several solid and hematological malignancies as well as toward leukemia stem cells.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Moreover, up-regulation of Hsp90 in several solid tumors likely unveils a “protective” role in tumorigenesis, thus confirming the key role of this chaperone protein in cancer cell growth and survival.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Besides, recent findings suggest a connection between Hsp90 and cytotoxic drug resistance.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Finally, Hsp90 would also seem to have higher affinity toward small-molecule inhibitors in tumor cells than in normal cells.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Taken together, all these data point out Hsp90 as an attractive therapeutic target for cancer.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Although the target has been validated using the natural products geldanamycin and radicicol (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), to date, there are no FDA approved Hsp90-targeting agents for human use. Currently, more than 10 Hsp90 inhibitors are in different stages of clinical trials and an impressive growth in scientific and patent literature confirms the great interest toward this pharmacologic target from the academic and the pharmaceutical industry.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Hsp90 inhibitor activity is mainly promoted by a competition with ATP binding to the N-terminus of the protein, although some inhibitors act through a noncompetitive mechanism.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Most of the drugs actually in clinical trials are active through the ATP-competitive mechanism, and some recent reviews collect most of the information on these molecules.<a onclick="showRef(event, 'ref10 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref10 ref13 ref14">(10, 13, 14)</a> However, regardless of the chemical scaffolds, the new Hsp90 inhibitors have benefited greatly from structure-based design using available X-ray cocrystal structures<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> of different molecules bound to the N-terminal domain of Hsp90, associated with innovative approaches like high-throughput screening, fragment-based screening, and virtual screening.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Despite the numerous efforts in developing new antitumor agents with Hsp90 inhibitory properties, the drugs currently under clinical investigation still show some critical limitations.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Therefore, a medical need in this field is still felt.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some selective Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In continuation of our interest in discovering new antitumor compounds,<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16-18)</a> we explored a new series of potential Hsp90 inhibitors having a 1,2,3-triazole scaffold. Although well-known in medicinal chemistry as a scaffold or a linker for diverse biomedical applications, 1,2,3-triazoles have never been investigated as core structures of heterocycles Hsp90 inhibitors. This fact is even more surprising, since parent heterocycles such as isoxazole,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> 1,2,3-thiadiazole,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> or 1,2,4 triazoles<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> have been very successful in targeting the ATP binding site of Hsp90.</div><div class="NLM_p last">After a preliminary exploration of the influence of substituent arrangement around the heterocycle on the activity as Hsp90 inhibitor, we report here the selective synthesis of various 1,4,5 trisubstituted 1,2,3-triazoles and their complete characterization as potent Hsp90 inhibitors with promising results in terms of metabolic stability and in vivo activity. From previous work on inhibitors of the Hsp90 ATP binding site,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> it is known that the presence of a resorcinol-like fragment is extremely important to drive the binding mode and to get a strong interaction with the enzyme. One of the resorcinol hydroxyl groups displaces one water molecule required for substrate binding in the ATP region, while the other phenolic group contributes to a hydrogen bond network with the Asp93 residue. Starting from preliminary computational fitting experiments of different triazole-based molecules on the Hsp90 X-ray structure,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> we decided to keep the resorcinol fragment in position 1 of the triazole and explore the substitution pattern at positions 4 and 5.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since 1,2,3-triazoles are suitably prepared by metal catalyzed [3 + 2] cycloaddition of azides and alkynes, the preparation of arylazide <b>1</b> was required. This novel molecule was prepared as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, starting from 2,4-dihydroxyacetophenone that was first protected as dibenzyl ether and then transformed<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> into alkene <b>2</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN followed by MePPh<sub>3</sub>Br, BuLi, THF; see ref  <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>. (b) H<sub>2</sub> (1 atm), Pd/C, EtOH, rt, 6 h followed by BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN reflux, 3 h (94% overall). (c) HNO<sub>3</sub> conc, AcOH, 70 °C, 30 min, (35%). (d) (i) SnCl<sub>2</sub>, HCl, EtOH, 80 °C, 3 h; (ii) <i>t</i>-BuONO, Me<sub>3</sub>SiN<sub>3</sub>, MeCN, rt, 12 h (75% over two steps).</p></p></figure><div class="NLM_p">Subsequent reduction followed by an additional step of benzylation of the phenolic OH (deprotected during reduction) gave compound <b>3</b>. The latter was selectively nitrated to give <b>4</b> which was then reduced and treated with TMSN<sub>3</sub> in the presence of <i>tert</i>-butyl nitrite to give the required azide <b>1</b> in good yield (75%). Azide <b>1</b> was submitted to Cu(II) catalyzed cycloaddition with phenylacetylene derivative <b>5</b>, giving compound <b>6</b> as a single regioisomer although in moderate yields (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The other regioisomer <b>7</b> was obtained via Ru catalysis (Cp*RuCl)<sub>4</sub> in good yields.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CuSO<sub>4</sub>, Na ascorbate, DMF, rt, 12 h (55%). (b) (Cp*RuCl)<sub>4</sub>, DMF, rt, 3 h (72%). (c) (i) MsCl, TEA, DCM, rt, 2–4 h; (ii) amine, DMF, Et<sub>3</sub>N, rt, 12 h. (d) BCl<sub>3</sub>, DCM, 0° C to rt, 2 h.</p></p></figure><div class="NLM_p">Alcohols <b>6</b> and <b>7</b> were therefore transformed into their corresponding mesylates which were submitted to nucleophilic displacement with <i>N</i>-phenyl- or <i>N</i>-benzylpiperidine. After the last removal of the phenolic benzyl protection, compounds <b>8</b>, <b>9</b>, <b>10</b>, and <b>11</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) were isolated in 65–85% yield and analyzed in an Hsp90 binding assay. Since the 1,5 disubstituted regioisomers appeared to be more active compounds than the corresponding 1,4 disubstitued triazoles (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), two alternative fragments were introduced in position 5 following the same synthetic procedure. Resulting compounds <b>12</b> and <b>13</b> showed even more encouraging Hsp90 binding properties in two-digit nanomolar range (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), confirming that the 1,5 arrangement around the 1,2,3-triazole ring was more profitable than 1,4 arrangement. However, the activity of compounds <b>10</b>–<b>13</b> against a selected panel of cancer cells was poor. Following experiences previously described in the literature,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> a carboxyamide was introduced in position 4. This kind of arrangement (1-aryl, 5-aryl, 4-carboxy, 1,2,3-triazole) has been scarcely studied, and only few examples of regiocontrolled preparation of trisubstituted 1,2,3-triazoles have been described in the literature.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Alkyne <b>5</b> was protected with TBDMSCl and, after deprotonation with LiHDMS, coupled with methyl chloroformate to give compound <b>14</b> in good yields, the latter being the key intermediate toward the synthesis of the carboxamide variants of <b>10</b>–<b>13</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity Data of 1,4- or 1,5-Disusbstituted Triazoles</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Binding to Hsp90 was determined by a fluorescence polarization (FP) assay and cytotoxicity on NCI-H460 non-small-cell lung carcinoma cells. Data are expressed as IC<sub>50</sub> mean values (±SD, <i>n</i> = 4) and are in nanomolar concentrations. For the detection limits of the FP assay, see ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</p></div></div><div></div></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBDMSCl, imidazole, DMF, rt, 12 h. (b) LiHDMS, MeOCOCl, THF, −78 °C (76% over two steps). (c) (Cp*RuCl)<sub>4</sub> DMF, rt, 12 h, (68%). (d) TBAF, THF, rt, 2 h (80%). (e) CBr<sub>4</sub>, PPh<sub>3</sub>, DCM, rt, 3 h (87%). (f) MsCl, Et<sub>3</sub>N, DCM, 0 °C, then rt for 12 h (90% crude). (g) Secondary amine, Et<sub>3</sub>N, DMF, rt. (h) Ethylamine, MeOH 80 °C, 48 h. (i) H<sub>2</sub> (1 atm), Pd(OH)<sub>2</sub> cat., 4 h, rt. (j) Primary amine Et<sub>3</sub>N, DMF, rt.</p></p></figure><div class="NLM_p">In fact, the Ru catalyzed cycloaddition of <b>14</b> with azide <b>1</b> proceeded with complete regioselectivity giving exclusively the isomer with the -COOMe opposite the residue coming from the azide (compound <b>15</b> in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The coordination between the carboxylate and the Ru probably makes it the most hindered group, consequently orienting the transition state toward compound <b>15</b>. Removal of the TBDMS group gave alcohol <b>16</b> that, after transformation into the corresponding mesylate, was submitted to reaction with different secondary amines that gave the expected mesylate displacement. After a further transformation of the methylcarboxylate in position 4 into ethylamide and removal of the benzylic protection, compounds <b>18</b>–<b>29</b> (entries 2–15 in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were obtained in good yields. However, when the reaction between the mesylate derived from <b>16</b> and a primary amine was attempted, the corresponding secondary amines were isolated in very poor yield. Thus, the procedure was slightly modified, transforming first the benzyl alcohol <b>16</b> into the corresponding benzyl bromide <b>17</b>. On this substrate, the nucleophilic displacement with the primary amines worked well and, after the synthetic sequence outlined above, compounds <b>30</b>–<b>35</b> (entries 16–21 in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were isolated in acceptable overall yields. With the aim of also exploring the influence of different substituents in position 4, morpholine was introduced on alcohol <b>16</b> and the corresponding methylcarboxylate <b>36</b> reacted with different amines to give, after phenolic hydroxyl group deprotection, amides <b>37</b>–<b>43</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and entries 22–28 in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Finally, in order to verify the possibility of getting an active prodrug, compound <b>18</b> was acetylated to give <b>44</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activity Data for 1,4,5-Trisubstituted 1,2,3-Triazole Carboxamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0014.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0015.gif" alt="" id="GRAPHIC-d2348e764-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Binding to Hsp90 was determined by a fluorescence polarization (FP) assay and cytotoxicity on NCI-H460 non-small-cell lung carcinoma cells. Data are expressed as IC<sub>50</sub> mean values (±SD, <i>n</i> = 4) and are in nanomolar concentrations. For the detection limits of the FP assay, see ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>.</p></div></div><div></div></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) MsCl, Et<sub>3</sub>N, DCM, 0 °C then rt for 12 h. (b) Morpholine, Et<sub>3</sub>N, DMF, rt, 12 h (75% over two steps). (c) (i) LiOH in THF H<sub>2</sub>O; (ii) (COCl)<sub>2</sub>; (iii) primary or secondary amine; (iv) BCl<sub>3</sub> in DCM, 0°C to rt (31% over three steps).</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We systematically investigated several molecules for their affinity to human Hsp90 and their antiproliferative activity on two tumor cell lines (NCI-H460 non-small-cell lung carcinoma and A431 epidermoid carcinoma cells). As shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, all the compounds showed appreciable binding to recombinant human Hsp90α protein in a fluorescence polarization (FP) assay (see Note S1 in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), with potency similar to or even higher than NVP-AUY922, one of the most active reference compounds.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In general, tertiary amines showed better binding than secondary analogues except in the case of the cyclohexylmethylamine containing derivatives <b>30</b> and <b>31</b> that retained a binding in the single-digit nanomolar concentration. Among tertiary amines, better results were obtained introducing a morpholine fragment (compound <b>18</b>, SST0287CL1), also present in the reference product. Analogously, piperazine derivatives <b>26</b> and <b>27</b> and the 4-amino substituted piperidine <b>28</b> have a high affinity with Hsp90. It is worth noting that the piperidine derivative <b>20</b> is at least 4 times less active than the corresponding morpholine or pirrolidine containing compounds <b>18</b> and <b>21</b>. Analogously, the presence of an aliphatic cycle in position 5 of the triazole is not mandatory for the activity if a second polar group is present (compare <b>25</b> and <b>18</b>). Regarding position 4, some variations of the substitution pattern are tolerated. The introduction of groups with more than four atoms (<b>38</b>) or with different functional group (<b>37</b>) causes only a partial reduction in the binding (33 and 17 nM, respectively). A significantly lower affinity is found when a cyclic substituent (<b>39</b>–<b>41</b>) or a branched side chain (<b>42</b>) is introduced. Although the presence of a substituted carboxamide is indispensable to get an acceptable level of cytotoxicity, the influence of the substituent nature on this property was more difficult to rationalize. Finally, while acetylation of the OH prevents the binding to Hsp90 (>1000 nM), the cytotoxicity of <b>44</b> is still comparable with that of the parent compound <b>18</b> (6.5 vs 4 nM, respectively), suggesting the possibility to intervene on this part of the molecule in order to improve the pharmacokinetic profile of the product.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">The cytotoxicity activity of some compounds of the series was comparable to that of the reference product NVP-AUY922, although they showed higher affinity to Hsp90 due to the many variables associated with a complex system such as a cell. In particular, <b>18</b>, <b>21</b>, and <b>31</b> were active toward NCI-H460 cells at one-digit nanomolar concentration. This antiproliferative activity trend of 1,2,3-triazole derivatives was confirmed by results obtained on an extensive panel of tumor cell lines by means of a sulforhodamine B (SRB) colorimetric test. The most active derivatives inhibited growth of all tumor cell lines evaluated irrespective of cancer types or genetics (see <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>). Tumor cell lines were selected based on their peculiar genotype, with particular attention to expression of key wild type or mutated Hsp90 client proteins or with the aim of covering a wide array of tumor types (see <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>) .</div><div class="NLM_p">In order to have a more precise picture of the interaction mode of our compounds with Hsp90, docking simulations were performed using the complex between the N-terminal domain of Hsp90α and NVP-AUY922 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI">2VCI</a>) as a template. Energy minimization of the resulting docked complexes showed triazole derivatives in an orientation almost identical to that of the reference inhibitor, with slight differences in the interaction pattern, the triazole N2 being involved in a water-bridged hydrogen bond with the carboxy terminus of Asp93.</div><div class="NLM_p">The resorcinol hydroxyl group at position 2 shows both direct and water-mediated hydrogen bonds with the carboxyl terminus of Asp93. In a similar way, the second resorcinol hydroxyl group is involved in water-mediated hydrogen bonds with both the carboxyl terminus of Asp93 and hydroxyl group of Ser52. A direct hydrogen bond is also found between the Ser52 OH and the Asp93 carboxyl moiety. The isopropyl group of the inhibitor is embedded within a large hydrophobic cavity delimited by Leu48, Leu107, Thr109, Phe138, Val150, and Val186. The NH and CO portions of the C4 amide group are anchored by hydrogen bond interactions with the Gly97 carbonyl and the terminal ammonium group of Lys58, respectively, while the terminal ethyl chain of the ligand is exposed to solvent and shows lipophilic contact with the side chain of Ile96 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stereographical representation of the complex between Hsp90 and <b>18</b> (ball and stick notation) as derived from molecular docking calculations and energy minimization (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI">2VCI</a>, 2.0 Å resolution). The triazole core and the resorcinol hydroxyl groups are involved in an extended network of water-bridged hydrogen bonds. The morpholine solubilizing group is exposed to the solvent and is able to block a water molecule. For the sake of clarity, only few amino acids are displayed and labeled, together with several water molecules (W). Hydrogen bond contacts are depicted as black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A structural motif that significantly contributes to the stability of the complex is constituted by an additional network of charge-reinforced hydrogen bond interaction involving the protonable portion of the ligand (i.e., the basic nitrogen atom of morpholine, piperidine, pyrrolidine, and acyclic amino groups), the Asp54 carboxy terminus and the ammonium group of Lys58. The terminal portion of the substituent at C5, beyond the benzyl moiety and usually corresponding to a solubilizing functionality (such as morpholine, piperidine, pyrrolidine, etc.), is pointing toward solvent and does not show any contact with the protein apart from the interaction between the protonated nitrogen (if present) and the carboxy terminus of Asp54. Depending on the terminal substituent, a different number of water molecules can be recruited.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">An analysis of molecular interactions between Hsp90 and <b>18</b> in comparison to those found in the crystallographic complex with AUY922 does not allow us to justify the difference in affinity measured between the two compounds. However, docking simulations and energy minimization performed on the Hsp90–<b>18</b> complex are based on a molecular mechanics approach (OPLS force fields) that is, by definition, almost unable to account for electronic contribution to binding. A quantum mechanics treatment of the interactions between Hsp90 and its inhibitors, which is not among the purposes of this work, is more appropriate to attempt to justify differences in activity. For example, HOMO and LUMO amplitude and their spatial location as well as dipole moment are significantly different in triazoles in comparison to oxazole, thus suggesting a possibly different behavior toward a protein binding site.</div><div class="NLM_p">The next step was to establish whether the new ligands retain the well-established molecular signature of known Hsp90 inhibitors in terms of capacity to modulate cellular markers expression (client proteins). To this aim, the ability of selected compounds (i.e., <b>18</b>, <b>19</b>, <b>20</b>, <b>24</b>, <b>31</b>, <b>32</b>, <b>39</b>, and <b>44</b>) to down-regulate the expression of representative Hsp90 client proteins and to induce the expression of Hsp70 protein was determined in the A431 (human squamous cell carcinoma) cell line (overexpressing EGFR). Western blot analysis, after 24 h of exposure to several concentrations (dose–response curves) of selected test compounds, indicated the expected depletion of the client proteins EGFR, CDK4, and Akt, as well as the induction of Hsp70 in a dose-dependent manner, thus confirming the efficacy of these compounds as novel potent Hsp90 inhibitors (Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and <a class="ref internalNav" href="#notes-1" aria-label="Figure S1">Figure S1</a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analysis of Hsp90 client protein levels (EGFR, Akt, CDK-4) and Hsp70 in A431 tumor cells treated with compound <b>19</b> vs17-DMAG and NVP-AUY922. Total cellular extracts were obtained 24 h after treatment. Actin is shown as a control for protein loading. A representative blot is shown. Results of densitometry analysis were reported as normalized (to β-actin) ratios. Western blot experiments were performed at least twice resulting in similar results.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Western blot analysis of Hsp90 client protein levels in A431 tumor cells treated with the lead compound <b>18</b> vs its diacetyl prodrug (<b>44</b>). Analysis was performed as described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">According to the previous data, <b>18</b> appeared to have the most interesting profile, displaying the ability to bind Hsp90 with an affinity comparable to (or even better than)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a>  that of the reference compound, associated with a strong antiproliferative activity. Furthermore, <b>18</b> caused dramatic depletion of typical Hsp90 client proteins in A431 cells, associated with a very strong increase in the expression levels of the chaperone Hsp70, consistent with inhibition of Hsp90 function (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). In addition, as reported in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, the diacetyl derivative <b>44</b> displayed an extremely reduced ability to bind to recombinant Hsp90α in the FP assay, without significant changes in its antiproliferative efficacy, as a consequence of the Hsp90 chaperone inhibitory property of its putative metabolite (<b>18</b>), also confirmed by the impressive effect on depletion of client proteins and on increase of Hsp70 levels.</div><div class="NLM_p">Flow cytometric analysis revealed that both <b>18</b> and NVP-AUY922 caused cell cycle arrest in G2/M upon treatment of NCI-H460 NSCLC cells, and a massive induction of apoptosis was triggered over the recovery times (<a class="ref internalNav" href="#notes-1" aria-label="Figure S2 and Table S2">Figure S2 and Table S2</a>).</div><div class="NLM_p">Subsequently, the antitumor efficacy of compounds <b>18</b> and <b>19</b> was evaluated in two tumor xenograft models (A431 epidermoid carcinoma and GTL-16 gastric carcinoma, overexpressing EGFR and c-Met, respectively). Both compounds, delivered intraperitoneally for 2 weeks according to the schedule q2d/wx2w or q4d/wx2w, were able to induce a significant tumor volume inhibition of about 40% (<i>P</i> < 0.05). Moreover, the compounds were shown to be well-tolerated, since a little variation of body weight loss was found except when the molecules were evaluated against GTL-16 which was a cachectic tumor xenograft (also the vehicle treated group revealed a significant body weight loss) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The reference compound was evaluated at a higher dose according to the schedule qdx5/wx2w, which was the maximum tolerated dose to investigate its efficacy (see Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). It is noteworthy that compounds <b>18</b> and <b>19</b> were administered at a total dose 6- to 10-fold lower than that used for NVP-AUY922. Its antitumor efficacy was lower than that found with <b>18</b> and <b>19</b> against A431 xenograft and comparable against GTL-16 tumor xenograft model, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antitumor efficacy of compounds <b>18</b> and <b>19</b> delivered intraperitoneally in comparison with NVP-AUY922 against A431 epidermoid carcinoma (overexpressing EGF receptor) (A, B) and GTL-16 gastric carcinoma (overepressing c-Met) (C), xenografted sc in nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antitumor Activity of <b>18</b> Administered ip (with Schedule q2d/wx2w) and of <b>19</b> Given ip (Schedule q4d/wx2w) on A431 Epidermoid Carcinoma and GTL-16 (Gastric Carcinoma) Cells Implanted Subcutaneously on CD-1 Nude Mice<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">BWL (%)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">lethal toxicity<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">TVI%<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center">A431 Epidermoid Carcinoma</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0/8</td><td class="colsep0 rowsep0" align="left">49<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0/8</td><td class="colsep0 rowsep0" align="left">45<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="5" align="center">GTL-16 Gastric Carcinoma<a class="ref internalNav" href="#t3fn7" aria-label="g">g</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">0/8</td><td class="colsep0 rowsep0" align="left">42<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">0/8</td><td class="colsep0 rowsep0" align="left">42<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Treatment started 3 days after tumor injection. Efficacy of drugs was evaluated 5 days after the last treatment.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Intraperitoneal dose (mg/(10 mL/kg)) used in each administration.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Maximum BWL percentage due to the drug treatment.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Dead/treated animals.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">TVI% versus control mice.</p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last"><i>P</i> < 0.05 vs vehicle-treated group (Mann–Whitney test).</p></div><div class="footnote" id="t3fn7"><sup>g</sup><p class="last">Tumor xenograft induced cachexia.</p></div></div></div><div class="NLM_p">To validate that the in vivo antitumor effect of test compounds was effectively related to the inhibition of Hsp90, the modulation of selected Hsp90 client proteins was assessed by Western blot in tumor xenografts a few hours after the last treatment. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, <b>18</b> induced a very strong decrease in the protein levels of three typical client proteins (EGFR, Akt, and Cdk4) in A431 tumor cell lysates and, at the same time, significantly increased the expression levels of the chaperone Hsp70, with a potency comparable to that of the reference compound (NVP-AUY922). Similar results were observed on the same animal model with compound <b>19</b> (data not shown).</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Analysis of Hsp90 client protein levels (EGFR, Akt, CDK-4, c-Met) and Hsp70 in A431 (A) and GTL-16 (B) tumor xenografts, following treatment with <b>18</b> and <b>19</b>, with respect to the reference compound (NVP-AUY922). Total proteins were purified 2 h (in the case of A431 tumors) or 6 h (in the case of GTL-16 tumors) after the last treatment. Actin is shown as a control for protein loading. Representative blots of two tumor samples/group are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The human gastric carcinoma cell line GTL-16 is characterized by the overexpression of c-Met (HGF receptor) protein, which is another key cellular protein tightly regulated by Hsp90.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> For this reason, c-Met expression was also evaluated, instead of EGFR, in GTL-16 tumor xenografts in order to check the in vivo efficacy of <b>18</b> and <b>19</b>. Also, in this animal model our compounds were shown to potently inhibit Hsp90, resulting in strong down-regulation of the selected client proteins and induction of Hsp70, with a similar behavior compared to the reference compound (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">In addition, our best candidate (<b>18</b>) showed a plasma stability comparable to that of the reference compound as shown by a quantitative LC/MS assay performed at 120 min (65% and 56%, respectively) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Plasma Stability of Lead Compound <b>18</b> vs Reference Compound<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">plasma stability (%) at 120 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NVP-AUY922</td><td class="colsep0 rowsep0" align="left">65.5 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">56.1 ± 2.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data represent the mean ± SD of a representative experiment.</p></div></div></div><div class="NLM_p">Finally, starting from the observation that a long chain residue installed on the amide did not significantly reduce the activity, a new derivative with a hydroxamic acid group on the hexamethylene chain was synthesized (compound <b>43</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This group is a zinc binding group widely used in histone deacetylase (HDAC) inhibitors to coordinate the Zn ion located within the enzymatic site. The introduction of the HDAC binding arm fragment on a chemical structure already active on HSP90 did not reduce the binding activity too much (31 nM), although it was associated with a reduction of the cytotoxic activity (>1 μM). On the other hand, <b>43</b> was also investigated as HDAC inhibitor on a panel of 10 isolated human HDAC isozymes (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The assays were done in the presence of a fluorogenic peptide bound to the RHKK(Ac) fragment of p53 (residues 379–392), as the substrate, and using SAHA as the reference compound (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Surprisingly, in addition to a good affinity to Hsp90, <b>43</b> also demonstrated a high selectivity toward the HDAC6 isoform. HDAC6 is predominantly a cytoplasmic, microtubule-associated member of the class IIB HDAC family, which is directly involved in controlling the HSP90 acetylation degree and function. Depletion of HDAC6 activity has been reported to affect HSP90 function in tumor cells.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These preliminary data support <b>43</b> as an interesting lead compound for further studies in the dual targeting HDAC/Hsp90 inhibition approach.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Different HDAC Isoform Inhibitory Activity (IC<sub>50</sub>, μM) of <b>43</b>, an HDAC/Hsp90 Dual Inhibitor, Compared with Suberoylamide Hydroxamic Acid (SAHA)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0016.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="11" align="center">HDAC isoform</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">1</th><th class="colsep0 rowsep0" align="center">2</th><th class="colsep0 rowsep0" align="center">3</th><th class="colsep0 rowsep0" align="center">4</th><th class="colsep0 rowsep0" align="center">5</th><th class="colsep0 rowsep0" align="center">6</th><th class="colsep0 rowsep0" align="center">7</th><th class="colsep0 rowsep0" align="center">8</th><th class="colsep0 rowsep0" align="center">9</th><th class="colsep0 rowsep0" align="center">10</th><th class="colsep0 rowsep0" align="center">11</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">3.10</td><td class="colsep0 rowsep0" align="left">5.61</td><td class="colsep0 rowsep0" align="left">2.79</td><td class="colsep0 rowsep0" align="left">71.50</td><td class="colsep0 rowsep0" align="left">1.91</td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left">45.50</td><td class="colsep0 rowsep0" align="left">0.717</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.22</td><td class="colsep0 rowsep0" align="left">1.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SAHA (vorinostat)</td><td class="colsep0 rowsep0" align="left">0.26</td><td class="colsep0 rowsep0" align="left">0.92</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.493</td><td class="colsep0 rowsep0" align="left">0.378</td><td class="colsep0 rowsep0" align="left">0.029</td><td class="colsep0 rowsep0" align="left">0.344</td><td class="colsep0 rowsep0" align="left">0.243</td><td class="colsep0 rowsep0" align="left">0.316</td><td class="colsep0 rowsep0" align="left">0.456</td><td class="colsep0 rowsep0" align="left">0.362</td></tr></tbody></table></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Among different 1,4,5-trisubstituted 1,2,3-triazole carboxamides prepared by regioselective Ru-catalyzed Huisgen reaction, the triazole scaffold carrying a resorcinol moiety in position 1, an ethylcarboxamide in position 4, and an arylmethylamine in position 5 were demonstrated to have nanomolar binding to the N-terminus of Hsp90 and to induce cell death in different tumor cell lines. The antitumor activity of this class of compounds was demonstrated to proceed through Hsp90 inhibition, justified by a dramatic decrease in the levels of three typical client proteins (EGFR, Akt, and Cdk4) in A431 cell lysates and, at the same time, a strong increment of expression levels of the chaperone Hsp70. Results of fluorescence activated cell sorting analysis showed that compound <b>18</b> caused cell cycle arrest in G2/M upon treatment of NCI-H460 NSCLC cells and that a massive induction of apoptosis was triggered over the recovery times. Several cancer cell lines were sensitive to different members of the class. Moreover, results of in vivo experiments carried out on different tumor xenograft models in mice showed that <b>18</b> (SST0287CL1) induces a significant tumor volume inhibition and is well-tolerated, being active at a lower dose with respect to the reference compound. The diacetate derivative of the most active compound, maintaining a nanomolar cytotoxicity, suggests the possibility of modifying this region of the structure to improve pharmacokinetic properties and bioavailability. These results point out that easily affordable 1,4,5-trisubstituted 1,2,3-triazoles are useful scaffolds to build new Hsp90 inhibitors (including potential HDAC/Hsp90 dual inhibitors). Further investigations are in progress to optimize the dose–activity profile of the compounds and to investigate this class of molecules in other therapeutic areas related to Hsp90 inhibition.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Animals</h3><div class="NLM_p last">In vivo experiments were carried out using female athymic nude mice, 5–6 weeks old (Harlan). Mice were maintained in laminar flow rooms, keeping temperature and humidity constant. Mice had free access to food and water. Experiments were approved by the Ethics Committee for Animal Experimentation of Sigma-Tau according to institutional guidelines.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Xenograft Tumor Model</h3><div class="NLM_p">For subcutaneous (sc) tumor model, exponentially growing tumor cells (5 × 10<sup>6</sup>/100 μL) were sc inoculated in the right flank of nude mice. Mice were treated starting 3 days after tumor injection. Tumor volume (TV) was measured biweekly, and it was calculated according to the formula TV (mm<sup>3</sup>) = <i>d</i><sup>2</sup><i>D</i>/2, where <i>d</i> and <i>D</i> are the shortest and the longest diameter, respectively. The selected molecules were delivered intraperitoneally according to the schedule q2d/wx2w or q4d/wx2w. Drug efficacy was assessed as (i) tumor volume inhibition percentage (TVI%) in drug-treated versus control mice, expressed as TVI% = 100 – [(mean TV treated/mean TV control) × 100]. The days of TVI evaluation are reported in the Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Toxic effects of the drug treatment were assessed as the following: (i) body weight loss percentage (BWL%), calculated as BWL% = 100 – [(mean BW day <i>x</i>/mean BW day 1) × 100], where day 1 was the first day of treatment and day <i>x</i> was any day thereafter; the highest (max) BWL% is reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>; (ii) lethal toxicity, assessed as deaths occurring in treated mice before the death of the first control mouse.</div><div class="NLM_p last">The in vivo effect of selected inhibitors on the expression of typical Hsp90 client proteins was carried out by Western blotting, as described in the section <a class="ref internalNav" href="#sec5_6" aria-label="Client Protein Degradation Assay">Client Protein Degradation Assay</a>, on whole protein lysates that were prepared through homogenization of tumor samples (excised 2 or 6 h after the last treatment) in T-PER tissue protein extraction reagent (Pierce, Rockland, IL, U.S.), supplemented with 10 μg/mL protease inhibitor cocktail (Sigma Chemical Co., St. Louis, MO, U.S.).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Cell Lines and Culture Conditions</h3><div class="NLM_p last">The A431 epithelial carcinoma cell line (ATCC), the NCI-H460 non-small-cell lung carcinoma cell line (ATCC), the ovarian carcinoma cell line A2780 (ECACC), the MDA-MB436 breast carcinoma cell line (ATCC), the HeLa cervix uteri carcinoma cell line (Istituto Zooprofilattico di Brescia, Italy), and the NB4 promyelocytic leukemia cell line (DSMZ) were routinely grown in RPMI-1640 medium (Lonza, Vierviers, Belgium), supplemented with 10% (v/v) heat-inactivated fetal bovine serum (GIBCO, Invitrogen, Paisley, U.K.). The GTL-16 gastric carcinoma cell line (kindly provided by Metheresis Translational Research S.A.) and the MiaPaCa2 pancreas carcinoma cell line (ECACC) were grown in DMEM (Lonza, Vierviers, Belgium), supplemented with 10% (v/v) heat-inactivated fetal bovine serum (GIBCO). The U87MG glioblastoma cell line (ATCC), the A498 renal carcinoma cell line (ATCC), and the MeWo melanoma cell line (ECACC) were grown in EMEM (Lonza, Vierviers, Belgium), supplemented with 10% (v/v) heat-inactivated fetal bovine serum (GIBCO). The HCT-116 colon carcinoma cell line (Istituto Zooprofilattico di Brescia) was grown in McCoy’s 5A medium (Lonza, Vierviers, Belgium), supplemented with 10% (v/v) heat-inactivated fetal bovine serum (GIBCO).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Cellular Sensitivity to Drugs</h3><div class="NLM_p last">NCI-H460 non-small-cell lung carcinoma and A431 epidermoid carcinoma cell lines were grown in a volume of 200 μL at approximately 10% confluence in 96-well-plates and were allowed to recover for an additional 24 h. Tumor cells were treated with either varying concentrations of drugs or solvent for 72 h. The fraction of cells surviving after compound treatment was determined using the SRB assay. IC<sub>50</sub> values were defined as the drug concentration causing a 50% reduction in cell number compared with that of vehicle-treated cells and evaluated by the “ALLFIT” computer program by analyzing dose–response inhibition curves.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Binding on Hsp90 by a Fluorescence Polarization (FP) Assay</h3><div class="NLM_p last">The ability of test compounds to compete with a fluorescently labeled probe for binding to full-length recombinant human Hsp90α (catalog no. SPP-776 Stressgene, Victoria, BC, Canada) was determined by means of a suited fluorescence polarization assay, as previously described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> GM-FITC, supplied by Invivogen (06C23-MT, CA, USA), was used as probe. Fluorescence polarization (FP) measurements were performed on a multilabel reader (Wallac Envision 2101, Perkin Elmer, Zaventem, Belgium). Measurements were taken in Opti-Plate-96F well plates (Perkin Elmer, Zaventem, Belgium). The compounds were previously dissolved in DMSO and kept at −20 °C until use. On the day of experiment, serial dilutions of stock solutions were prepared in assay buffer (HFB) containing 20 mM HEPES, pH 7.3, 50 mM KCl, 5 mM MgCl<sub>2</sub>, 20 mM Na<sub>2</sub>MoO<sub>4</sub>, and 0.01% NP40. Bovine γ globulin (0.1 mg/mL) and 2 mM DTT were freshly added to the assay buffer immediately before use. Each assay was carried out by adding 50 μL of the GM-FTC solution (5 nM) to 30 nM of Hsp90 in the presence of 5 μL of the test compounds at increasing concentrations. The plates were heated at 4 °C for 4 h, and then the FP values in mP (millipolarization unit) were recorded. The IC<sub>50</sub> values were calculated as the inhibitor concentration allowing displacement of 50% of the tracer, through nonlinear least-squares analyses and curve fitting using the Prism GraphPad software program (GraphPad Software, Inc., San Diego, CA).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Client Protein Degradation Assay</h3><div class="NLM_p last">Client protein degradation was determined by Western blotting as previously described.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Twenty-four hours after seeding, A431 (human epidermoid carcinoma) cells were treated for 24 h with test compounds at various concentrations (dose–response curve), depending on their relative potency, and then processed to obtain whole-cell extracts. 17-DMAG (at a concentration of 0.2 μM) was used as internal reference inhibitor. Following treatment, cells were rinsed twice with ice-cold PBS and then lysed in RIPA buffer supplemented with protease and phosphatase inhibitors. Protein concentration was determined by the Bradford protein assay (Thermo Scientific, Rockford, IL, USA). Equal amounts of total proteins were separated through SDS–PAGE and then blotted onto nitrocellulose membranes. Nonspecific binding sites were blocked by incubation of the membranes with 5% nonfat dry milk in TBS, overnight at 4 °C. Membranes were finally probed with the following primary antibodies: anti-EGFR (Upstate Biotechnology, Millipore Corporate, Billerica, MA, USA), anti-Cdk4 (Santa Cruz Biotechnology Inc., CA, USA), anti-Akt (Cell Signaling Technology, Inc., MA, USA), anti-HSP70 (BRM-22), and anti-actin (Sigma Chemical Co., St. Louis, MO, USA). After extensive washings in TBS-T, membranes were incubated with appropriate dilutions of a horseradish peroxidase conjugated corresponding secondary antibody. Finally, immunoreactive bands were detected by means of the ECL Plus detection system (GE Healthcare Bio-Sciences, Uppsala, Sweden) and acquired by a phosphorimaging system (STORM 860; Molecular Dynamics, Sunnyvale, CA).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Plasma Stability</h3><div class="NLM_p last">Test compounds were added to human plasma to get a final concentration of 5 μM and incubated at 37 °C at different times (until 120 min). Then 0.1 mL of each sample was taken, added in a corresponding 2-fold amount of chilled acetonitrile, centrifuged at +4 °C. The supernatant was then submitted to LC–MS/MS analysis. At the end of incubation, the % of residual intact compound remaining was calculated.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Docking</h3><div class="NLM_p">The three-dimensional structure of Hsp90 in complex with a 4,5-diarylisoxazole inhibitor derived from X-ray crystallography (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI">2VCI</a>, 2.0 Å resolution)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> was used to create the initial coordinates for docking calculations. Protein Preparation Wizard (implemented within Maestro 9.2, Schroedinger, LCC) was used to prepare the protein structure, also adding hydrogen atoms and sampling water orientation. HOH2232, HOH2099, HOH2233, and HOH2115, which constitute a network of ordered and conserved water molecules, were kept for next calculations.</div><div class="NLM_p">For preliminary fitting calculations of different triazole-based molecules on the Hsp90 ATP binding site,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> inhibitor structures were prepared with LigPrep routine (implemented within Maestro 9.2, Schroedinger, LCC). Their conformations were generated by means of MacroModel, version 9.9 (Monte Carlo multiple minimum algorithm and an energy window of 10 kcal/mol), and docking calculations were performed with Glide (version 5.6). Final rescoring of best poses was carried out with Prime 2.2, MM-GBSA routine.</div><div class="NLM_p last">Since Glide only modifies the torsional internal coordinates of the ligand during docking, without taking into account the remaining geometric parameters, we chose to apply a conformational search/energy minimization protocol to study the interaction between Hsp90 and the new triazole inhibitors. In particular, the structure of the cocrystallized isoxazole inhibitor was replaced by that of triazole derivatives (built with LigPrep) and the resulting complexes were submitted to a statistical conformational search (10 000 steps of statistical pseudo Monte Carlo algorithm), sampling all the rotatable bonds of the inhibitors. Moreover, the overall structure of the ligand was allowed to rotate and translate within the Hsp90 binding site. A continuum solvation approach was also applied, with the OPLS_2005 force fields and the Polak–Ribiere conjugate gradient algorithm for energy minimization (derivative convergence 0.01 kcal Å<sup>–1</sup> mol<sup>–1</sup>). Only a substructure constituted by the inhibitor and a shell of amino acids within a 5 Å radius from the inhibitor was submitted to energy minimization while keeping fixed the remaining part of the complex.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p last">Reagents were purchased from commercial suppliers and used without further purification. <sup>1</sup>H NMR spectra were recorded at the field frequency and in the solvent indicated. Peak positions are given in parts per million downfield from tetramethylsilane as the internal standard. <i>J</i> values are expressed in hertz. LC–MS data were recorded on a Waters Micromass ZQ-2000 instrument or on a double-focusing Finnigan MAT 95 instrument with BE geometry. Thin layer chromatography (TLC) was carried out using Merck precoated silica gel F-254 plates. Flash chromatography was done using Merck silica gel 60 (0.063–0.200 mm), using light petroleum (bp 40–60 °C) PE. Solvents were dried according to standard procedures, and reactions requiring neutral atmosphere conditions were performed under argon. Solutions containing the final products were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure using a rotatory evaporator. All of the final products undergoing biological testing were >95% pure as demonstrated by analysis carried out with a Varian Prostar HPLC system equipped with an UV variable wavelength detector at 254 nm (column Gemini-NX C18 (150 mm × 4.8 mm, gradient A/B 95/5 to 50/50 in 15 min, A consisting of 0.1% formic acid in H<sub>2</sub>O, B consisting of 0.1% formic acid in acetonitrile, flow rate of 1.5 mL/min, room temperature).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2,4-Bis(benzyloxy)cumene (<b>3</b>)</h3><div class="NLM_p last">Pd/C (223 mg, 0.6 mmol) was added to a solution of <b>2</b> (4 g, 12.11 mmol)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> in ethanol (40 mL) at room temperature, and the mixture was hydrogenated (balloon, 1 atm) for 12 h. The catalyst was filtered out through Celite, and the ethanol was removed under reduced pressure. The residue was dissolved in CH<sub>3</sub>CN (25 mL), and K<sub>2</sub>CO<sub>3</sub> (7.00 g, 50.6 mmol) was added. The suspension was stirred for 15 min at room temperature. Benzyl bromide (5.49 mL, 50.6 mmol) was then added dropwise, and the reaction mixture was refluxed for 3 h. H<sub>2</sub>O (40 mL) was added, and the organic phase was extracted with EtOAc (3 × 30 mL). The organic phase was dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent removed. The title compound was obtained as a colorless solid (3.8 g, 94%). Mp 76–78 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.45–7.31 (m, 10 H), 7.11 (d, <i>J</i> = 8.4 Hz, 1 H), 6.60–6.53 (m, 2 H), 5.04 (s, 2 H), 5.02 (s, 2 H), 3.41–3.25 (m, 1 H), 1.21 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 157.9, 157.7, 136.6, 136.0, 129.2, 128.5, 128.4, 128.3, 127.9, 127.1, 126.6, 108.3, 102.3, 70.3, 70.0, 27.1, 23.3.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1- Nitro-2,4-bis(benzyloxy)cumene(<b>4</b>)</h3><div class="NLM_p last">HNO<sub>3</sub> (1.11 mL, 13.73 mmol) was added to a suspension of <b>3</b> (3.8 g, 11.44 mmol) in AcOH (46 mL), and the mixture was heated at 70 °C for 30 min. The solution was cooled to 0 °C and neutralized with aqueous NaHCO<sub>3</sub>. The organic phase was extracted with EtOAc, and the solvent was removed under reduced pressure. The crude was purified by flash chromatography (PE/EtOAc, 95/5 to 90/10), and the title compound was obtained as a yellow solid (1.51 g, 35%). Mp: 89–90 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.87 (s, 1 H), 7.43–7.31 (m, 10), 6.52 (s, 1 H), 5.14 (s, 2 H), 5.05 (s, 2 H), 3.30–3.23 (m, 1 H), 1.20 (d, <i>J</i> = 7.2 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 160.1, 156.8, 138.3, 136.6, 134.8, 129.1, 128.4, 127.9, 126.6, 125.9, 124.6, 98.7, 72.1, 70.3, 26.5, 22.8.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1- Azido-2,4-bis(benzyloxy)cumene (<b>1</b>)</h3><div class="NLM_p last">SnCl<sub>2</sub>·2 H<sub>2</sub>O (5.38 g, 23.85 mmol) and HCl (4.7 mL, 56.85 mmol) were added to a suspension of <b>4</b> (1.5 g, 3.98 mmol) in EtOH (38 mL). The mixture was heated at 80 °C for 3–4 h. Then it was cooled to 0 °C and NaOH (28 mL of a 20% water solution) was added. The separated salts were filtered through Celite and washed with EtOAc. The organic phase was extracted three times with EtOAc, and the solvent was evaporated. To the residue (1.10 g, 3.18 mmol, 80%) dissolved in CH<sub>3</sub>CN (40 mL) were added <i>t</i>-BuONO (2.25 mL, 19 mmol) and TMSN<sub>3</sub> (2 mL, 15.2 mmol), and the mixture was stirred for 1 h at 0 °C and for 12 h at room temperature. The solvent was evaporated, and the reaction crude was purified by flash chromatography (PE/EtOAc, 95/5 to 90/10). The title compound was obtained as a brown waxy material (890 mg, 75%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.40–7.31 (m, 10 H), 6.82 (s, 1 H), 6.52 (s, 1 H), 5.04 (s, 2 H), 4.96 (s, 2 H), 3.31–3.24 (m, 1 H), 1.16 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 157.8, 150.2, 139.3, 136.6, 132.6, 128.4, 127.8, 126.6, 125.6, 124.8, 117.7, 101.8, 70.3, 70.1, 26.3, 22.7. HRMS (ESI) calcd for C<sub>23</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>Na (M + Na)<sup>+</sup> 396.1688; found 396.1687.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-[2,4-Bis(benzyloxy)cumenyl]-4-[<i>p</i>-(hydroxymethyl)phenyl]-1<i>H</i>-1,2,3-triazole (<b>6</b>)</h3><div class="NLM_p last">Azide <b>1</b> (100 mg, 0.27 mmol) was dissolved in DMF (1.5 mL) followed by (<i>p</i>-ethynylphenyl)methanol <b>5</b> (35 mg, 0.27 mmol), sodium ascorbate (5 mg, 0.027 mmol), and CuSO<sub>4</sub>·5H<sub>2</sub>O (0.67 mg, 0.0027 mmol). The mixture was stirred at room temperature for 12 h. Water and EtOAc were added. The organic layer was separated, dried over anhydrous MgSO<sub>4</sub> and the solvent evaporated. Column chromatography on silica gel (PE/EtOAc, 60/40) gave compound <b>6</b> as a waxy material (76 mg, 55%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.63 (m, 2H), 7.40–7.22 (m, 12 H), 6.66 (s, 1H), 5.08 (s, 2H), 5.05 (s, 2H), 4.72 (s, 2H), 3.35 (qn, <i>J</i> = 7 Hz, 1 H), 2.25 (bs, 1H), 1.23 (d, 6 H, <i>J</i> = 7 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 160.5, 156.4, 151.8, 142.5, 136.0, 135.9, 135.2, 128.7, 128.4, 128.0, 127.8, 127.6, 127.2, 126.5, 124.4, 123.8, 120.0, 112.1, 102.6, 70.1, 70.1, 64.2.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-[2,4-Bis(benzyloxy)cumenyl]-5-[<i>p</i>-(hydroxymethyl)phenyl]-1<i>H</i>-1,2,3-triazole (<b>7</b>)</h3><div class="NLM_p last">Azide <b>1</b> (890 mg, 2.38 mmol) was dissolved in DMF (5 mL), and (<i>p</i>-ethynylphenyl)methanol <b>5</b> (286 mg, 2.16 mmol) was added at room temperature. The flask was subjected to three vacuum–nitrogen cycles. Then [Cp*RuCl]<sub>4</sub> (116 mg, 0.11 mmol) was added followed by other three vacuum–nitrogen cycles. The mixture was stirred at room temperature for 6 h. EtOAc (10 mL) and water (20 mL) were then added. The organic phase was extracted four times with EtOAc (10 mL), washed with water (three times) and brine (one time), and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed, and the mixture was purified by column chromatography (PE/EtOAc, 60/40). The title compound was obtained as a purple oil (866 mg, 72%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.85 (s, 1 H), 7.36–7.14 (m, 13 H), 6.87–6.83 (m, 2 H), 6.45 (s, 1 H), 4.97 (s, 2 H), 4.71 (s, 2 H), 4.69 (s, 2 H), 3.32 (qn, <i>J</i> = 6.8 Hz, 1 H), 1.21 (d, 6 H, <i>J</i> = 6.8 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 157.65, 151.46, 141.66, 139.27, 136.42, 136.09, 131.75, 130.62, 128.61, 128.37, 128.04, 127.83, 127.62, 127.11, 126.95, 126.69, 126.48, 125.84, 118.56, 99.08, 70.71, 70.31, 64.60, 26.44, 22.57.</div></div><div id="sec5_15_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 4-(5-{<i>p</i>-[(4-Phenyl-1-piperazinyl)methyl]phenyl}-1<i>H</i>-1,2,3-triazol-1-yl)-1,3-cumenediol (<b>10</b>). General Procedure</h3><div class="NLM_p last">Et<sub>3</sub>N (160 μL, 1.17 mmol) and MsCl (90 μL, 1.17 mmol) were added to a solution of <b>7</b> (200 mg, 0.39 mmol) in DCM (5 mL) at 0 °C. The solution was stirred for 30 min at 0 °C and for 12 h at room temperature. The solvent was removed under reduced pressure, and the reaction crude was dissolved in DMF (2–3 mL). 1-Phenylpiperazine (189 mg, 1.17 mmol) and Et<sub>3</sub>N (160 μL, 1.17 mmol) were added, and the mixture was stirred for 12 h at room temperature. The mixture was diluted with H<sub>2</sub>O and EtOAc, and the organic phase was extracted with EtOAc (4 × 30 mL) and washed with H<sub>2</sub>O (2 × 30 mL) and with brine (2 × 30 mL). The solvent was evaporated, and the reaction crude was purified by passing through a silica gel cartridge, eluting with EtOAc. The fraction was collected, and the solvent was removed. The residue obtained was dissolved in dry DCM (3 mL), cooled to 0 °C, and BCl<sub>3</sub> (680 μL of a solution 1 M in DCM, 0.68 mmol) was added. The mixture was stirred for 2 h at room temperature. Saturated aqueous solution of NaHCO<sub>3</sub> was added (until the pH became slightly basic), and the organic phase was extracted with DCM (3 × 10 mL), washed with H<sub>2</sub>O, and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed under reduced pressure. The reaction crude was purified by column chromatography (DCM/MeOH, 90/10), and the title compound was obtained as a purple oil (157 mg 86%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.25 (bs, 1 H), 10.09 (bs, 1 H), 9.25 (s, 1 H), 7.44–7.35 (m, 6 H), 7.20–7.16 (m, 2 H), 6.90–6.88 (m, 2 H), 6.77–6.73 (m, 1 H), 6.51 (s, 1 H), 3.52 (s, 2 H), 3.15–3.07 (m, 5 H), 2.49–2.47 (m, 4 H), 1.09 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 150.2, 150.1, 149.9, 144.3, 138.5, 131.2, 130.1, 129.1, 127.0, 125.7, 122.2, 120.4, 120.3, 116.8, 105.6, 62.9, 53.7, 50.7, 25.3, 22.7. HRMS (ESI) calcd for C<sub>28</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub> (M + 1)<sup>+</sup> 470.2556; found 470.2554.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-(4-{<i>p</i>-[(4-Phenyl-1-piperazinyl)methyl]phenyl}-1<i>H</i>-1,2,3-triazol-1-yl)-1,3-cumenediol (<b>8</b>)</h3><div class="NLM_p last">Column chromatography was carried out with (DCM/MeOH, 90/10). The title compound was obtained as a dense gray oil (110 mg, 60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.03 (bs, 2H), 7.84–7.04 (m, 6H), 7.06–6.61 (m, 4H), 6.67–6.19 (m, 2H), 3.52 (s, 2H), 3.46–2.88 (m, 5H), 2.83–2.12 (m, 4H), 1.07 (d, <i>J</i> = 6.8 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 155.7, 151.8, 151.2, 150.2, 140.3, 129.1, 128.1, 126.7, 126.4, 124.1, 122.1, 120.3, 120.0, 116.8, 113.5, 100.5, 62.8, 56.7, 51.4, 23.3, 20.7. HRMS (ESI) calcd for C<sub>28</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub> (M + 1)<sup>+</sup> 470.2556; found 470.2553.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 4-(4-{<i>p</i>-[(4-Benzyl-1-piperazinyl)methyl]phenyl}-1<i>H</i>-1,2,3-triazol-1-yl)-1,3-cumenediol (<b>9</b>)</h3><div class="NLM_p last">Column chromatography was carried out with (DCM/MeOH, 90/10). The title compound was obtained as a purple oil (97 mg, 52%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.13 (bs, 2H), 7.77–7.06 (m, 10H), 6.56 (m 1H), 6.40 (s, 1H), 3.52 (s, 4H), 3.22(q, <i>J</i> = 7 Hz, 1H), 2.81–2.18 (m, 8H), 1.11 (d, <i>J</i> = 7 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>): δ 155.7, 151.8, 151.2, 140.6, 137.8, 129.2, 128.1, 128.1, 127.5, 126.7, 126.4, 124.1, 122.1, 120.0, 113.5, 100.5, 62.9, 62.7, 52.8, 51.5, 25.7, 21.4. HRMS (ESI) calcd for C<sub>29</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub> (M + 1)<sup>+</sup> 484.2713; found 484.2711.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 4-(5-{<i>p</i>-[(4-Benzyl-1-piperazinyl)methyl]phenyl}-1<i>H</i>-1,2,3-triazol-1-yl)-1,3-cumenediol (<b>11</b>)</h3><div class="NLM_p last">Column chromatography was carried out with (DCM/MeOH, 90/10). The title compound was obtained as a purple oil (158 mg, 85%). <sup>1</sup>H NMR (400 MHz, DMSO): δ 10.26 (bs, 1 H), 10.11 (bs, 1 H), 9.24 (s, 1 H), 7.43–7.29 (m, 10 H), 6.54 (s, 1 H), 3.48–3.31 (m, 6 H), 3.13–3.06 (m, 1 H), 2.42–2.32 (m, 6 H), 1.08 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, DMSO): δ 150.1, 149.9, 144.3, 138.7, 137.8, 131.1, 130.1, 129.2, 128.1, 127.5, 127.0, 127.0, 125.7, 122.2, 120.4, 105.6, 62.9, 62.7, 52.8, 25.3, 22.7. HRMS (ESI) calcd for C<sub>29</sub>H<sub>34</sub>N<sub>5</sub>O<sub>2</sub> (M + 1)<sup>+</sup> 484.2713; found 484.2715.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-(5-{<i>p</i>-[(1-Morpholyl)methyl]phenyl}-1<i>H</i>-1,2,3-triazol-1-yl)-1,3-cumenediol (<b>12</b>)</h3><div class="NLM_p last">Column chromatography was carried out with (DCM/MeOH, 95/5). The title compound was obtained as a purple oil (105 mg. 68%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.92 (s, 1 H), 7.47 (s, 4 H), 7.20 (s, 1 H), 6.38 (s, 1 H), 4.90 (bs, 2 H), 3.82 (s, 2 H), 3.75–3.68 (m, 4 H), 3.25–3.12 (m, 1 H), 2.78–2.70 (m, 4 H), 1.15 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 150.1, 149.9, 144.3, 138.0, 131.1, 130.1, 127.1, 126.8, 125.7, 122.2, 120.4, 105.6, 67.1, 63.2, 53.8, 25.3, 22.7. HRMS (ESI) calcd for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub> (M + 1)<sup>+</sup>395.2083; found 395.2080.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(5-{<i>p</i>-[(3-Hydroxy-1-piperazinyl)methyl]phenyl}-1<i>H</i>-1,2,3-triazol-1-yl)-1,3-cumenediol (<b>13</b>)</h3><div class="NLM_p last">Column chromatography was carried out with (DCM/MeOH, 90/10). The title compound was obtained as a purple oil (105 mg, 66%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.93 (s, 1 H), 7.49 (s, 4 H), 7.21 (s, 1 H), 6.40 (s, 1 H), 4.88 (bs, 3 H), 3.90 (s, 2 H), 3.92–3.77 (m, 1 H), 3.24–3.12 (m, 1 H), 2.95–2.50 (m, 4 H), 1.90–1.40 (m, 4 H), 1.16 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 150.1, 149.9, 144.3, 139.3, 131.1, 130.1, 127.2, 126.6, 125.7, 122.2, 120.4, 105.6, 66.9, 66.8, 61.6, 55.4, 33.3, 25.3, 23.3, 22.7. HRMS (ESI) calcd for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 409.2240; found 409.2237.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Methyl 3-[<i>p</i>-(<i>tert</i>-Butyldimethylsilyloxymethyl)phenyl]propiolate (<b>14</b>)</h3><div class="NLM_p last">LiHMDS (5.8 mL of a solution 1 M in toluene, 5.8 mmol) was added to a solution of the <i>tert</i>-butyldimethylsilyl ether of <b>5</b> (820 mg, 3.33 mmol) in dry THF (28 mL) at −78 °C. The reaction mixture was slowly warmed to −40 °C and left for 1 h at this temperature. ClCOOMe (420 μL, 5.41 mmol) was dissolved in THF (9.6 mL) and cooled to −40 °C. The mixture prepared before was added to this solution via cannula, and the mixture was warmed to room temperature. A saturated solution of NH<sub>4</sub>Cl was added to the mixture reaction. The organic phase was extracted with EtOAc (3 × 20 mL) and dried. The solvent was removed under reduced pressure, and the reaction crude was purified by column chromatography (PE/EtOAc, 95:5). The title compound was obtained as a yellow oil that solidified on standing (0.769 g, 76%). Mp 56–58 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.51 (d, <i>J</i> = 8.0 Hz, 2 H), 7.30 (d, <i>J</i> = 8.0 Hz, 2 H), 4.72 (s, 2 H), 3.79 (s, 3 H), 0.91 (s, 9 H), 0.07 (s, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 154.0, 144.2, 132.5, 125.5, 117.4, 86.3, 79.7, 63.9, 52.2, 25.4, 17.9, −5.8.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 1-[2,4-Bis(benzyloxy)cumenyl]-5-[<i>p</i>-(<i>tert</i>-butyldimethylsilyloxymethyl)phenyl]-1<i>H</i>-1,2,3-triazole-4-carboxylate (<b>15</b>)</h3><div class="NLM_p last">Compound <b>14</b> (277 mg, 0.91 mmol) was added at room temperature to a solution of azide <b>1</b> (373 mg, 1 mmol), dissolved in DMF (2.5 mL). The flask was subjected to three vacuum–nitrogen cycles. Then [Cp*RuCl]<sub>4</sub> (49 mg, 0.045 mmol) was added and the reaction mixture was purged again three times. The reaction was left at room temperature until completion (12 h, monitored by TLC). EtOAc (20 mL) and water (10 mL) were then added. The organic phase was extracted four times with EtOAc, washed with water (three times) and brine (one time), and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was removed, and the mixture was purified by column chromatography (PE/EtOAc, 60/40). The title compound was obtained as a purple oil (419 mg, 68%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.31–7.16 (m, 13 H), 6.94 (d, <i>J</i> = 7.2 Hz, 2 H), 6.41 (s, 1 H), 4.92 (s, 2 H), 4.72 (s, 4 H), 3.82 (s, 3 H), 3.30–3.23 (m, 1 H), 1.13 (d, <i>J</i> = 6.8 Hz, 6 H), 0.93 (s, 9 H), 0.09 (s, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 161.3, 157.47 151.2, 142.6, 136.0, 135.7, 135.1, 129.8, 129.4, 128.12 128.1, 127.6, 127.5, 126.7, 126.4, 125.6, 124.9, 124.1, 117.1, 98.5, 70.2, 69.9, 64.1, 51.4, 25.9, 25.5, 22.1, 17.97, −5.66. HRMS (ESI) calcd for C<sub>40</sub>H<sub>47</sub>N<sub>3</sub>O<sub>5</sub>SiNa (M + Na)<sup>+</sup> 701.3217 (43.3%), 700.3183 (100%); found 701.3215 (43%), 700.3181 (100%).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Methyl 1-[2,4-Bis(benzyloxy)cumenyl]-5-[<i>p</i>-(hydroxymethyl)phenyl]-1<i>H</i>-1,2,3-triazole-4-carboxylate (<b>16</b>)</h3><div class="NLM_p last">TBAF (270 mg, 1.25 mmol) was added to a solution of <b>15</b> (460 mg, 0.68 mmol) in THF (4 mL), and the mixture was stirred for 2 h at room temperature. EtOAc (20 mL) was added, and the organic phase was washed with a saturated solution of NH<sub>4</sub>Cl and with H<sub>2</sub>O. After the mixture was dried over Na<sub>2</sub>SO<sub>4</sub>, the solvent was removed under reduced pressure and the reaction crude was purified by column chromatography (PE/EtOAc, 40:60). The title compound was obtained as a purple oil (310 mg, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.29–7.15 (m, 13 H), 6.93 (d, <i>J</i> = 6.8 Hz, 2 H), 6.37 (s, 1 H), 4.89 (s, 2 H), 4.70 (s, 2 H), 4.62 (s, 2 H), 3.79 (s, 3 H), 3.31–3.18 (m, 1 H), 1.12 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 161.35, 157.57, 151.25, 142.69, 142.59, 136.01, 135.64, 135.10, 129.92, 129.53, 128.27, 128.16, 127.70, 127.63, 126.78, 126.45, 125.74, 125.62, 124.30, 116.98, 98.40, 70.33, 69.91, 63.87, 51.66, 26.04, 22.20. HRMS (ESI) calcd for C<sub>34</sub>H<sub>33</sub>N<sub>3</sub>O<sub>5</sub>Na (M + Na)<sup>+</sup> 587.2352 (36.8%) 586.2318 (100%); found 587.2350 (36.6%) 586.2316 (100%).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Methyl 1-[2,4-Bis(benzyloxy)cumenyl]-5-[<i>p</i>-(bromomethyl)phenyl]-1<i>H</i>-1,2,3-triazole-4-carboxylate (<b>17</b>)</h3><div class="NLM_p last">Triphenylphosphine (1.45 g, 5.54 mmol) and carbon tetrabromide (1.84 g, 5.54 mmol) were added to a solution of alcohol <b>16</b> (2.4 g, 4.26 mmol) in dry DCM (48 mL) at 0 °C. The mixture was stirred at this temperature for 1 h. Then the solvent was removed under reduced pressure and the residue was purified by column chromatography (PE/EtOAc, 70/30). The title compound was obtained as a purple oil (2.32 g, 87%). However, the crude product could be directly employed in the next step without any chromatographic purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.40–7.16 (m, 13 H), 7.08–6.99 (m, 2 H), 6.41 (s, 1 H), 4.96 (s, 2 H), 4.71 (s, 2 H), 4.44 (s, 2 H), 3.89 (s, 3 H), 3.32–3.20 (m, 1 H), 1.16 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 161.2, 157.5, 151.0, 141.8, 138.6, 135.9, 135.6, 135.2, 130.1, 129.7, 128.6, 128.1, 127.6, 126.7, 126.4, 125.7, 125.5, 117.0, 98.5, 70.4, 69.9, 51.6, 32.3, 26.0, 22.1. HRMS (ESI) calcd for C<sub>34</sub>H<sub>32</sub>BrN<sub>3</sub>O<sub>4</sub>Na (M + Na)<sup>+</sup> 650.1454 (97.5%), 648.1474 (100%); found 650.1452 (97%), 648.1471 (100%).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> {1-[2,4-Dihydroxycumenyl]-5-[<i>p</i>-(4-morpholin-4-ylmethy)phenyl]-1<i>H</i>-1,2,3-triazol-4-yl}(ethylamino)formaldehyde (<b>18</b>). General Procedure</h3><div class="NLM_p last">Et<sub>3</sub>N (230 μL, 1.65 mmol) and MsCl (130 μL, 1.65 mmol) were added to a solution of <b>16</b> (310 mg, 0.55 mmol) in DCM (7 mL) at 0 °C. The solution was stirred for 30 min at 0 °C and for 12 h at room temperature. The solvent was removed under reduced pressure, and the reaction crude was dissolved in DMF (3–4 mL). Morpholine (143 mg, 1.65 mmol) and Et<sub>3</sub>N (230 μL, 1.65 mmol) were added, and the mixture was stirred for 12 h at room temperature. The mixture was diluted with H<sub>2</sub>O and EtOAc. The organic phase was extracted four times with EtOAc (4 × 30 mL) and washed with H<sub>2</sub>O (2 × 30 mL) and brine (2 × 30 mL). The solvent was evaporated, and EtNH<sub>2</sub> (1.5 mL of a solution 2 M in MeOH) was added to the crude reaction product. The mixture was heated for 24 h at 80 °C in a sealed tube. The solvent and the excess of amine were removed under reduced pressure. The residue was dissolved in EtOH (5 mL), and Pd(OH)<sub>2</sub>/C (0.01 mmol) was added. The mixture was stirred under an atmosphere of hydrogen (balloon) for 1 h. The catalyst was filtered off through Celite, and the ethanol was removed under reduced pressure. The reaction crude was purified by column chromatography (DCM/MeOH, 90/10). The title compound was obtained as a purple oil (174 mg, 68%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.30–7.25 (m, 4 H), 6.82 (s, 1 H), 6.31 (s, 1 H), 4.84 (bs, 3 H), 3.63–3.61 (m, 4 H), 3.46 (s, 2 H), 3.37 (q, <i>J</i> = 7.2 Hz, 2 H), 3.10 (qn, <i>J</i> = 6.8 Hz, 1 H), 2.41–2.39 (m, 4 H), 1.19 (t, <i>J</i> = 7.2 Hz, 3 H), 1.03 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.1, 156.6, 150.8, 140.0, 137.8, 137.4, 129.4, 128.1, 126.3, 125.1, 125.0, 114.4, 101.8, 65.8, 62.0, 52.7, 33.2, 25.5, 21.1, 13.2. HRMS (ESI) calcd for C<sub>25</sub>H<sub>32</sub>N<sub>5</sub>O<sub>4</sub> (M + 1)<sup>+</sup> 466.2454; found 466.2452.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Compound <b>19</b></h3><div class="NLM_p last">Column chromatography with (DCM/MeOH, 90/10) gave compound <b>19</b> as a purple oil (166 mg, 63%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.29 (AB system, <i>J</i> = 8.0 Hz, 4 H), 6.85 (s, 1 H), 6.33 (s, 1 H), 4.85 (bs, 3 H), 3.66–3.61 (m, 1 H), 3.51 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2H), 3.11 (qn, <i>J</i> = 6.8 Hz, 1 H), 2.87–2.84 (m, 1 H), 2.64–2.61 (m, 1 H), 2.01–1.85 (m, 4H), 1.70–1.67 (m, 1 H), 1.54–1.44 (m, 1 H), 1.22 (t, <i>J</i> = 7.2 Hz, 3 H), 1.04 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (400 MHz, MeOD): δ 161.1, 156.5, 150.8, 140.8, 137.9, 137.4, 129.3, 128.2, 126.3, 125.0, 114.4, 101.9, 65.9, 61.7, 59.8, 52.3, 33.2, 31.9, 25.5, 22.0, 21.1, 13.2. HRMS (ESI) calcd for C<sub>26</sub>H<sub>34</sub>N<sub>5</sub>O<sub>4</sub> (M + 1)<sup>+</sup> 80.2611; found 480.2608.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Compound <i>S</i>-<b>19</b></h3><div class="NLM_p last">The product was isolated using (<i>S</i>)-3-hydroxypiperidine and following the same procedure as <b>19</b> (161 mg, 61%). It showed the same spectroscopic features as <b>19</b>. [a]<sup>25</sup><sub>D</sub> +12.2 (<i>c</i> 0.1, MeOD).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Compound <i>R</i>-<b>19</b></h3><div class="NLM_p last">The product was isolated using (<i>R</i>)-3-hydroxypiperidine and following the same procedure as <b>19</b> (146 mg, 55%). It showed the same spectroscopic features as <b>19</b>. [a]<sup>25</sup><sub>D</sub> −11.9 (<i>c</i> 0.1, MeOD).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Compound <b>20</b></h3><div class="NLM_p last">Column chromatography with (DCM/MeOH, 90/10) gave compound <b>20</b> as a purple oil (165 mg, 65%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.31 (AB system, <i>J</i> = 8.6 Hz, 4 H), 6.84 (s, 1 H), 6.33 (s, 1 H), 4.87 (bs, 3 H), 3.59 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.10 (qn, <i>J</i> = 6.8 Hz, 1 H), 2.53–2.49 (m, 4 H), 1.61–1.57 (m, 4 H), 1.49–1.45 (m, 2 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.06 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.6, 150.9, 139.9, 137.4, 136.3, 129.4, 128.7, 126.3, 125.6, 125.0, 114.3, 101.9, 61.9, 53.2, 33.2, 25.5, 24.1, 22.8, 21.1, 13.21. HRMS (ESI) calcd for C<sub>26</sub>H<sub>34</sub>N<sub>5</sub>O<sub>3</sub> (M + 1)<sup>+</sup>464.2662; found 464.2659.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Compound <b>21</b></h3><div class="NLM_p last">Column chromatography with (DCM/MeOH, 97/3) gave compound <b>21</b> as a solid (212 mg, 85%). Mp 106–108 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.32 (bs, 2H), 7.31 (AB system, <i>J</i> = 8.0 Hz, 4 H), 6.85 (s, 1 H), 6.32 (s, 1H), 3.66 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.13–3.06 (m, 1 H), 2.58–2.54 (m, 4 H), 1.81–1.77 (m, 4 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.06 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.6, 150.9, 140.0, 138.2, 137.4, 129.5, 128.0, 126.2, 125.2, 125.0, 114.4, 101.9, 59.0, 53.4, 33.2, 25.5, 22.1, 21.1, 13.1. HRMS (ESI) calcd for C<sub>25</sub>H<sub>32</sub>N<sub>5</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 450.2505; found 450.2503.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Compound <b>22</b></h3><div class="NLM_p last">Column chromatography on silica gel previously conditioned with ammonia (DCM/MeOH, 95/5 to 90/10) gave compound <b>22</b> as a white solid. Mp 110–112 °C (132 mg, 54%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.26 (bs, 2H), 7.71 (s, 1 H), 7.25 (AX system, <i>J</i> = 8.0 Hz, 4 H), 7.06 (s, 1 H), 6.96 (s, 1 H), 6.88 (s, 1 H), 6.32 (s, 1 H), 5.17 (s, 2 H), 3.37 (q, <i>J</i> = 7.2 Hz, 2 H), 3.14–3.05 (m, 1 H), 1.20 (t, <i>J</i> = 7.2 Hz, 3 H), 1.06 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.6, 150.6, 139.7, 137.5, 136.7, 129.9, 127.3, 126.4, 126.1, 125.9, 125.0, 119.2, 114.3, 101.9, 49.4, 33.2, 25.5, 21.1, 13.2. HRMS (ESI) calcd for C<sub>24</sub>H<sub>27</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 447.2145; found 447.2143.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Compound <b>23</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 88/12) was used. The title compound was obtained as a purple oil (162 mg, 58%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.36 (s, 5 H), 6.85 (s, 1 H), 6.33 (s, 1 H), 4.83 (bs, 4 H), 4.17 (d, <i>J</i> = 13.2 Hz, 1 H), 3.72–3.59 (m, 2 H), 3.56 (<i>J</i> = 13.2 Hz, 1 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.10 (qn, <i>J</i> = 6.8 Hz, 1 H), 2.87–2.84 (m, 1 H), 2.76–2.72 (m, 1 H), 2.35–2.31 (m,1 H), 2.08–2.03 (m, 1 H), 1.82–1.35 (m, 6 H), 1.20 (t, <i>J</i> = 7.2 Hz, 3 H), 1.03 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 160.9, 150.2, 149.9, 144.0, 138.1, 130.2, 130.0, 127.7, 127.4, 126.1, 122.0, 119.8, 105.7, 61.6, 60.2, 58.5, 52.0, 34.3, 33.3, 28.4, 25.4, 25.3, 22.8, 22.7, 14.7. HRMS (ESI) calcd for C<sub>28</sub>H<sub>38</sub>N<sub>5</sub>O<sub>4</sub> (M + 1)<sup>+</sup> 508.2924; found 508.2921.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Compound <b>24</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 90/10) gave compound <b>24</b> as a reddish oil (136 mg, 55%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.33 (AB system, <i>J</i> = 8.4 Hz, 4 H), 6.84 (s, 1 H), 6.32 (s, 1 H), 4.83 (bs, 3 H), 3.73 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.10 (qn, <i>J</i> = 6.8 Hz, 1 H), 2.65 (q, <i>J</i> = 7.2 Hz, 4 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.11–1.06 (m, 12 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 160.9, 150.2, 149.9, 144.0, 143.3, 130.0, 128.6, 128.1, 127.0, 126.0, 122.0, 119.8, 105.7, 61.2, 46.7, 34.3, 25.3, 22.7, 14.7, 11.8. HRMS (ESI) calcd for C<sub>25</sub>H<sub>34</sub>N<sub>5</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 452.2662; found 452.2664.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Compound <b>25</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 90/10) gave compound <b>25</b> as a purple oil (185 mg, 72%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.30 (s, 5 H), 6.85 (s, 1 H), 6.33 (s, 1 H), 4.88 (bs, 4 H), 3.63 (s, 2 H), 3.60 (t, <i>J</i> = 6.2 Hz, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.11 (qn, <i>J</i> = 6.8 Hz, 1 H), 2.61 (t, <i>J</i> = 6.2 Hz, 2 H), 2.54 (q, <i>J</i> = 7.2 Hz, 2 H), 1.21 (t, <i>J</i> = 7.2 Hz, 2 H), 1.07 (d, <i>J</i> = 6.8 Hz, 6 H), 1.02 (t, <i>J</i> = 7.2 Hz, 3 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.1, 156.5, 150.87, 140.1, 139.6, 137.4, 129.3, 127.8, 126.3, 125.0, 124.7, 114.4, 101.9, 58.6, 57.2, 54.2, 47.0, 33.2, 25.5, 21.1, 13.2, 9.9. HRMS (ESI) calcd for C<sub>25</sub>H<sub>34</sub>N<sub>5</sub>O<sub>4</sub> (M + 1)<sup>+</sup> 468.2611; found 468.2608</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Compound <b>26</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 75/25) gave compound <b>26</b> as a white solid (102 mg 40%). Mp 79–81 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.16 (bs, 2H), 7.30 (AB system, <i>J</i> = 8.0 Hz, 4 H), 6.84 (s, 1 H), 6.35 (s, 1 H), 3.53 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.17–3.07 (m, 1 H), 3.04 (t, <i>J</i> = 4.8 Hz, 4 H), 2.55 (m,6H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.06 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.6, 150.9, 140.0, 137.9, 137.4, 129.4, 127.9, 126.2, 125.1, 124.9, 114.4, 101.9, 61.4, 50.3, 43.4, 33.2, 25.5, 21.1, 13.1. HRMS (ESI) calcd for C<sub>25</sub>H<sub>33</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 465.2614; found 465.2610.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Compound <b>27</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 88/12) gave compound <b>27</b> as a pale yellow solid (121 mg, 46%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.10 (βσ, 2H), 7.29 (AB system, <i>J</i> = 8.0 Hz, 4 H), 6.84 (s, 1 H), 6.33 (s, 1 H); 3.50 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.14–3.07 (m, 1 H), 2.60–2.40 (m, 9 H), 2.32 (s, 3 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.06 (d, <i>J</i> = 6.4 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.5, 150.8, 140.0, 138.0, 137.4, 129.4, 128.0, 126.3, 125.1, 124.9, 114.4, 101.91, 61.4, 53.6, 51.3, 43.8, 33.2, 25.5, 21.1, 13.2. HRMS (ESI) calcd for C<sub>26</sub>H<sub>35</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 479.2771; found 479.2767.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Compound <b>28</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 93/7) gave compound <b>28</b> as a purple oil (58%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.37–7.15 (m, 6 H), 7.09 (s, 1 H), 6.41 (s, 1 H), 4.94 (s, 2 H), 4.75 (s, 2 H), 3.89 (s, 3 H), 3.28–3.21 (bm, 2H), 2.88 (d, <i>J</i> = 11.2 Hz, 2 H), 2.29 (s, 6 H), 2.22–2.16 (m, 1 H), 1.95 (t, <i>J</i> = 11.2 Hz, 2 H), 1.78 (d, <i>J</i> = 12.0 Hz, 2 H), 1.57–1.48 (m, 2 H), 1.11 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 161.3, 157.3, 151.3, 142.4, 139.8, 135.9, 135.64, 134.9, 130.0, 129.3, 128.2, 128.1, 127.9, 127.6, 127.5, 126.6, 126.4, 125.6, 124.0, 117.3, 98.5, 70.4, 69.9, 62.1, 61.9, 52.6, 51.5, 41.0, 27.6, 25.9, 22.1. HRMS (ESI) calcd for C<sub>28</sub>H<sub>39</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 507.3084; found 507.3080.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Compound <b>29</b></h3><div class="NLM_p last">Column chromatography on silica gel previously conditioned with ammonia (DCM/MeOH, 85/15 to 60/40) gave compound <b>29</b> as a waxy material that solidified on standing (113 mg, 42%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.94 (bs, 2H), 7.29 (AB system, <i>J</i> = 8.0 Hz, 4H), 6.84 (s, 1 H), 6.33 (s, 1 H), 3.59 (q, <i>J</i> = 7.2 Hz, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.13–3.07 (m, 1 H), 2.94–2.78 (m, 2 H), 2.71–2.65 (m, 1 H), 2.56–2.50 (m, 1 H), 2.36–2.32 (m, 1 H), 2.26 (s, 6 H), 2.09–1.97 (m, 1 H), 1.78–1.67 (m, 1 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.07 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>): δ 161.0, 156.5, 150.8, 140.0, 138.8, 129.4, 127.6, 126.3, 125.0, 114.4, 101.9, 64.6, 59.0, 56.0, 52.2, 41.7, 33.2, 27.4, 25.5, 21.1, 13.1. HRMS (ESI) calcd for C<sub>27</sub>H<sub>37</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 493.2923; found 493.2919.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Compound <b>30</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 95/5) gave compound <b>30</b> as a purple oil (79 mg, 30%). <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.98 (bs, 2H), 7.39 (AB system, <i>J</i> = 8.4 Hz, 4 H), 6.91 (s, 1 H), 6.30 (s, 1 H), 4.01 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.14–3.05 (m, 1 H), 2.88–2.80 (m, 1 H), 2.08–2.03 (m, 3 H), 1.85–1.80 (m, 3 H), 1.68 (d, <i>J</i> = 12.0 Hz, 1 H), 1.35–1.26 (m, 5 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.09 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 160.9, 156.7, 150.9, 139.8, 137.6, 135.1, 130.0, 127.9, 126,4, 126.2, 125.1, 114.3, 101.8, 56.2, 33.2, 29.69, 25.6, 24.6, 23.9, 21.1, 13.1. HRMS (ESI) calcd for C<sub>27</sub>H<sub>36</sub>N<sub>5</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 478.2818; found 478.2821.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Compound <b>31</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 90/10) gave compound <b>31</b> as a white solid (113 mg, 42%). Mp 77–79 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ8.25 (bs, 2 H), 7.35 (AB system, <i>J</i> = 8.4 Hz, 4 H), 6.88 (s, 1 H), 6.31 (s, 1 H), 3.86 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.15–3.05 (m, 1 H), 2.52 (d, <i>J</i> = 6.8 Hz, 2 H), 1.78–1.50 (m, 8H), 1.27–1.24 (m, 3 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.08 (d, <i>J</i> = 6.8 Hz, 6 H), 0.99–0.87 (m, 2 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.6, 150.9, 139.9, 137.5, 137.1, 129.7, 127.6, 126.2, 125.7, 125.4, 114.3, 101.9, 54.0, 51.6, 35.9, 33.2, 30.2, 25.5, 25.0, 21.1, 13.1. HRMS (ESI) calcd for C<sub>28</sub>H<sub>38</sub>N<sub>5</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 492.2975; found 492.2977.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Compound <b>32</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 80/20) gave compound <b>32</b> as a white solid (120 mg, 43%). Mp < 50 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.86 (bs, 2 H), 7.33 (AB system, <i>J</i> = 8.0 Hz, 4 H), 6.89 (s, 1 H), 6.31 (s, 1 H), 3.84 (s, 2 H), 3.65 (t, <i>J</i> = 4.4 Hz, 4 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.14–3.07 (m, 2 H), 2.72 (m, 3 H), 2.48 (t, <i>J</i> = 6.4 Hz, 2 H), 2.38 (t, <i>J</i> = 4.4 Hz, 4 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.08 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.6, 150.8, 140.0, 138.4, 137.6, 129.7, 127.3, 126.3, 125.4, 125.0, 114.3, 101.8, 65.9, 55.9, 52.8, 51.5, 43.4, 33.2, 25.5, 21.1, 13.1. HRMS (ESI) calcd for C<sub>27</sub>H<sub>37</sub>N<sub>6</sub>O<sub>4</sub> (M + 1)<sup>+</sup> 509.2876; found 509.2876.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Compound <b>33</b></h3><div class="NLM_p last">Column chromatography on silica gel previously conditioned with ammonia (DCM/MeOH, 90/10 to 80/20) gave compound <b>33</b> as a white solid (87 mg, 32%). Mp 69–71 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.1 (bs, 2 H), 7.3 (AB system, <i>J</i> = 8.0 Hz, 4 H), 6.8 (s, 1 H), 6.2 (s, 1 H), 3.7 (s, 2 H), 3.3 (q, <i>J</i> = 2 H), 3.1–3.0 (m, 1 H), 2.6–2.5 (m, 6 H), 2.5 (q, <i>J</i> = 7.2 Hz, 4 H), 1.2 (t, <i>J</i> = 7.2 Hz, 3 H), 1.0 (d, <i>J</i> = 7.2 Hz, 6 H), 1.0 (t, <i>J</i> = 7.2 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.1, 156.7, 142.0, 140.0, 137.5, 129.5, 127.0, 125.7, 124.9, 114.5, 102.2, 52.2, 50.9, 46.2, 44.8, 33.2, 25.5, 21.2, 13.1, 9.6. HRMS (ESI) calcd for C<sub>27</sub>H<sub>39</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 495.3084; found 495.3086.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Compound <b>34</b></h3><div class="NLM_p last">Column chromatography on silica gel previously conditioned with ammonia (DCM/MeOH, 90:10 to 80:20) gave compound <b>34</b> as a white solid (89 mg, 35%). Mp 56–58 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.95 (bs, 2 H), 7.31 (AB system, <i>J</i> = 8.0 Hz, 4 H), 6.74 (s, 1 H), 6.25 (s, 1 H), 3.71 (s, 2 H), 3.38 (q, <i>J</i> = 7.2 Hz, 2 H), 3.11–3.04 (m, 1 H), 2.57–2.45 (m, 10 H), 1.69–1.62 (m, 2 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.06–1.00 (m, 12 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.2, 156.8, 140.0, 139.9, 129.6, 127.0, 124.8, 124.7, 114.8, 102.9, 52.7, 52.2, 50.1, 45.8, 33.2, 25.4, 24.8, 21.2, 13.1, 9.4. HRMS (ESI) calcd for C<sub>28</sub>H<sub>41</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup> 509.3240; found 509.3238.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Compound <b>35</b></h3><div class="NLM_p last">Column chromatography on silica gel previously conditioned with ammonia (DCM/MeOH, 50/50) gave compound <b>35</b> as a white solid (95 mg, 35%). Mp 67–69 °C. <sup>1</sup>H NMR (400 MHz, MeOD): δ 8.08 (bs, 2 H), 7.31 (AB system, <i>J</i> = 8.4 Hz, 4 H), 6.87 (s, 1 H), 6.30 (s, 1 H), 3.76 (s, 2 H), 3.39 (q, <i>J</i> = 7.2 Hz, 2 H), 3.16–3.07 (m, 1 H), 2.86–2.83 (m, 2 H), 2.49–2.42 (m, 2 H), 2.25 (s, 3 H), 2.01 (t, <i>J</i> = 11.2 Hz, 2 H), 1.91–1.87 (m, 2 H), 1.48–1.38 (m, 3 H), 1.21 (t, <i>J</i> = 7.2 Hz, 3 H), 1.08 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 156.6, 150.8, 140.0, 137.8, 137.63, 129.7, 127.4, 126.3, 125.6, 125.1, 114.3, 101.8, 52.7, 52.1, 48.6, 43.3, 33.2, 28.8, 25.5, 21.1, 13.1. HRMS (ESI) calcd for C<sub>27</sub>H<sub>37</sub>N<sub>6</sub>O<sub>3</sub> (M + 1)<sup>+</sup>493.2927; found 493.2923.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl 1-[2,4-Bis(benzyloxy)cumenyl]-5-[<i>p</i>-(morpholin-4-ylmethyl)phenyl]-1<i>H</i>-1,2,3-triazole-4-carboxylate (<b>36</b>)</h3><div class="NLM_p last">Et<sub>3</sub>N (230 μL, 1.65 mmol) and MsCl (130 μL, 1.65 mmol) were added to a solution of <b>16</b> (310 mg, 0.55 mmol) in DCM (7 mL) at 0 °C. The solution was stirred for 30 min at 0 °C and for 12 h at room temperature. The solvent was removed under reduced pressure, and the reaction crude was dissolved in DMF (3–4 mL). Morpholine (143 mg, 1.65 mmol) and Et<sub>3</sub>N (230 μL, 1.65 mmol) were added, and the mixture was stirred for 12 h at room temperature. The mixture was diluted with H<sub>2</sub>O and EtOAc. The organic phase was extracted four times with EtOAc (4 × 30 mL) and washed with H<sub>2</sub>O (2 × 30 mL) and with brine (2 × 30 mL). The solvent was evaporated. Column chromatography (DCM/MeOH, 98/2) gave the title compound as a pale yellow oil (372 mg, 75%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>Cl): δ 7.37–7.22 (m, 10 H), 7.17 (d, <i>J</i> = 8.4 Hz, 2 H), 7.08 (s, 1 H), 7.01–6.99 (m, 2 H), 6.40 (s, 1 H), 4.93 (s, 2 H), 4.74 (s, 2 H), 3.88 (s, 3 H), 3.67 (t, <i>J</i> = 4.4 Hz, 4 H), 3.47 (s, 2 H), 3.24 (qn, <i>J</i> = 6.8 Hz, 1 H), 2.42–2.38 (m, 4 H), 1.10 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>Cl): δ 160.6, 158.4, 156.9, 151.3, 140.0, 139.2, 136.6, 136.0, 131.9, 130.7, 128.4, 128.4, 128.4, 128.0, 127.8, 127.8, 127.6, 126.6, 125.2, 121.1, 100.2, 70.3, 70.1, 67.1, 63.2, 53.8, 52.0, 26.3, 22.8.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (2-Chloroethylamino)(1-(2,4-dihydroxycumenyl)-5-[<i>p</i>-(morpholin-4-ylmethyl)phenyl]-1<i>H</i>-1,2,3-triazol-4-yl)formaldehyde (<b>37</b>). General Procedure</h3><div class="NLM_p last">Compound <b>36</b> (50 mg, 0.07 mmol) was dissolved in a mixture of THF/H<sub>2</sub>O (2 mL) containing LiOH (5 mg, 0.2 mmol) and stirred at room temperature for 12 h. The solvent was evaporated under vacuum and the crude product treated directly with oxalyl chloride (1 mL). The vial was stirred for 2 h and the oxalyl chloride evaporated under vacuum. The residue was dissolved in dry DCM (2 mL), cooled to 0 °C, and DIPEA (0.2 mL, 2 mmol) and 2-chloroethylamine hydrochloride (58 mg, 0.5 mmol) were subsequently added. The mixture was stirred at room temperature for 12 h. Then the solvent was evaporated and the residue treated with EtOAc and passed through a short cartridge containing silica gel (eluting with EtOAc). The collected eluate was dried on anhydrous MgSO<sub>4</sub>, and the solvent was evaporated and treated several times with dry toluene that was further evaporated in order to remove azeotropically any trace of water. The residue was dissolved in DCM (0.1 mL), and the mixture was cooled to 0 °C and treated with 0.2 mL of a 1 M solution of BCl<sub>3</sub> in DCM. After the mixture was stirred for 2 h at room temperature, the solvent was evaporated and the residue purified by column chromatography (DCM/MeOH, 96/4) to give compound <b>37</b> as a waxy material (11 mg, 31% yield). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.70 (bs, 2H), 8.75 (t, <i>J</i> = 5.8 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 2H), 7.20 (d, <i>J</i> = 8.4 Hz, 2H), 6.90 (s, 1H), 6.37 (s, 1H), 3.70 (t, <i>J</i> = 6.0, <i>J</i> = 6.7 Hz, 2H), 3.51–3.57 (m, 6H), 3.4 (bs, 2H), 3.00 (hept, <i>J</i> = 6.9 Hz, 1H), 2.27–2.30 (m, 4H), 0.99 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.7, 150.2, 149.9, 142.0, 140.3, 130.3, 130.0, 128.4, 127.8, 127.7, 122.0, 120.6, 105.7, 67.1, 63.2, 53.8, 43.7, 41.9, 25.3, 22.7. HRMS (ESI) calcd for C<sub>25</sub>H<sub>31</sub>ClN<sub>5</sub>O<sub>4</sub> (M + 1)<sup>+</sup> 502.2035 (32.4%), 500.2065 (100%); found 502.2034 (32%), 500.2061 (100%).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Compound <b>38</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 98/2) gave compound <b>38</b> as a waxy material (15 mg, 42%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.78 (bs, 1H), 9.70 (bs, 1H), 8.49 (t, <i>J</i> = 5.9 Hz, 1H), 7.23 (d, <i>J</i> = 8.5 Hz, 2H), 7.19 (d, <i>J</i> = 8.5 Hz, 2H), 6.87 (s, 1H),6.37 (s, 1H), 3.51–3.54 (m, 4H), 3.39 (s, 2H), 3.16–3.22 (m, 2H), 3.00 (hept, <i>J</i> = 6.7 Hz, 1H), 2.29–2.30 (m, 4H), 1.45–1.48 (m, 2H), 1.22–1.25 (m, 7H), 1.01 (d, <i>J</i> = 6.9 Hz, 6H), 0.84 (t, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.7, 150.2, 149.9, 143.9, 140.3, 130.4, 130.0, 128.4, 127.7, 127.7, 122.0, 120.6, 105.7, 67.1, 63.2, 53.8, 40.7, 31.7, 27.6, 26.0, 25.3, 22.8, 22.7, 14.1. HRMS (ESI) calcd for C<sub>30</sub>H<sub>41</sub>N<sub>5</sub>O<sub>4</sub>Na (M + Na)<sup>+</sup> 559.3090 (32.4%), 558.30565 (100%); found 559.3087 (33%), 558.30567 (100%).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Compound <b>39</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 96/4) gave compound <b>39</b> as a waxy material (13 mg, 38%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.69 (s, 1H),9.66 (s, 1H), 8.28 (d, <i>J</i> = 7.8 Hz, 1H), 7.23 (d, <i>J</i> = 8.5 Hz, 2H), 7.20 (d, <i>J</i> = 8.5 Hz, 2H), 6.87 (s, 1H), 6.37 (s, 1H), 4.10–4.22 (m, 1H), 3.52–3.55 (m, 4H), 3.41 (bs, 2H), 3.00 (hept, <i>J</i> = 6.9 Hz, 1H), 2.30 (bs, 4H), 1.45–1.90 (m, 8H), 0.99 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.8, 150.2, 149.9, 144.6, 140.3, 130.4, 130.0, 128.4, 127.8, 127.7, 122.1, 120.6, 105.7, 67.1, 63.2, 53.8, 50.2, 32.6, 25.3, 23.1, 22.7. HRMS (ESI) calcd for C<sub>28</sub>H<sub>35</sub>N<sub>5</sub>O<sub>4</sub>Na (M + Na)<sup>+</sup> 529.2620 (30.3%), 528.2587 (100%); found 529.2623 (31%), 528.2590 (100%).</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Compound <b>40</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 98/2) gave compound <b>40</b> as a waxy material (15 mg, 42%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.74 (bs, 1H), 9.69 (bs, 1H), 8.19 (d, <i>J</i> = 8.6 Hz, 1H), 7.23 (d, <i>J</i> = 8.4 Hz, 2H), 7.19 (d, <i>J</i> = 8.4 Hz, 2H), 6.87 (s, 1H), 6.37 (s, 1H), 3.69 (bs, 1H), 3.51–3.54 (m, 4H), 3.39 (bs, 2H), 3.00 (hept, <i>J</i> = 6.7 Hz, 1H), 2.28–2.30 (m, 4H), 1.54–1.75 (m, 5H), 1.18–1.41 (m, 5H), 0.99 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.8, 150.2, 149.9, 144.6, 140.3, 130.4, 130.0, 128.4, 127.8, 127.7, 122.1, 120.6, 105.7, 67.1, 63.2, 53.8, 48.1, 32.4, 25.4, 25.3, 25.2, 22.7. HRMS (ESI) calcd for C<sub>29</sub>H<sub>38</sub>N<sub>5</sub>O<sub>4</sub> (M + 1)<sup>+</sup> 520.2924; found 520.2927.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Compound <b>41</b></h3><div class="NLM_p last">Column chromatography (DCM/MeOH, 95/5) gave compound <b>41</b> as a waxy material (8 mg, 22%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.76 (bs, 2H), 7.26 (d, <i>J</i> = 8.1 Hz, 2H), 7.17 (d, <i>J</i> = 8.1 Hz, 2H), 6.99 (s, 1H), 6.40 (s, 1H), 3.51–3.54 (m, 8H), 3.41 (bs, 2H), 3.2–3.3 (bm, 4H), 3.04 (hept, <i>J</i> = 6.9 Hz, 1H), 2.27–2.30 (m, 4H), 1.03 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 162.6, 150.2, 149.9, 143.5, 140.3, 130.3, 130.0, 128.4, 127.8, 127.7, 122.0, 120.6, 105.7, 67.1, 66.4, 63.2, 53.8, 45.3, 44.6, 25.3, 22.8. HRMS (ESI) calcd for C<sub>27</sub>H<sub>34</sub>N<sub>5</sub>O<sub>5</sub> (M + 1)<sup>+</sup> 508.2560; found 508.2563.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Compound <b>42</b></h3><div class="NLM_p last">The desired amide was obtained after purification by preparative HPLC using a gradient of a binary mixture of H<sub>2</sub>O/CH<sub>3</sub>CN further containing 0.1% TFA from 90/10 to 10/90. The yield was 7 mg of <b>42</b> (19%). <sup>1</sup>H NMR (300 MHz, MeOD): δ 7.44–7.51 (m, 4H), 7.46 (d, <i>J</i> = 8.7 Hz, 2H), 6.97 (s, 1H), 6.31 (s, 1H), 4.49 (m, 1H), 4.33 (bs, 2H), 3.88 (bs, 4H) 3.27 (bs, 4H), 3.12 (hept, <i>J</i> = 6.9 Hz, 1H), 2.31 (m, 1H), 1.10 (d, <i>J</i> = 6.9 Hz, 6H), 1.04 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 174.5, 158.9, 150.2, 149.9, 142.9, 140.3, 130.3, 130.0, 128.4, 127.8, 127.7, 122.0, 120.6, 105.7, 67.1, 63.2, 58.6, 53.8, 31.2, 25.3, 22.8, 19.3, 18.2. HRMS (ESI) calcd for C<sub>28</sub>H<sub>35</sub>N<sub>5</sub>O<sub>6</sub> M<sup>+</sup> 537.2588; found 537.2586.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Compound <b>45</b></h3><div class="NLM_p last">Methyl 7-aminoheptanoate HCl (31 mg, 0.16 mmol), DIPEA (51 μL, 0.28 mmol), and PyBOP (62 mg, 0.12 mmol) were added to a solution of acid obtained from <b>36</b> as previously described (62 mg, 0.10 mmol) in 4 mL of DCM. The reaction mixture was stirred at room temperature until complete conversion (6 h, TLC check with eluent DCM/MeOH, 96/4) and then diluted with DCM and washed with H<sub>2</sub>O. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated at reduced pressure. The crude product was purified by flash chromatography (DCM/MeOH, 98/2) to give <b>45</b> (46 mg, 58%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.57 (t, 1H, <i>J</i> = 5.7 Hz), 7.43 (m, 5H), 7.31 (m, 5H), 7.23 (s, 1H), 7.19 (m, 4H), 6.91 (s, 1H), 5.13 (s, 2H), 4.97 (s, 2H), 3.57 (s, 3H), 3.54 (m, 4H), 3.43 (s, 2H), 3.21 (m, 2H), 3.16 (m, 1H), 2.31 (bm, 4H), 2.28 (t, 2H, <i>J</i> = 7.3 Hz), 1.51 (m, 4H), 1.27 (m, 4H). 1.06 (d, 6H, <i>J</i> = 7.1 Hz). <sup>13</sup>C NMR (75 MHz, MeOD): δ 173.5, 160.7, 158.4, 156.8, 143.9, 140.3, 136.6, 136.0, 131.2, 130.8, 128.4, 128.3, 127.9, 127.8, 127.7, 127.6, 126.6, 124.9, 120.9, 100.4, 70.3, 70.1, 67.1, 63.2, 53.8, 51.1, 40.4, 33.6, 28.8, 27.0, 26.3, 25.4, 25.0, 22.8. ESI-MS <i>m</i>/<i>z</i> = 782.4 [M + Na]<sup>+</sup>.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Compound <b>46</b></h3><div class="NLM_p last">BCl<sub>3</sub> at 1 M in DCM (240 μL, 0.24 mmol) was added to a solution of <b>45</b> (46 mg, 0.06 mmol) in DCM (2 mL), and the mixture was stirred at 0 °C. The reaction mixture was allowed to warm to room temperature, and after 3 h the conversion of <b>45</b> was complete. Ethyl acetate was added, and the mixture was washed with a saturated solution of NaHCO<sub>3</sub>. The aqueous phase was extracted 3 times with EtOAc, and organic phases were collected, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated at reduced pressure. The crude product was purified by flash chromatography (DCM/MeOH, 95/5) to give the desired product (35 mg, 93%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.70 (bs, 1H), 9.65 (s, 1H), 8.51 (t, 1H, <i>J</i> = 5.8 Hz), 7.21 (m, 4H), 6.84 (s, 1H), 6.38 (s, 1H), 3.56 (s, 3H), 3.51 (bs, 4H), 3.40 (bs, 2H), 3.20 (m, 2H), 3.02 (m, 1H), 2.25 (m, 6H), 1.47 (m, 4H), 1.28 (m, 4H), 1.05 (d, 6H, <i>J</i> = 7.0 Hz). ESI-MS <i>m</i>/<i>z</i> = 782.4 [M + Na]<sup>+</sup>, 758.3 [M – H]<sup>−</sup>.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Compound <b>43</b></h3><div class="NLM_p last">Hydroxylamine (50% acqueous solution, 50 μL, 0.75 mmol) and 1 M NaOH (500 μL, 0.50 mmol) were added to a stirred solution of <b>46</b> (30 mg, 0.05 mmol) in MeOH (500 μL, 0.1 M) at 0 °C. The reaction mixture was warmed to room temperature, and after 2 h, TLC analysis showed complete conversion of starting material. The solution was extracted with AcOEt, and the organic phase was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by preparative HPLC with TFA buffered eluents to give salified <b>43</b> (18 mg, 49%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.35 (bs, 2H), 9.75 (bs, 2H), 8.58 (t, <i>J</i> = 5.6 Hz, 1H), 7.40 (m, 4H), 6.94 (s, 1H), 6.39 (s, 1H), 4.30 (s, 2H), 3.92 (bm, 2H), 3.65 (bm, 2H), 3.17 (m, 2H), 3.10 (bm, 4H), 3.01 (m, 1H), 1.90 (t, <i>J</i> = 7.3 Hz, 2H), 1.43 (m, 4H), 1.24 (m, 4H). 1.09 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 172.4, 160.7, 150.2, 149.9, 143.9, 140.3, 130.4, 130.0, 128.4, 127.8, 127.7, 122.1, 120.6, 105.7, 67.1, 63.3, 53.8, 40.4, 32.1, 27.2, 25.5, 25.4, 25.3, 24.5, 22.8. ESI-MS <i>m</i>/<i>z</i> = 581.3 [M + H]<sup>+</sup>. ESI-MS <i>m</i>/<i>z</i> = 579.4 [M – H]<sup>−</sup>. HRMS (ESI) calcd for C<sub>30</sub>H<sub>41</sub>N<sub>6</sub>O<sub>6</sub> (M + 1)<sup>+</sup> 581.3088; found 581.3085.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Compound <b>44</b></h3><div class="NLM_p last">Compound <b>18</b> (46 mg, 0.1 mmol) was dissolved in acetic anhydride (1 mL) with a catalytic amount of perchlorate (0.2 mmol), and the mixture was stirred at room temperature for 12 h. The acetic anhydride solution was treated with 1 N HCl in order to transform it into acetic acid that was removed by co-distillation with hexane (rotavapor). The solid resulting <b>44</b> (48 mg, 92%) was obtained with 100% purity. <sup>1</sup>H NMR (400 MHz, MeOD): δ 7.30–7.25 (m, 4 H), 6.82 (s, 1 H), 6.31 (s, 1 H), 4.84 (bs, 3 H), 3.63–3.61 (m, 4 H), 3.46 (s, 2 H), 3.37 (q, <i>J</i> = 7.2 Hz, 2 H), 2.41–2.39 (m, 4 H), 2.08 (s, 6 H), 1.19 (t, <i>J</i> = 7.2 Hz, 3 H), 1.03 (d, <i>J</i> = 6.8 Hz, 6 H). <sup>13</sup>C NMR (100 MHz, MeOD): δ 161.0, 156.5, 150.8, 140.0, 137.8, 137.4, 129.4, 128.1, 126.3, 125.1, 125.0, 114.4, 101.8, 65.8, 62.0, 52.7, 33.2, 25.5, 21.1, 20.3, 13.2. HRMS (ESI) calcd for C<sub>29</sub>H<sub>36</sub>N<sub>5</sub>O<sub>6</sub> (M + 1)<sup>+</sup> 550.2666; found 550.2665.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66"><a href="/doi/suppl/10.1021/jm401536b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic scheme of compound <b>43</b>, analysis of Hsp90 client protein levels, and the antiproliferative activity of all 1,2,3-triazoles on a panel of tumor cell lines. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401536b/suppl_file/jm401536b_si_001.pdf">jm401536b_si_001.pdf (282.33 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401536b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maurizio Taddei</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Biotecnologie, Chimica
e Farmacia, Università degli Studi
di Siena, Via A. Moro
2, I-53100 Siena, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b9d4d8cccbd0c3d0d697cdd8dddddcd0f9ccd7d0cad097d0cd"><span class="__cf_email__" data-cfemail="a5c8c4d0d7ccdfccca8bd1c4c1c1c0cce5d0cbccd6cc8bccd1">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Giannini</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#086f617d7b6d78786d266f61696666616661487b616f6569257c697d26617c"><span class="__cf_email__" data-cfemail="73141a0600160303165d141a121d1d1a1d1a33001a141e125e0712065d1a07">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Serena Ferrini</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Biotecnologie, Chimica
e Farmacia, Università degli Studi
di Siena, Via A. Moro
2, I-53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Giannotti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Biotecnologie, Chimica
e Farmacia, Università degli Studi
di Siena, Via A. Moro
2, I-53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Massimo Corsi</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Biotecnologie, Chimica
e Farmacia, Università degli Studi
di Siena, Via A. Moro
2, I-53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabrizio Manetti</span> - <span class="hlFld-Affiliation affiliation">Dipartimento di Biotecnologie, Chimica
e Farmacia, Università degli Studi
di Siena, Via A. Moro
2, I-53100 Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Loredana Vesci</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ferdinando M. Milazzo</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Domenico Alloatti</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario B. Guglielmi</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Massimo Castorina</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria L. Cervoni</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marcella Barbarino</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosanna Foderà</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valeria Carollo</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudio Pisano</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Armaroli</span> - <span class="hlFld-Affiliation affiliation">Sigma-Tau Research Switzerland S.A., Via Motta, 2a, CH-6850 Mendrisio-Stazione, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter Cabri</span> - <span class="hlFld-Affiliation affiliation">R&D Sigma-Tau Industrie Farmaceutiche
Riunite S.p.A., Via Pontina
Km 30,400, I-00040, Pomezia, Roma, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2348e3986-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from Sigma-Tau Research Switzerland S.A. that retains the property rights of all the compounds described in the paper. The authors thank Dr. Tiziana Brunetti and Dr. Gianfranco Battistuzzi for their useful support in the preparation of the manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sreedhar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csermely, P.</span><span> </span><span class="NLM_article-title">Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1016%2Fj.pharmthera.2003.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=15031001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFeitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=227-257&author=A.+S.+Sreedharauthor=P.+Csermely&title=Heat+shock+proteins+in+the+regulation+of+apoptosis%3A+new+strategies+in+tumor+therapy%3A+a+comprehensive+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy. A comprehensive review</span></div><div class="casAuthors">Sreedhar, Amere Subbarao; Csermely, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-257</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock proteins (Hsp) form the most ancient defense system in all living organisms on earth.  These proteins act as mol. chaperones by helping in the refolding of misfolded proteins and assisting in their elimination if they become irreversibly damaged.  Hsp interact with a no. of cellular systems and form efficient cytoprotective mechanisms.  However, in some cases, wherein it is better if the cell dies, there is no reason for any further defense.  Programmed cell death is a widely conserved general phenomenon helping in many processes involving the reconstruction of multicellular organisms, as well as in the elimination of old or damaged cells.  Here, we review some novel elements of the apoptotic process, such as its interrelationship with cellular senescence and necrosis, as well as bacterial apoptosis.  We also give a survey of the most important elements of the apoptotic machinery and show the various modes of how Hsp interact with the apoptotic events in detail.  We review caspase-independent apoptotic pathways and anoikis as well.  Finally, we show the emerging variety of pharmacol. interventions inhibiting or, just conversely, inducing Hsp and review the emergence of Hsp as novel therapeutic targets in anticancer protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsa9XUmpeTJbVg90H21EOLACvtfcHk0lgUiFA_tjWXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFeitbs%253D&md5=f06c05fedd52f2b2a960177072f09f5d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2003.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2003.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DSreedhar%26aufirst%3DA.%2BS.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DHeat%2520shock%2520proteins%2520in%2520the%2520regulation%2520of%2520apoptosis%253A%2520new%2520strategies%2520in%2520tumor%2520therapy%253A%2520a%2520comprehensive%2520review%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D101%26spage%3D227%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Stravopodis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margaritis, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voutsinas, G. E.</span><span> </span><span class="NLM_article-title">Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3122</span><span class="NLM_x">–</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.2174%2F092986707782793925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=18220746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=3122-3138&author=D.+J.+Stravopodisauthor=L.+H.+Margaritisauthor=G.+E.+Voutsinas&title=Drug-mediated+targeted+disruption+of+multiple+protein+activities+through+functional+inhibition+of+the+Hsp90+chaperone+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex</span></div><div class="casAuthors">Stravopodis, Dimitrios J.; Margaritis, Lukas H.; Voutsinas, Gerassimos E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3122-3138</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an evolutionarily conserved and ubiquitously expressed mol. chaperone that mainly modulates, along with a group of co-chaperones, the general platform of protein folding and prevents the nonspecific aggregation of misfolded or unfolded proteins.  In the voluminous Hsp90 clientele, a large variety of important regulatory proteins can be identified, including many whose deregulation may lead to cancer initiation and progression, such as the oncogenic clients pp60v-src, Bcr-Abl, mutated p53, ErbB2 (Her-2), Akt, Flt3, HIF-1α and B-Raf.  Therefore, inhibition of Hsp90 function offers the prospect of simultaneously disrupting multiple signaling pathways directly implicated in the development of malignant phenotypes.  During the last few years, there has been a major focus on the development of Hsp90 specific inhibitors.  This started with the discovery that certain natural products could specifically disrupt Hsp90 chaperone activities.  The benzoquinone ansamycin antibiotic geldanamycin and its less toxic deriv. 17-AAG have been shown to possess strong anti-proliferative and apoptotic activity in cancer cells, whereas 17-AAG has demonstrated potent anti-tumor activity in several human xenograft models, including breast, prostate and colon cancer.  In an effort to overcome difficulties with drug toxicity and soly., a no. of novel bioengineered 17-AAG analogs, such as 17-DMAG and IPI-504, and small-mol. inhibitors, including purine and pyrazole derivs., have emerged from rational drug design followed by high-throughput screening approaches.  17-AAG was the leader inhibitor to enter and successfully complete phase I clin. trials, thus demonstrating that Hsp90 constitutes a valid drug target for cancer therapy.  This review includes information on the current model of ternary interactions between Hsp90, client proteins and a vast array of co-chaperones followed by a list of characteristic inhibitors and ongoing clin. trials reported thus far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMIOuCiSvkbLVg90H21EOLACvtfcHk0lgUiFA_tjWXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrsLg%253D&md5=d3c9b6ec73e1250e37fef98512b8aac3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F092986707782793925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782793925%26sid%3Dliteratum%253Aachs%26aulast%3DStravopodis%26aufirst%3DD.%2BJ.%26aulast%3DMargaritis%26aufirst%3DL.%2BH.%26aulast%3DVoutsinas%26aufirst%3DG.%2BE.%26atitle%3DDrug-mediated%2520targeted%2520disruption%2520of%2520multiple%2520protein%2520activities%2520through%2520functional%2520inhibition%2520of%2520the%2520Hsp90%2520chaperone%2520complex%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D3122%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Banerji, U.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 as a drug target: some like it hot</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1158%2F1078-0432.CCR-08-0132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=9-14&author=U.+Banerji&title=Heat+shock+protein+90+as+a+drug+target%3A+some+like+it+hot"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0132%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26atitle%3DHeat%2520shock%2520protein%252090%2520as%2520a%2520drug%2520target%253A%2520some%2520like%2520it%2520hot%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D1%26spage%3D9%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: the cancer chaperone</span> <span class="citation_source-journal">J Biosci .</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1007%2Fs12038-007-0051-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=17536171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=517-530&author=L.+Neckers&title=Heat+shock+protein+90%3A+the+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90: the cancer chaperone</span></div><div class="casAuthors">Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biosciences (Bangalore, India)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-530</span>CODEN:
                <span class="NLM_cas:coden">JOBSDN</span>;
        ISSN:<span class="NLM_cas:issn">0250-5991</span>.
    
            (<span class="NLM_cas:orgname">Indian Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of a no. of conditionally activated and/or expressed signaling proteins, as well as multiple mutated, chimeric, and/or overexpressed signaling proteins, that promote cancer cell growth and/or survival.  Hsp90 inhibitors are unique in that, although they are directed towards a specific mol. target, they simultaneously inhibit multiple cellular signaling pathways.  By inhibiting nodal points in multiple overlapping survival pathways utilized by cancer cells, combination of an Hsp90 inhibitor with std. chemotherapeutic agents may dramatically increase the in vivo efficacy of the std. agent.  Hsp90 inhibitors may circumvent the characteristic genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.  The mechanism-based use of Hsp90 inhibitors, both alone and in combination with other drugs, should be effective toward multiple forms of cancer.  Further, because Hsp90 inhibitors also induce Hsf-1-dependent expression of Hsp70, and because certain mutated Hsp90 client proteins are neurotoxic, these drugs display ameliorative properties in several neurodegenerative disease models, suggesting a novel role for Hsp90 inhibitors in treating multiple pathologies involving neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorZSMvQPzup7Vg90H21EOLACvtfcHk0lgUiFA_tjWXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D&md5=ffc9fd7cba8e3b9e03b2da9c29bc275f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12038-007-0051-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12038-007-0051-y%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520the%2520cancer%2520chaperone%26jtitle%3DJ%2520Biosci%2520.%26date%3D2007%26volume%3D32%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ho, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 and role of its chemical inhibitors in treatment of hematologic malignancies</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=779-801&author=N.+Hoauthor=A.+Liauthor=S.+Liauthor=H.+Zhang&title=Heat+shock+protein+90+and+role+of+its+chemical+inhibitors+in+treatment+of+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DHeat%2520shock%2520protein%252090%2520and%2520role%2520of%2520its%2520chemical%2520inhibitors%2520in%2520treatment%2520of%2520hematologic%2520malignancies%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D779%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of small molecule Hsp90 probes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2603-2614&author=T.+Taldoneauthor=D.+Zatorskaauthor=P.+D.+Patelauthor=H.+Zongauthor=A.+Rodinaauthor=J.+H.+Ahnauthor=K.+Moulickauthor=M.+L.+Guzmanauthor=G.+Chiosis&title=Design%2C+synthesis%2C+and+evaluation+of+small+molecule+Hsp90+probes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DZong%26aufirst%3DH.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520small%2520molecule%2520Hsp90%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2603%26epage%3D2614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span> </span><span class="NLM_article-title">Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=246-250&author=G.+Chenauthor=W.+D.+Bradfordauthor=C.+W.+Seidelauthor=R.+Li&title=Hsp90+stress+potentiates+rapid+cellular+adaptation+through+induction+of+aneuploidy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DBradford%26aufirst%3DW.%2BD.%26aulast%3DSeidel%26aufirst%3DC.%2BW.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DHsp90%2520stress%2520potentiates%2520rapid%2520cellular%2520adaptation%2520through%2520induction%2520of%2520aneuploidy%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D246%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruden, M. D.</span><span> </span><span class="NLM_article-title">Hsp90 Inhibitors and the reduction of anti-cancer drug resistance by non-genetic and genetic mechanisms</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=890-898&author=X.+Luauthor=L.+Wangauthor=M.+D.+Ruden&title=Hsp90+Inhibitors+and+the+reduction+of+anti-cancer+drug+resistance+by+non-genetic+and+genetic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRuden%26aufirst%3DM.%2BD.%26atitle%3DHsp90%2520Inhibitors%2520and%2520the%2520reduction%2520of%2520anti-cancer%2520drug%2520resistance%2520by%2520non-genetic%2520and%2520genetic%2520mechanisms%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D890%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Turbyville, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kithsiri Wijeratne, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seliga, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luevano, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeth, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunatilaka, A. A. L.</span><span> </span><span class="NLM_article-title">Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/doi/10.1021/np058095b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=178-184&author=T.+J.+Turbyvilleauthor=E.+M.+Kithsiri+Wijeratneauthor=M.+X.+Liuauthor=A.+M.+Burnsauthor=C.+J.+Seligaauthor=L.+A.+Luevanoauthor=C.+L.+Davidauthor=S.+H.+Faethauthor=L.+Whitesellauthor=A.+A.+L.+Gunatilaka&title=Search+for+Hsp90+inhibitors+with+potential+anticancer+activity%3A+isolation+and+SAR+studies+of+radicicol+and+monocillin+I+from+two+plant-associated+fungi+of+the+Sonoran+desert"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Search for Hsp90 Inhibitors with Potential Anticancer Activity: Isolation and SAR Studies of Radicicol and Monocillin I from Two Plant-Associated Fungi of the Sonoran Desert</span></div><div class="casAuthors">Turbyville, Thomas J.; Wijeratne, E. M. Kithsiri; Liu, Manping X.; Burns, Anna M.; Seliga, Christopher J.; Luevano, Libia A.; David, Cynthia L.; Faeth, Stanley H.; Whitesell, Luke; Gunatilaka, A. A. Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-184</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">In an effort to discover small mol. inhibitors of Hsp90, we have screened over 500 EtOAc exts. of Sonoran desert plant-assocd. fungi using a two-stage strategy consisting of a primary cell-based heat shock induction assay (HSIA) followed by a secondary biochem. luciferase refolding assay (LRA).  Bioassay-guided fractionation of exts. active in these assays derived from Chaetomium chiversii and Paraphaeosphaeria quadriseptata furnished the Hsp90 inhibitors radicicol (1) and monocillin I (2), resp.  In SAR studies, 1, 2, and their analogs, 3-16, were evaluated in these assays, and the antiproliferative activity of compds. active in both assays was detd. using the breast cancer cell line MCF-7.  Radicicol and monocillin I were also evaluated in a solid-phase competition assay for their ability to bind Hsp90 and to deplete cellular levels of two known Hsp90 client proteins with relevance to breast cancer, estrogen receptor (ER), and the type 1 insulin-like growth factor receptor (IGF-1R).  Some inferences on SAR were made considering the crystal structure of the N-terminus of yeast Hsp90 bound to 1 and the obsd. biol. activities of 1-16.  Isolation of radicicol and monocillin I in this study provides evidence that we have developed an effective strategy for discovering natural product-based Hsp90 inhibitors with potential anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps5fEK1mAeWLVg90H21EOLACvtfcHk0lhuldaKSuPALQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajs74%253D&md5=b46997bda895934e2287f9eb3093bf18</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fnp058095b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp058095b%26sid%3Dliteratum%253Aachs%26aulast%3DTurbyville%26aufirst%3DT.%2BJ.%26aulast%3DKithsiri%2BWijeratne%26aufirst%3DE.%2BM.%26aulast%3DLiu%26aufirst%3DM.%2BX.%26aulast%3DBurns%26aufirst%3DA.%2BM.%26aulast%3DSeliga%26aufirst%3DC.%2BJ.%26aulast%3DLuevano%26aufirst%3DL.%2BA.%26aulast%3DDavid%26aufirst%3DC.%2BL.%26aulast%3DFaeth%26aufirst%3DS.%2BH.%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DGunatilaka%26aufirst%3DA.%2BA.%2BL.%26atitle%3DSearch%2520for%2520Hsp90%2520inhibitors%2520with%2520potential%2520anticancer%2520activity%253A%2520isolation%2520and%2520SAR%2520studies%2520of%2520radicicol%2520and%2520monocillin%2520I%2520from%2520two%2520plant-associated%2520fungi%2520of%2520the%2520Sonoran%2520desert%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2006%26volume%3D69%26spage%3D178%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: Are we there yet?</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+Are+we+there+yet%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lhOmbsM-Rz8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520Are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Patki, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawar, S. S.</span><span> </span><span class="NLM_article-title">Hsp90: chaperone-me-not</span> <span class="citation_source-journal">Pathol. Oncol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1007%2Fs12253-013-9675-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=23900891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=631-640&author=J.+M.+Patkiauthor=S.+S.+Pawar&title=Hsp90%3A+chaperone-me-not"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90: Chaperone-me-not</span></div><div class="casAuthors">Patki, J. M.; Pawar, S. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  With increasing understanding of the mol. basis of carcinogenesis, its progression and metastasis, the cancer therapy has shifted from empirical approaches to targeting specific mols. that regulate the complex network of signalling pathways for cell survival and proliferation.  These include key players in malignant transformation like protein kinases, transcription factors, steroid hormone receptors, cell cycle regulators, signal transduction proteins and regulators of apoptosis.  Almost all these proteins depend upon the mol. chaperone Hsp90 for their proper folding, stability and function and thus are a part of the Hsp90 clientele.  Dependence of these proteins on Hsp90 makes this chaperone an appealing target for cancer therapeutics.  Inhibition of Hsp90 can affect multiple oncogenic pathways simultaneously.  Moreover Hsp90 inhibitors selectively kill cancer cells compared to normal cells and cancer cells have greater dependence on Hsp90 for the maintenance of intracellular protein homeostasis.  All this has led to a rapid pace discovery of Hsp90 clients as well as chem. inhibitors of Hsp90.  The role of hsp90 in cancer, tumor selectivity of Hsp90 inhibitors and the current status of Hsp90 inhibitors are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-L7_keMms8rVg90H21EOLACvtfcHk0lhOmbsM-Rz8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM&md5=31ad299d632f57170a06a6d00dc79c4b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12253-013-9675-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-013-9675-4%26sid%3Dliteratum%253Aachs%26aulast%3DPatki%26aufirst%3DJ.%2BM.%26aulast%3DPawar%26aufirst%3DS.%2BS.%26atitle%3DHsp90%253A%2520chaperone-me-not%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D631%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chang, D.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K-s.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, W.-G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (Hsp90) inhibitors targeting proliferation and angiogenesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10863</span><span class="NLM_x">–</span> <span class="NLM_lpage">10884</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301488q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10863-10884&author=D.-J.+Changauthor=H.+Anauthor=K-s.+Kimauthor=H.+H.+Kimauthor=J.+Jungauthor=M.+L.+Leeauthor=N.-J.+Kimauthor=Y.+T.+Hanauthor=H.+Yunauthor=S.+Leeauthor=G.+Leeauthor=S.+Leeauthor=J.+S.+Leeauthor=J.-H.+Chaauthor=J.-H.+Parkauthor=J.+W.+Parkauthor=S.-C.+Leeauthor=S.+G.+Kimauthor=J.+H.+Kimauthor=H.+Y.+Leeauthor=K.-W.+Kimauthor=W.-G.+Suh&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+deguelin-based+heat+shock+protein+90+%28Hsp90%29+inhibitors+targeting+proliferation+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm301488q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301488q%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DD.-J.%26aulast%3DAn%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK-s.%26aulast%3DKim%26aufirst%3DH.%2BH.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BL.%26aulast%3DKim%26aufirst%3DN.-J.%26aulast%3DHan%26aufirst%3DY.%2BT.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DCha%26aufirst%3DJ.-H.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DS.-C.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DK.-W.%26aulast%3DSuh%26aufirst%3DW.-G.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520deguelin-based%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520targeting%2520proliferation%2520and%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10863%26epage%3D10884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.2174%2F138161213804143617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=22920907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=366-376&author=S.+Sogaauthor=S.+Akinagaauthor=Y.+Shiotsu&title=Hsp90+inhibitors+as+anti-cancer+agents%2C+from+basic+discoveries+to+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development</span></div><div class="casAuthors">Soga, Shiro; Akinaga, Shiro; Shiotsu, Yukimasa</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">366-376</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone which stabilizes various oncogenic kinases, including HER2, EGFR, BCR-ABL, B-Raf and EML4-ALK, which are essential for tumor growth.  Several monoclonal antibodies and small mol. kinase inhibitors which target these kinases have been identified as potential new mol. target therapeutics.  Previous reports have shown that many oncogenic proteins essential for cancer transformation are chaperoned by the Hsp90 complex, and some of these client proteins have been discovered by using Hsp90 inhibitors, such as geldanamycin (GA) and radicicol (RD).  Thus far more than 200 client proteins have been identified.  In past derivs. of these natural products have been evaluated in clin. trials, but none of the 1st generation of Hsp90 inhibitors has been approved yet because of their limitations in physico-chem. properties and/or safety profiles.  However, recent reports have indicated that more than 10 new agents, 2nd generation of Hsp90 inhibitors with different chemotypes from GA and RD, have entered clin. trials and some of them showed clin. efficacy.  In this review article, we describe the discoveries of major Hsp90 client proteins in the cancer field by RD derivs., the history of KW-2478 discovery and development by Kyowa Hakko Kirin, and gave an update on the current status of new Hsp90 inhibitors in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6siL38h_pnbVg90H21EOLACvtfcHk0lhOmbsM-Rz8AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsLw%253D&md5=6b8012a64a3cb1b3ef19d646d90dc109</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138161213804143617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143617%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26atitle%3DHsp90%2520inhibitors%2520as%2520anti-cancer%2520agents%252C%2520from%2520basic%2520discoveries%2520to%2520clinical%2520development%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D366%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Water, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-C.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.-C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0lipvMLa4LEsOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.-C.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalniak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leskovar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Conserved conformational changes in the ATPase cycle of human Hsp90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">17757</span><span class="NLM_x">–</span> <span class="NLM_lpage">17765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=17757-17765&author=K.+Richterauthor=J.+Sorokaauthor=L.+Skalniakauthor=A.+Leskovarauthor=M.+Hesslingauthor=J.+Reinsteinauthor=J.+Buchner&title=Conserved+conformational+changes+in+the+ATPase+cycle+of+human+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DSoroka%26aufirst%3DJ.%26aulast%3DSkalniak%26aufirst%3DL.%26aulast%3DLeskovar%26aufirst%3DA.%26aulast%3DHessling%26aufirst%3DM.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DConserved%2520conformational%2520changes%2520in%2520the%2520ATPase%2520cycle%2520of%2520human%2520Hsp90%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D17757%26epage%3D17765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auzzas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span> </span><span class="NLM_article-title">Vorinostat-like molecules as structural, stereochemical, and pharmacological tools</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100028g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=70-74&author=S.+Hanessianauthor=L.+Auzzasauthor=A.+Larssonauthor=J.+Zhangauthor=G.+Gianniniauthor=G.+Galloauthor=A.+Ciacciauthor=W.+Cabri&title=Vorinostat-like+molecules+as+structural%2C+stereochemical%2C+and+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml100028g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100028g%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DAuzzas%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DCiacci%26aufirst%3DA.%26aulast%3DCabri%26aufirst%3DW.%26atitle%3DVorinostat-like%2520molecules%2520as%2520structural%252C%2520stereochemical%252C%2520and%2520pharmacological%2520tools%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D70%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Botta, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cesare, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondinelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriquez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span> </span><span class="NLM_article-title">Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2165</span><span class="NLM_x">–</span> <span class="NLM_lpage">2182</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101373a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2165-2182&author=C.+B.+Bottaauthor=W.+Cabriauthor=E.+Ciniauthor=L.+De+Cesareauthor=C.+Fattorussoauthor=G.+Gianniniauthor=M.+Persicoauthor=A.+Petrellaauthor=F.+Rondinelliauthor=M.+Rodriquezauthor=A.+Russoauthor=M.+Taddei&title=Oxime+amides+as+a+novel+zinc+binding+group+in+histone+deacetylase+inhibitors%3A+synthesis%2C+biological+activity%2C+and+computational+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm101373a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101373a%26sid%3Dliteratum%253Aachs%26aulast%3DBotta%26aufirst%3DC.%2BB.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DCini%26aufirst%3DE.%26aulast%3DDe%2BCesare%26aufirst%3DL.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DPersico%26aufirst%3DM.%26aulast%3DPetrella%26aufirst%3DA.%26aulast%3DRondinelli%26aufirst%3DF.%26aulast%3DRodriquez%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DA.%26aulast%3DTaddei%26aufirst%3DM.%26atitle%3DOxime%2520amides%2520as%2520a%2520novel%2520zinc%2520binding%2520group%2520in%2520histone%2520deacetylase%2520inhibitors%253A%2520synthesis%252C%2520biological%2520activity%252C%2520and%2520computational%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2165%26epage%3D2182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Baruchello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisolia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondanin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloatti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milazzo, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervoni, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmi, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbarino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foderà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span> </span><span class="NLM_article-title">Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8592</span><span class="NLM_x">–</span> <span class="NLM_lpage">8604</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201155e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8592-8604&author=R.+Baruchelloauthor=D.+Simoniauthor=G.+Grisoliaauthor=G.+Barbatoauthor=P.+Marchettiauthor=R.+Rondaninauthor=S.+Mangiolaauthor=G.+Gianniniauthor=T.+Brunettiauthor=D.+Alloattiauthor=G.+Galloauthor=A.+Ciacciauthor=L.+Vesciauthor=M.+Castorinaauthor=F.+M.+Milazzoauthor=M.+L.+Cervoniauthor=M.+B.+Guglielmiauthor=M.+Barbarinoauthor=R.+Foder%C3%A0author=C.+Pisanoauthor=W.+Cabri&title=Novel+3%2C4-isoxazolediamides+as+potent+inhibitors+of+chaperone+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201155e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201155e%26sid%3Dliteratum%253Aachs%26aulast%3DBaruchello%26aufirst%3DR.%26aulast%3DSimoni%26aufirst%3DD.%26aulast%3DGrisolia%26aufirst%3DG.%26aulast%3DBarbato%26aufirst%3DG.%26aulast%3DMarchetti%26aufirst%3DP.%26aulast%3DRondanin%26aufirst%3DR.%26aulast%3DMangiola%26aufirst%3DS.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DBrunetti%26aufirst%3DT.%26aulast%3DAlloatti%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DCiacci%26aufirst%3DA.%26aulast%3DVesci%26aufirst%3DL.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DMilazzo%26aufirst%3DF.%2BM.%26aulast%3DCervoni%26aufirst%3DM.%2BL.%26aulast%3DGuglielmi%26aufirst%3DM.%2BB.%26aulast%3DBarbarino%26aufirst%3DM.%26aulast%3DFoder%25C3%25A0%26aufirst%3DR.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DCabri%26aufirst%3DW.%26atitle%3DNovel%25203%252C4-isoxazolediamides%2520as%2520potent%2520inhibitors%2520of%2520chaperone%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8592%26epage%3D8604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.-M.+J.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+E.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BE.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Cikotiene, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matuliene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michailoviene, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torresan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jachno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulis, D.</span><span> </span><span class="NLM_article-title">5-Aryl-4-(5-substituted-2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1089-1092&author=I.+Cikotieneauthor=E.+Kazlauskasauthor=J.+Matulieneauthor=V.+Michailovieneauthor=J.+Torresanauthor=J.+Jachnoauthor=D.+Matulis&title=5-Aryl-4-%285-substituted-2%2C4-dihydroxyphenyl%29-1%2C2%2C3-thiadiazoles+as+inhibitors+of+Hsp90+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCikotiene%26aufirst%3DI.%26aulast%3DKazlauskas%26aufirst%3DE.%26aulast%3DMatuliene%26aufirst%3DJ.%26aulast%3DMichailoviene%26aufirst%3DV.%26aulast%3DTorresan%26aufirst%3DJ.%26aulast%3DJachno%26aufirst%3DJ.%26aulast%3DMatulis%26aufirst%3DD.%26atitle%3D5-Aryl-4-%25285-substituted-2%252C4-dihydroxyphenyl%2529-1%252C2%252C3-thiadiazoles%2520as%2520inhibitors%2520of%2520Hsp90%2520chaperone%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1089%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hong, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, J.-S.</span><span> </span><span class="NLM_article-title">Identification of new Hsp90 inhibitors by structure-based virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4839</span><span class="NLM_x">–</span> <span class="NLM_lpage">4842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4839-4842&author=T.-J.+Hongauthor=H.+Parkauthor=Y.-J.+Kimauthor=J.-H.+Jeongauthor=J.-S.+Hahn&title=Identification+of+new+Hsp90+inhibitors+by+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DT.-J.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DY.-J.%26aulast%3DJeong%26aufirst%3DJ.-H.%26aulast%3DHahn%26aufirst%3DJ.-S.%26atitle%3DIdentification%2520of%2520new%2520Hsp90%2520inhibitors%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4839%26epage%3D4842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McCleese, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalek, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C. A.</span><span> </span><span class="NLM_article-title">The novel Hsp90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines</span> <span class="citation_source-journal">Int. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2792</span><span class="NLM_x">–</span> <span class="NLM_lpage">2801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1002%2Fijc.24660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=19544563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2009&pages=2792-2801&author=J.+K.+McCleeseauthor=M.+D.+Bearauthor=S.+L.+Fosseyauthor=R.+M.+Mihalekauthor=K.+P.+Foleyauthor=W.+Yingauthor=J.+Barsoumauthor=C.+A.+London&title=The+novel+Hsp90+inhibitor+STA-1474+exhibits+biologic+activity+against+osteosarcoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines</span></div><div class="casAuthors">McCleese, Jennifer K.; Bear, Misty D.; Fossey, Stacey L.; Mihalek, Robert M.; Foley, Kevin P.; Ying, Weiwen; Barsoum, James; London, Cheryl A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2792-2801</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Osteosarcoma (OSA), the most common malignant bone tumor in dogs and children, exhibits a similar clin. presentation and mol. biol. in both species.  Unfortunately, 30-40% of children and 90% of dogs still die of disease despite aggressive therapy.  The purpose of this study was to test the biol. activity of a novel heat shock protein 90 (HSP90) inhibitor, STA-1474, against OSA.  Canine and human OSA cell lines and normal canine osteoblasts were treated with STA-1474 and evaluated for effects on proliferation (CyQuant), apoptosis (Annexin V, PARP cleavage, caspase 3/7 activation) and known HSP90 client proteins.  HSP90 was immunopptd. from normal and malignant osteoblasts and Western blotting for co-chaperones was performed.  Mice bearing canine OSA xenografts were treated with STA-1474, and tumors samples were evaluated for caspase-3 activation and loss of p-Akt/Akt.  Treatment with STA-1474 promoted loss of cell viability, inhibition of cell proliferation and induction of apoptosis in OSA cell lines.  STA-1474 and its active metabolite STA-9090 also demonstrated increased potency compared to 17-AAG.  STA-1474 exhibited selectivity for OSA cells vs. normal canine osteoblasts, and HSP90 co-pptd. with co-chaperones p23 and Hop in canine OSA cells but not in normal canine osteoblasts.  Furthermore, STA-1474 downregulated the expression of p-Met/Met, p-Akt/Akt and p-STAT3.  Finally, STA-1474 induced tumor regression, caspase-3 activation and downregulation of p-Met/Met and p-Akt/Akt in OSA xenografts.  Together, these data suggest that HSP90 represents a relevant target for therapeutic intervention in OSA. © 2009 UICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6OY9Zp2J7BLVg90H21EOLACvtfcHk0liQEeTM23q4aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsLjM&md5=fb4fdefb903eed2f78ecf5ac96afaa50</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2Fijc.24660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24660%26sid%3Dliteratum%253Aachs%26aulast%3DMcCleese%26aufirst%3DJ.%2BK.%26aulast%3DBear%26aufirst%3DM.%2BD.%26aulast%3DFossey%26aufirst%3DS.%2BL.%26aulast%3DMihalek%26aufirst%3DR.%2BM.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DLondon%26aufirst%3DC.%2BA.%26atitle%3DThe%2520novel%2520Hsp90%2520inhibitor%2520STA-1474%2520exhibits%2520biologic%2520activity%2520against%2520osteosarcoma%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Cancer.%26date%3D2009%26volume%3D125%26spage%3D2792%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chimmanamada, D.; Burlinson, J. A.; Ying, W.; Sun, L.; Schweizer, S. M.; Zhang, S.; Demko, Z.; James, D.; Prezwloka, T.</span><span> </span><span class="NLM_article-title">Triazole compounds that modulate Hsp90 activity</span>. US2011105483 (A1),<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Chimmanamada&author=J.+A.+Burlinson&author=W.+Ying&author=L.+Sun&author=S.+M.+Schweizer&author=S.+Zhang&author=Z.+Demko&author=D.+James&author=T.+Prezwloka&title=Triazole+compounds+that+modulate+Hsp90+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChimmanamada%26aufirst%3DD.%26atitle%3DTriazole%2520compounds%2520that%2520modulate%2520Hsp90%2520activity%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Majireck, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, S. M.</span><span> </span><span class="NLM_article-title">A Study of the scope and regioselectivity of the ruthenium-catalyzed [3 + 2]-cycloaddition of azides with internal alkynes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">8680</span><span class="NLM_x">–</span> <span class="NLM_lpage">8683</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo061688m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVaqs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=8680-8683&author=M.+M.+Majireckauthor=S.+M.+Weinreb&title=A+Study+of+the+scope+and+regioselectivity+of+the+ruthenium-catalyzed+%5B3+%2B+2%5D-cycloaddition+of+azides+with+internal+alkynes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Study of the Scope and Regioselectivity of the Ruthenium-Catalyzed [3 + 2]-Cycloaddition of Azides with Internal Alkynes</span></div><div class="casAuthors">Majireck, Max M.; Weinreb, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8680-8683</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">[3 + 2]-Cycloaddns. of alkyl azides with various unsym. internal alkynes in the presence of Cp*RuCl(PPh3)2 as catalyst in refluxing benzene have been examd., leading to 1,4,5-trisubstituted-1,2,3-triazoles, e.g., I.  Whereas alkyl Ph and dialkyl acetylenes undergo cycloaddns. to afford mixts. of regioisomeric 1,2,3-triazoles, acyl-substituted internal alkynes react with complete regioselectivity.  In addn., propargyl alcs. and propargyl amines were found to react with azides to afford single regioisomeric products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFceK7OGLHwrVg90H21EOLACvtfcHk0lgaZ4Gre6mmWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVaqs7bN&md5=93ea6404f7e2a5219b799b0db84e29ca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo061688m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061688m%26sid%3Dliteratum%253Aachs%26aulast%3DMajireck%26aufirst%3DM.%2BM.%26aulast%3DWeinreb%26aufirst%3DS.%2BM.%26atitle%3DA%2520Study%2520of%2520the%2520scope%2520and%2520regioselectivity%2520of%2520the%2520ruthenium-catalyzed%2520%255B3%2520%252B%25202%255D-cycloaddition%2520of%2520azides%2520with%2520internal%2520alkynes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D8680%26epage%3D8683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Spiteri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Copper-catalyzed azide–alkyne cycloaddition: regioselective synthesis of 1,4,5-trisubstituted 1,2,3-triazoles</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=31-33&author=C.+Spiteriauthor=J.+E.+Moses&title=Copper-catalyzed+azide%E2%80%93alkyne+cycloaddition%3A+regioselective+synthesis+of+1%2C4%2C5-trisubstituted+1%2C2%2C3-triazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpiteri%26aufirst%3DC.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DCopper-catalyzed%2520azide%25E2%2580%2593alkyne%2520cycloaddition%253A%2520regioselective%2520synthesis%2520of%25201%252C4%252C5-trisubstituted%25201%252C2%252C3-triazoles%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D31%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">Because of detection limits of the assay, the most active compounds were reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> as having IC<sub>50</sub> < 5 nM. However, curve fitting using the GraphPad Prism software program suggested a binding lower than 3.0 nM for compounds <b>18</b>, <b>21</b>, <b>25</b>, <b>26</b>, <b>27</b>, while the best IC<sub>50</sub> value was found for pyrrolidine derivative <b>21</b> (IC<sub>50</sub> = 1 nM). For the limits of the assay see the following:</p></div><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=L.+Llaugerauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0lgaZ4Gre6mmWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><div class="note"><p class="first last">LC/MS analysis showed that compound <b>44</b> is stable under conditions employed in the FP assay. For resorcinol esterification in order to get an effective pro-drug see the following:</p></div><span class="NLM_contrib-group">London, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paalangara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span> </span><span class="NLM_article-title">Phase I evaluation of STA-1474, a prodrug of the novel Hsp90 inhibitor ganetespib, in dogs with spontaneous cancer</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e2701&author=C.+A.+Londonauthor=M.+D.+Bearauthor=J.+McCleeseauthor=K.+P.+Foleyauthor=R.+Paalangaraauthor=T.+Inoueauthor=W.+Yingauthor=J.+Barsoum&title=Phase+I+evaluation+of+STA-1474%2C+a+prodrug+of+the+novel+Hsp90+inhibitor+ganetespib%2C+in+dogs+with+spontaneous+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DC.%2BA.%26aulast%3DBear%26aufirst%3DM.%2BD.%26aulast%3DMcCleese%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DPaalangara%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26atitle%3DPhase%2520I%2520evaluation%2520of%2520STA-1474%252C%2520a%2520prodrug%2520of%2520the%2520novel%2520Hsp90%2520inhibitor%2520ganetespib%252C%2520in%2520dogs%2520with%2520spontaneous%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">Compound <b>18</b> and NVP-AUY922 bind Hsp90 comparably with the diverse STA-9090 (ganatesib):</p></div><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Ganetespib (STA-9090), a nongeldanamycin Hsp90 inhibitor, has potent antitumor activity in vitro and in vivo models of non-small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1158%2F1078-0432.CCR-11-2967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=22806877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4973-4982&author=T.+Shimamuraauthor=S.+A.+Pereraauthor=K.+P.+Foleyauthor=J.+Sangauthor=S.+J.+Rodigauthor=T.+Inoueauthor=L.+Chenauthor=D.+Liauthor=J.+Carreteroauthor=Y.-C.+Liauthor=P.+Sinhaauthor=C.+D.+Careyauthor=C.+L.+Borgmanauthor=J.-P.+Jimenezauthor=M.+Meyersonauthor=W.+Yingauthor=J.+Barsoumauthor=K.-K.+Wongauthor=G.+I.+Shapiro&title=Ganetespib+%28STA-9090%29%2C+a+nongeldanamycin+Hsp90+inhibitor%2C+has+potent+antitumor+activity+in+vitro+and+in+vivo+models+of+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Shimamura, Takeshi; Perera, Samanthi A.; Foley, Kevin P.; Sang, Jim; Rodig, Scott J.; Inoue, Takayo; Chen, Liang; Li, Danan; Carretero, Julian; Li, Yu-Chen; Sinha, Papiya; Carey, Christopher D.; Borgman, Christa L.; Jimenez, John-Paul; Meyerson, Matthew; Ying, Weiwen; Barsoum, James; Wong, Kwok-Kin; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4973-4985</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We describe the anticancer activity of ganetespib, a novel non-geldanamycin heat shock protein 90 (HSP90) inhibitor, in non-small cell lung cancer (NSCLC) models.  Exptl. Design: The activity of ganetespib was compared with that of the geldanamycin 17-AAG in biochem. assays, cell lines, and xenografts, and evaluated in an ERBB2 YVMA-driven mouse lung adenocarcinoma model.  Results: Ganetespib blocked the ability of HSP90 to bind to biotinylated geldanamycin and disrupted the assocn. of HSP90 with its cochaperone, p23, more potently than 17-AAG.  In genomically defined NSCLC cell lines, ganetespib caused depletion of receptor tyrosine kinases, extinguishing of downstream signaling, inhibition of proliferation and induction of apoptosis with IC50 values ranging 2 to 30 nmol/L, substantially lower than those required for 17-AAG (20-3,500 nmol/L).  Ganetespib was also approx. 20-fold more potent in isogenic Ba/F3 pro-B cells rendered IL-3 independent by expression of EGFR and ERBB2 mutants.  In mice bearing NCI-H1975 (EGFR L858R/T790M) xenografts, ganetespib was rapidly eliminated from plasma and normal tissues but was maintained in tumor with t1/2 58.3 h, supporting once-weekly dosing expts., in which ganetespib produced greater tumor growth inhibition than 17-AAG.  However, after a single dose, reexpression of mutant EGFR occurred by 72 h, correlating with reversal of antiproliferative and proapoptotic effects.  Consecutive day dosing resulted in xenograft regressions, accompanied by more sustained pharmacodynamic effects.  Ganetespib also showed activity against mouse lung adenocarcinomas driven by oncogenic ERBB2 YVMA.  Conclusions: Ganetespib has greater potency than 17-AAG and potential efficacy against several NSCLC subsets, including those harboring EGFR or ERBB2 mutation.  Clin Cancer Res; 18(18); 4973-85. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoOaAHBIqU6bVg90H21EOLACvtfcHk0lgw-atuW5oJgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ&md5=92bb99dd7de0f7d4fc4f1d1a897605ea</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2967%26sid%3Dliteratum%253Aachs%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DPerera%26aufirst%3DS.%2BA.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCarretero%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-C.%26aulast%3DSinha%26aufirst%3DP.%26aulast%3DCarey%26aufirst%3DC.%2BD.%26aulast%3DBorgman%26aufirst%3DC.%2BL.%26aulast%3DJimenez%26aufirst%3DJ.-P.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DGanetespib%2520%2528STA-9090%2529%252C%2520a%2520nongeldanamycin%2520Hsp90%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D4973%26epage%3D4982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Koga, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1393-402&author=F.+Kogaauthor=S.+Tsutsumiauthor=L.+M.+Neckers&title=Low+dose+geldanamycin+inhibits+hepatocyte+growth+factor+and+hypoxia-stimulated+invasion+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DF.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DLow%2520dose%2520geldanamycin%2520inhibits%2520hepatocyte%2520growth%2520factor%2520and%2520hypoxia-stimulated%2520invasion%2520of%2520cancer%2520cells%26jtitle%3DCell%2520Cycle%26date%3D2007%26volume%3D6%26spage%3D1393%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kijima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibaldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=11839685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFens7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=620-7&author=G.+Maulikauthor=T.+Kijimaauthor=P.+C.+Maauthor=S.+K.+Ghoshauthor=J.+Linauthor=G.+I.+Shapiroauthor=E.+Schaeferauthor=E.+Tibaldiauthor=B.+E.+Johnsonauthor=R.+Salgia&title=Modulation+of+the+c-Met%2Fhepatocyte+growth+factor+pathway+in+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer</span></div><div class="casAuthors">Maulik, Gautam; Kijima, Takashi; Ma, Patrick C.; Ghosh, Sudip K.; Lin, Jeffrey; Shapiro, Geoffrey I.; Schaefer, Erik; Tibaldi, Elena; Johnson, Bruce E.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">620-627</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand HGF (hepatocyte growth factor) have been shown to be involved in angiogenesis, cellular motility, growth, invasion, and differentiation.  The role of c-Met/HGF axis in small cell lung cancer (SCLC) has not been reported previously.  We have detd. the expression of p170c-Met precursor and p140c-Met β-chain in seven SCLC cell lines by immunoblotting.  We used the SCLC cell line H69, which expressed an abundant amt. of c-Met to study the function and downstream effects of c-Met activation.  Stimulation of H69 cells with HGF (40 ng/mL, 6-h stimulation) significantly altered cell motility of the SCLC cells with increased formation of filopodia and membrane ruffling, characterized as membrane blebbing, as well as increased migration of the cellular clusters were seen.  We have further studied the signal transduction pathways of HGF/c-Met in the H69 cell line.  The stimulation of H69 with HGF (40 ng/mL, >24 h, maximal at 1 h) increased the amt. of reactive oxygen species formed by 34%.  HGF stimulation (40 ng/mL, 7.5-min stimulation) of H69 cells showed increased tyrosine phosphorylated bands identified at Mr 68,000, 120,000-140,000, and 200,000.  Some of these tyrosine-phosphorylated bands were identified as the focal adhesion proteins paxillin, FAK, PYK2, and the c-Met receptor itself.  Phospho-specific antibodies show that tyrosines at amino acid (a.a.) 31 of paxillin, and autophosphorylation sites at a.a. 397 of p125FAK, and a.a. 402 of PYK2 are phosphorylated in response to HGF/c-Met signaling.  We also demonstrate that the Hsp90 inhibitor geldanamycin, which also affects c-Met, reduced the growth and viability of four of four SCLC cell lines by 25% to 85%, over a 72-h time period.  Geldanamycin caused apoptosis of SCLC cells, as well as led to increased levels of Hsp70 but not Hsp90.  These results demonstrate that c-Met/HGF pathway is functional in SCLC, and it would be useful to target this pathway toward novel therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_d-kEyrq5bVg90H21EOLACvtfcHk0lgw-atuW5oJgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFens7w%253D&md5=528b03929eccc62a21f6fcbfb8e3e237</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DKijima%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DGhosh%26aufirst%3DS.%2BK.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DTibaldi%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DModulation%2520of%2520the%2520c-Met%252Fhepatocyte%2520growth%2520factor%2520pathway%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D620%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">Compounds <b>18</b> and <b>19</b> were dosed differently and according to different schedules because the experimental conditions were chosen upon a series of preliminary experiments to identify the best tolerability and efficacy.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><div class="note"><p class="first last">Screening was performed by Reaction Biology Corp., Malvern, PA. See the following:</p></div><span class="NLM_contrib-group">Auzzas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschênes-Simard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanessian, S.</span><span> </span><span class="NLM_article-title">Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8387</span><span class="NLM_x">–</span> <span class="NLM_lpage">8399</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101092u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWrtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8387-8399&author=L.+Auzzasauthor=A.+Larssonauthor=R.+Materaauthor=A.+Baraldiauthor=B.+Desch%C3%AAnes-Simardauthor=G.+Gianniniauthor=W.+Cabriauthor=G.+Battistuzziauthor=G.+Galloauthor=A.+Ciacciauthor=L.+Vesciauthor=C.+Pisanoauthor=S.+Hanessian&title=Non-natural+macrocyclic+inhibitors+of+histone+deacetylases%3A+design%2C+synthesis%2C+and+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity</span></div><div class="casAuthors">Auzzas, Luciana; Larsson, Andreas; Matera, Riccardo; Baraldi, Annamaria; Deschenes-Simard, Benoit; Giannini, Giuseppe; Cabri, Walter; Battistuzzi, Gianfranco; Gallo, Grazia; Ciacci, Andrea; Vesci, Loredana; Pisano, Claudio; Hanessian, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8387-8399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonpeptidic chiral macrocycles, e.g. I [X = (CH2)n, n = 1-3], were designed on the basis of an analog of suberoylanilide hydroxamic acid II (SAHA, vorinostat) and evaluated against 11 histone deacetylase (HDAC) isoforms.  The identification of crit. amino acid residues highly conserved in the cap region of HDACs guided the design of the suberoyl-based macrocycles, which were expected to bear a max. common substructure required to target the whole HDAC panel.  A nanomolar HDAC inhibitory profile was obsd. for several compds., which was comparable, if not superior, to that of II.  A promising cytotoxic activity was found for selected macrocycles against lung and colon cancer cell lines.  Further elaboration of selected candidates led to compds. with an improved selectivity against HDAC6 over the other isoenzymes.  Pair-fitting anal. was used to compare one of the best candidates with the natural tetrapeptide apicidin, in an effort to define a general pharmacophore that might be useful in the design of surrogates of peptidic macrocycles as potent and isoform-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJOcBz2w8SRLVg90H21EOLACvtfcHk0lh4EkatWo0XuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWrtb%252FI&md5=061fb93af453824141ca9c0fdb09a701</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm101092u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101092u%26sid%3Dliteratum%253Aachs%26aulast%3DAuzzas%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DMatera%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DA.%26aulast%3DDesch%25C3%25AAnes-Simard%26aufirst%3DB.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DBattistuzzi%26aufirst%3DG.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DCiacci%26aufirst%3DA.%26aulast%3DVesci%26aufirst%3DL.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DHanessian%26aufirst%3DS.%26atitle%3DNon-natural%2520macrocyclic%2520inhibitors%2520of%2520histone%2520deacetylases%253A%2520design%252C%2520synthesis%252C%2520and%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8387%26epage%3D8399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kekatpure, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subbaramaiah, K.</span><span> </span><span class="NLM_article-title">HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">7436</span><span class="NLM_x">–</span> <span class="NLM_lpage">7445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=7436-7445&author=V.+D.+Kekatpureauthor=A.+J.+Dannenbergauthor=K.+Subbaramaiah&title=HDAC6+modulates+Hsp90+chaperone+activity+and+regulates+activation+of+aryl+hydrocarbon+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKekatpure%26aufirst%3DV.%2BD.%26aulast%3DDannenberg%26aufirst%3DA.%2BJ.%26aulast%3DSubbaramaiah%26aufirst%3DK.%26atitle%3DHDAC6%2520modulates%2520Hsp90%2520chaperone%2520activity%2520and%2520regulates%2520activation%2520of%2520aryl%2520hydrocarbon%2520receptor%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D7436%26epage%3D7445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bali, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pranpar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaraswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyapalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span> </span><span class="NLM_article-title">Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">26729</span><span class="NLM_x">–</span> <span class="NLM_lpage">26734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=26729-26734&author=P.+Baliauthor=M.+Pranparauthor=J.+Bradnerauthor=M.+Balasisauthor=W.+Fiskusauthor=F.+Guoauthor=K.+Rochaauthor=S.+Kumaraswamyauthor=S.+Boyapalleauthor=P.+Atadjaauthor=E.+Setoauthor=K.+Bhalla&title=Inhibition+of+histone+deacetylase+6+acetylates+and+disrupts+the+chaperone+function+of+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBali%26aufirst%3DP.%26aulast%3DPranpar%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DBalasis%26aufirst%3DM.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DRocha%26aufirst%3DK.%26aulast%3DKumaraswamy%26aufirst%3DS.%26aulast%3DBoyapalle%26aufirst%3DS.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DSeto%26aufirst%3DE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%25206%2520acetylates%2520and%2520disrupts%2520the%2520chaperone%2520function%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D26729%26epage%3D26734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandawat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span> </span><span class="NLM_article-title">HDAC6 inhibition enhances 17-AAG mediated abrogation of Hsp90 chaperone function in human leukemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">1886</span><span class="NLM_x">–</span> <span class="NLM_lpage">1893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1886-1893&author=R.+Raoauthor=W.+Fiskusauthor=Y.+Yangauthor=P.+Leeauthor=R.+Joshiauthor=P.+Fernandezauthor=A.+Mandawatauthor=P.+Atadjaauthor=J.+E.+Bradnerauthor=K.+Bhalla&title=HDAC6+inhibition+enhances+17-AAG+mediated+abrogation+of+Hsp90+chaperone+function+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DP.%26aulast%3DMandawat%26aufirst%3DA.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DHDAC6%2520inhibition%2520enhances%252017-AAG%2520mediated%2520abrogation%2520of%2520Hsp90%2520chaperone%2520function%2520in%2520human%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1886%26epage%3D1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':[],'ref31':['cit31'],'ref32':['cit32a','cit32b','cit32c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ercheng Wang, Huiyong Sun, Junmei Wang, Zhe Wang, Hui Liu, John Z. H. Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Tingjun Hou</span>. </span><span class="cited-content_cbyCitation_article-title">End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2019,</strong> <em>119 </em>
                                    (16)
                                     , 9478-9508. <a href="https://doi.org/10.1021/acs.chemrev.9b00055" title="DOI URL">https://doi.org/10.1021/acs.chemrev.9b00055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.9b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.9b00055%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DEnd-Point%252BBinding%252BFree%252BEnergy%252BCalculation%252Bwith%252BMM%25252FPBSA%252Band%252BMM%25252FGBSA%25253A%252BStrategies%252Band%252BApplications%252Bin%252BDrug%252BDesign%26aulast%3DWang%26aufirst%3DErcheng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21012019%26date%3D24062019%26volume%3D119%26issue%3D16%26spage%3D9478%26epage%3D9508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fen  Jiang</span>, <span class="hlFld-ContribAuthor ">Hui-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yu-Hui  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Min  Jia</span>, <span class="hlFld-ContribAuthor ">Fang  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Chao  Bao</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Qi-Dong  You</span>, and <span class="hlFld-ContribAuthor ">Xiao-Li  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Tetrahydropyrido[4,3-d]pyrimidines as Potent Inhibitors of Chaperone Heat Shock Protein 90. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10498-10519. <a href="https://doi.org/10.1021/acs.jmedchem.6b00912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00912%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BTetrahydropyrido%25255B4%25252C3-d%25255Dpyrimidines%252Bas%252BPotent%252BInhibitors%252Bof%252BChaperone%252BHeat%252BShock%252BProtein%252B90%26aulast%3DJiang%26aufirst%3DFen%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D17062016%26date%3D22112016%26date%3D08122016%26date%3D09112016%26volume%3D59%26issue%3D23%26spage%3D10498%26epage%3D10519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serena  Ferrini</span>, <span class="hlFld-ContribAuthor ">Jay Zumbar  Chandanshive</span>, <span class="hlFld-ContribAuthor ">Stefano  Lena</span>, <span class="hlFld-ContribAuthor ">Mauro  Comes Franchini</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Andrea  Tafi</span>, and <span class="hlFld-ContribAuthor ">Maurizio  Taddei</span>  . </span><span class="cited-content_cbyCitation_article-title">Ruthenium-Catalyzed Synthesis of 5-Amino-1,2,3-triazole-4-carboxylates for Triazole-Based Scaffolds: Beyond the Dimroth Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (5)
                                     , 2562-2572. <a href="https://doi.org/10.1021/jo502577e" title="DOI URL">https://doi.org/10.1021/jo502577e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo502577e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo502577e%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRuthenium-Catalyzed%252BSynthesis%252Bof%252B5-Amino-1%25252C2%25252C3-triazole-4-carboxylates%252Bfor%252BTriazole-Based%252BScaffolds%25253A%252BBeyond%252Bthe%252BDimroth%252BRearrangement%26aulast%3DFerrini%26aufirst%3DSerena%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D11112014%26date%3D16022015%26date%3D06032015%26date%3D05022015%26volume%3D80%26issue%3D5%26spage%3D2562%26epage%3D2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rohit  Bhat</span>, <span class="hlFld-ContribAuthor ">Sreedhar R.  Tummalapalli</span>, and <span class="hlFld-ContribAuthor ">David P.  Rotella</span>  . </span><span class="cited-content_cbyCitation_article-title">Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (21)
                                     , 8718-8728. <a href="https://doi.org/10.1021/jm500823a" title="DOI URL">https://doi.org/10.1021/jm500823a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500823a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500823a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252Bthe%252BDiscovery%252Band%252BDevelopment%252Bof%252BHeat%252BShock%252BProtein%252B90%252B%252528Hsp90%252529%252BInhibitors%26aulast%3DBhat%26aufirst%3DRohit%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D30052014%26date%3D29082014%26date%3D13112014%26date%3D20082014%26volume%3D57%26issue%3D21%26spage%3D8718%26epage%3D8728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nazariy  Pokhodylo</span>, <span class="hlFld-ContribAuthor ">Nazar  Manko</span>, <span class="hlFld-ContribAuthor ">Nataliya  Finiuk</span>, <span class="hlFld-ContribAuthor ">Olha  Klyuchivska</span>, <span class="hlFld-ContribAuthor ">Vasyl  Matiychuk</span>, <span class="hlFld-ContribAuthor ">Mykola  Obushak</span>, <span class="hlFld-ContribAuthor ">Rostyslav  Stoika</span>. </span><span class="cited-content_cbyCitation_article-title">Primary discovery of 1-aryl-5-substituted-1H-1,2,3-triazole-4-carboxamides as promising antimicrobial agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1246 </em>, 131146. <a href="https://doi.org/10.1016/j.molstruc.2021.131146" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131146%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DPrimary%252Bdiscovery%252Bof%252B1-aryl-5-substituted-1H-1%25252C2%25252C3-triazole-4-carboxamides%252Bas%252Bpromising%252Bantimicrobial%252Bagents%26aulast%3DPokhodylo%26aufirst%3DNazariy%26date%3D2021%26volume%3D1246%26spage%3D131146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Yuan</span>, <span class="hlFld-ContribAuthor ">Jie  Tu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Xi  Chen</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Microbiology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fmicb.2021.680382" title="DOI URL">https://doi.org/10.3389/fmicb.2021.680382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmicb.2021.680382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmicb.2021.680382%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Microbiology%26atitle%3DEffects%252Bof%252BHsp90%252BInhibitor%252BGanetespib%252Bon%252BInhibition%252Bof%252BAzole-Resistant%252BCandida%252Balbicans%26aulast%3DYuan%26aufirst%3DRui%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisha  Poonia</span>, <span class="hlFld-ContribAuthor ">Kashmiri  Lal</span>, <span class="hlFld-ContribAuthor ">Ashwani  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, antimicrobial evaluation and in silico studies of symmetrical bis (urea-1,2,3-triazole) hybrids. </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2021,</strong> <em>47 </em>
                                    (3)
                                     , 1087-1103. <a href="https://doi.org/10.1007/s11164-020-04318-1" title="DOI URL">https://doi.org/10.1007/s11164-020-04318-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-020-04318-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-020-04318-1%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bantimicrobial%252Bevaluation%252Band%252Bin%252Bsilico%252Bstudies%252Bof%252Bsymmetrical%252Bbis%252B%252528urea-1%25252C2%25252C3-triazole%252529%252Bhybrids%26aulast%3DPoonia%26aufirst%3DNisha%26date%3D2021%26date%3D2020%26volume%3D47%26issue%3D3%26spage%3D1087%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">De-pu  Wang</span>, <span class="hlFld-ContribAuthor ">Kai-li  Liu</span>, <span class="hlFld-ContribAuthor ">Xin-yang  Li</span>, <span class="hlFld-ContribAuthor ">Guo-qing  Lu</span>, <span class="hlFld-ContribAuthor ">Wen-han  Xue</span>, <span class="hlFld-ContribAuthor ">Xin-hua  Qian</span>, <span class="hlFld-ContribAuthor ">Kamara  Mohamed O</span>, <span class="hlFld-ContribAuthor ">Fan-hao  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113083. <a href="https://doi.org/10.1016/j.ejmech.2020.113083" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113083%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Banti-angiogenesis%252Bstudy%252Bof%252Ba%252Bnovel%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor-2%252B%252528VEGFR-2%252529%252Binhibitor%252Bbased%252Bon%252B1%25252C2%25252C3-triazole%252Bscaffold%26aulast%3DWang%26aufirst%3DDe-pu%26date%3D2021%26volume%3D211%26spage%3D113083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  Cianferotti</span>, <span class="hlFld-ContribAuthor ">Valentina  Faltoni</span>, <span class="hlFld-ContribAuthor ">Elena  Cini</span>, <span class="hlFld-ContribAuthor ">Elena  Ermini</span>, <span class="hlFld-ContribAuthor ">Francesca  Migliorini</span>, <span class="hlFld-ContribAuthor ">Elena  Petricci</span>, <span class="hlFld-ContribAuthor ">Maurizio  Taddei</span>, <span class="hlFld-ContribAuthor ">Laura  Salvini</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Battistuzzi</span>, <span class="hlFld-ContribAuthor ">Ferdinando Maria  Milazzo</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Anastasi</span>, <span class="hlFld-ContribAuthor ">Caterina  Chiapparino</span>, <span class="hlFld-ContribAuthor ">Rita  De Santis</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>. </span><span class="cited-content_cbyCitation_article-title">Antibody drug conjugates with hydroxamic acid cargos for histone deacetylase (HDAC) inhibition. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2021,</strong> <em>57 </em>
                                    (7)
                                     , 867-870. <a href="https://doi.org/10.1039/D0CC06131J" title="DOI URL">https://doi.org/10.1039/D0CC06131J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC06131J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC06131J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DAntibody%252Bdrug%252Bconjugates%252Bwith%252Bhydroxamic%252Bacid%252Bcargos%252Bfor%252Bhistone%252Bdeacetylase%252B%252528HDAC%252529%252Binhibition%26aulast%3DCianferotti%26aufirst%3DClaudio%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D7%26spage%3D867%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeevan  Patra</span>, <span class="hlFld-ContribAuthor ">Deepanmol  Singh</span>, <span class="hlFld-ContribAuthor ">Sapna  Jain</span>, <span class="hlFld-ContribAuthor ">Neeraj  Mahindroo</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Docking for Lead Optimization. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 271-294. <a href="https://doi.org/10.1016/B978-0-12-822312-3.00012-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-822312-3.00012-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-822312-3.00012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-822312-3.00012-6%26sid%3Dliteratum%253Aachs%26atitle%3DApplication%252Bof%252BDocking%252Bfor%252BLead%252BOptimization%26aulast%3DPatra%26aufirst%3DJeevan%26date%3D2021%26spage%3D271%26epage%3D294%26pub%3DElsevier%26atitle%3DMolecular%252BDocking%252Bfor%252BComputer-Aided%252BDrug%252BDesign%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xue  Cui</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Tingting  Zeng</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yinfeng  Tan</span>, <span class="hlFld-ContribAuthor ">Dongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Xuesong  Wang</span>, <span class="hlFld-ContribAuthor ">Youbin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Base‐Promoted Regiospecific Synthesis of Fully Substituted 1,2,3‐Triazoles and 1,5‐Disubstituted 1,2,3‐Triazoles. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>9 </em>
                                    (12)
                                     , 2176-2183. <a href="https://doi.org/10.1002/ajoc.202000479" title="DOI URL">https://doi.org/10.1002/ajoc.202000479</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.202000479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.202000479%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DBase%2525E2%252580%252590Promoted%252BRegiospecific%252BSynthesis%252Bof%252BFully%252BSubstituted%252B1%25252C2%25252C3%2525E2%252580%252590Triazoles%252Band%252B1%25252C5%2525E2%252580%252590Disubstituted%252B1%25252C2%25252C3%2525E2%252580%252590Triazoles%26aulast%3DZhang%26aufirst%3DXueying%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D12%26spage%3D2176%26epage%3D2183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamed W.  El-Shafey</span>, <span class="hlFld-ContribAuthor ">Rania M.  Gomaa</span>, <span class="hlFld-ContribAuthor ">Shahenda M.  El-Messery</span>, <span class="hlFld-ContribAuthor ">Fatma E.  Goda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches, anticancer potential, HSP90 inhibition, multitarget evaluation, molecular modeling and apoptosis mechanistic study of thioquinazolinone skeleton: Promising antibreast cancer agent. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 103987. <a href="https://doi.org/10.1016/j.bioorg.2020.103987" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103987</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103987%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%25252C%252Banticancer%252Bpotential%25252C%252BHSP90%252Binhibition%25252C%252Bmultitarget%252Bevaluation%25252C%252Bmolecular%252Bmodeling%252Band%252Bapoptosis%252Bmechanistic%252Bstudy%252Bof%252Bthioquinazolinone%252Bskeleton%25253A%252BPromising%252Bantibreast%252Bcancer%252Bagent%26aulast%3DEl-Shafey%26aufirst%3DHamed%2BW.%26date%3D2020%26volume%3D101%26spage%3D103987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. G.  Hosseini</span>, <span class="hlFld-ContribAuthor ">K.  Moeini</span>, <span class="hlFld-ContribAuthor ">M. S. M.  Abdelbaky</span>, <span class="hlFld-ContribAuthor ">S.  García-Granda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Characterization, Crystal Structure, and Thermal Behavior of New Triazolium Salt Along with Docking Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Structural Chemistry</span><span> <strong>2020,</strong> <em>61 </em>
                                    (3)
                                     , 366-376. <a href="https://doi.org/10.1134/S002247662003004X" title="DOI URL">https://doi.org/10.1134/S002247662003004X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S002247662003004X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS002247662003004X%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Structural%2520Chemistry%26atitle%3DSynthesis%25252C%252BCharacterization%25252C%252BCrystal%252BStructure%25252C%252Band%252BThermal%252BBehavior%252Bof%252BNew%252BTriazolium%252BSalt%252BAlong%252Bwith%252BDocking%252BStudies%26aulast%3DHosseini%26aufirst%3DS.%2BG.%26date%3D2020%26date%3D2020%26volume%3D61%26issue%3D3%26spage%3D366%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caterina  Risi</span>, <span class="hlFld-ContribAuthor ">Massimo  Calamante</span>, <span class="hlFld-ContribAuthor ">Elena  Cini</span>, <span class="hlFld-ContribAuthor ">Valentina  Faltoni</span>, <span class="hlFld-ContribAuthor ">Elena  Petricci</span>, <span class="hlFld-ContribAuthor ">Filippo  Rosati</span>, <span class="hlFld-ContribAuthor ">Maurizio  Taddei</span>. </span><span class="cited-content_cbyCitation_article-title">In water alkylation of amines with alcohols through a borrowing hydrogen process catalysed by ruthenium nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (2)
                                     , 327-331. <a href="https://doi.org/10.1039/C9GC03351C" title="DOI URL">https://doi.org/10.1039/C9GC03351C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC03351C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC03351C%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DIn%252Bwater%252Balkylation%252Bof%252Bamines%252Bwith%252Balcohols%252Bthrough%252Ba%252Bborrowing%252Bhydrogen%252Bprocess%252Bcatalysed%252Bby%252Bruthenium%252Bnanoparticles%26aulast%3DRisi%26aufirst%3DCaterina%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D2%26spage%3D327%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sejin  Jung</span>, <span class="hlFld-ContribAuthor ">Nam Gu  Yoon</span>, <span class="hlFld-ContribAuthor ">Sujae  Yang</span>, <span class="hlFld-ContribAuthor ">Darong  Kim</span>, <span class="hlFld-ContribAuthor ">Won Seok  Lee</span>, <span class="hlFld-ContribAuthor ">Ki Bum  Hong</span>, <span class="hlFld-ContribAuthor ">Changwook  Lee</span>, <span class="hlFld-ContribAuthor ">Byoung Heon  Kang</span>, <span class="hlFld-ContribAuthor ">Ji Hoon  Lee</span>, <span class="hlFld-ContribAuthor ">Soosung  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126809. <a href="https://doi.org/10.1016/j.bmcl.2019.126809" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126809</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126809%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-%252528%2525284-resorcinolyl%252529-5-aryl-1%25252C2%25252C3-triazol-1-yl%252529acetates%252Bas%252Bpotent%252BHsp90%252Binhibitors%252Bwith%252Bselectivity%252Bover%252BTRAP1%26aulast%3DJung%26aufirst%3DSejin%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Matysiak</span>, <span class="hlFld-ContribAuthor ">Monika M.  Karpińska</span>, <span class="hlFld-ContribAuthor ">Alicja  Skrzypek</span>, <span class="hlFld-ContribAuthor ">Joanna  Wietrzyk</span>, <span class="hlFld-ContribAuthor ">Dagmara  Kłopotowska</span>, <span class="hlFld-ContribAuthor ">Andrzej  Niewiadomy</span>, <span class="hlFld-ContribAuthor ">Beata  Paw</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Juszczak</span>, <span class="hlFld-ContribAuthor ">Wojciech  Rzeski</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antiproliferative activity against human cancer cell lines of novel benzo-, benzofuro-, azolo- and thieno-1,3-thiazinone resorcinol hybrids. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2019,</strong> <em>12 </em>
                                    (8)
                                     , 2655-2667. <a href="https://doi.org/10.1016/j.arabjc.2015.05.006" title="DOI URL">https://doi.org/10.1016/j.arabjc.2015.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2015.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2015.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantiproliferative%252Bactivity%252Bagainst%252Bhuman%252Bcancer%252Bcell%252Blines%252Bof%252Bnovel%252Bbenzo-%25252C%252Bbenzofuro-%25252C%252Bazolo-%252Band%252Bthieno-1%25252C3-thiazinone%252Bresorcinol%252Bhybrids%26aulast%3DMatysiak%26aufirst%3DJoanna%26date%3D2019%26volume%3D12%26issue%3D8%26spage%3D2655%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, <span class="hlFld-ContribAuthor ">Mei-Hsiang  Lin</span>, <span class="hlFld-ContribAuthor ">Min-Wu  Chao</span>, <span class="hlFld-ContribAuthor ">Sheng-Jhih  Peng</span>, <span class="hlFld-ContribAuthor ">Kai-Cheng  Hsu</span>, <span class="hlFld-ContribAuthor ">Tony  Eight Lin</span>, <span class="hlFld-ContribAuthor ">Mei-Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Mei-Jung  Lai</span>, <span class="hlFld-ContribAuthor ">Shiow-Lin  Pan</span>, <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Amide-tethered quinoline-resorcinol conjugates as a new class of HSP90 inhibitors suppressing the growth of prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>91 </em>, 103119. <a href="https://doi.org/10.1016/j.bioorg.2019.103119" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103119%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAmide-tethered%252Bquinoline-resorcinol%252Bconjugates%252Bas%252Ba%252Bnew%252Bclass%252Bof%252BHSP90%252Binhibitors%252Bsuppressing%252Bthe%252Bgrowth%252Bof%252Bprostate%252Bcancer%252Bcells%26aulast%3DNepali%26aufirst%3DKunal%26date%3D2019%26volume%3D91%26spage%3D103119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hande  Gunduz</span>, <span class="hlFld-ContribAuthor ">Volkan  Kumbaraci</span>, <span class="hlFld-ContribAuthor ">Yılmaz  Özkılıç</span>, <span class="hlFld-ContribAuthor ">Nurcan Ş.  Tüzün</span>, <span class="hlFld-ContribAuthor ">Naciye  Talinli</span>. </span><span class="cited-content_cbyCitation_article-title">Amberlyst‐15‐catalyzed Procedure for the Synthesis of Novel 2,4‐Dihydroxybenzoyl‐1,2,3‐triazoles and Molecular Modelling Studies for Hsp‐90 Inhibition. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (24)
                                     , 7278-7283. <a href="https://doi.org/10.1002/slct.201901403" title="DOI URL">https://doi.org/10.1002/slct.201901403</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201901403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201901403%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAmberlyst%2525E2%252580%25259015%2525E2%252580%252590catalyzed%252BProcedure%252Bfor%252Bthe%252BSynthesis%252Bof%252BNovel%252B2%25252C4%2525E2%252580%252590Dihydroxybenzoyl%2525E2%252580%2525901%25252C2%25252C3%2525E2%252580%252590triazoles%252Band%252BMolecular%252BModelling%252BStudies%252Bfor%252BHsp%2525E2%252580%25259090%252BInhibition%26aulast%3DGunduz%26aufirst%3DHande%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D24%26spage%3D7278%26epage%3D7283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">Balakrishna  Moku</span>, <span class="hlFld-ContribAuthor ">Jing  Leng</span>, <span class="hlFld-ContribAuthor ">K. P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">2-Azidoethane-1-sulfonylfluoride (ASF): A Versatile
              Bis
              -clickable Reagent for SuFEx and CuAAC Click Reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (8)
                                     , 1763-1769. <a href="https://doi.org/10.1002/ejoc.201801825" title="DOI URL">https://doi.org/10.1002/ejoc.201801825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801825%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D2-Azidoethane-1-sulfonylfluoride%252B%252528ASF%252529%25253A%252BA%252BVersatile%252BBis%252B-clickable%252BReagent%252Bfor%252BSuFEx%252Band%252BCuAAC%252BClick%252BReactions%26aulast%3DZhang%26aufirst%3DXu%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D8%26spage%3D1763%26epage%3D1769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu  Zhang</span>, <span class="hlFld-ContribAuthor ">K. P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Transition-metal-free regioselective construction of 1,5-diaryl-1,2,3-triazoles through dehydrative cycloaddition of alcohols with aryl azides mediated by SO
              2
              F
              2. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (19)
                                     , 2845-2848. <a href="https://doi.org/10.1039/C8CC09693G" title="DOI URL">https://doi.org/10.1039/C8CC09693G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC09693G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC09693G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DTransition-metal-free%252Bregioselective%252Bconstruction%252Bof%252B1%25252C5-diaryl-1%25252C2%25252C3-triazoles%252Bthrough%252Bdehydrative%252Bcycloaddition%252Bof%252Balcohols%252Bwith%252Baryl%252Bazides%252Bmediated%252Bby%252BSO%252B2%252BF%252B2%26aulast%3DZhang%26aufirst%3DXu%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D19%26spage%3D2845%26epage%3D2848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anlian  Zhu</span>, <span class="hlFld-ContribAuthor ">Lingjun  Li</span>, <span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yutan  Shen</span>, <span class="hlFld-ContribAuthor ">Mingjie  Tang</span>, <span class="hlFld-ContribAuthor ">Lili  Bai</span>, <span class="hlFld-ContribAuthor ">Chunyan  Du</span>, <span class="hlFld-ContribAuthor ">Suojiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianji  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An integrated high-throughput strategy enables the discovery of multifunctional ionic liquids for sustainable chemical processes. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (2)
                                     , 307-313. <a href="https://doi.org/10.1039/C8GC03119C" title="DOI URL">https://doi.org/10.1039/C8GC03119C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8GC03119C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8GC03119C%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DAn%252Bintegrated%252Bhigh-throughput%252Bstrategy%252Benables%252Bthe%252Bdiscovery%252Bof%252Bmultifunctional%252Bionic%252Bliquids%252Bfor%252Bsustainable%252Bchemical%252Bprocesses%26aulast%3DZhu%26aufirst%3DAnlian%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D2%26spage%3D307%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingjun  Li</span>, <span class="hlFld-ContribAuthor ">Xiaofang  Xing</span>, <span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Anlian  Zhu</span>, <span class="hlFld-ContribAuthor ">Xincui  Fan</span>, <span class="hlFld-ContribAuthor ">Changpo  Chen</span>, <span class="hlFld-ContribAuthor ">Guisheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel synthesis of 5-iodo-1,2,3-triazoles using an aqueous iodination system under air. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2018,</strong> <em>59 </em>
                                    (39)
                                     , 3563-3566. <a href="https://doi.org/10.1016/j.tetlet.2018.08.039" title="DOI URL">https://doi.org/10.1016/j.tetlet.2018.08.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2018.08.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2018.08.039%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DNovel%252Bsynthesis%252Bof%252B5-iodo-1%25252C2%25252C3-triazoles%252Busing%252Ban%252Baqueous%252Biodination%252Bsystem%252Bunder%252Bair%26aulast%3DLi%26aufirst%3DLingjun%26date%3D2018%26volume%3D59%26issue%3D39%26spage%3D3563%26epage%3D3566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Chuanle  Zhu</span>, <span class="hlFld-ContribAuthor ">Minke  Li</span>, <span class="hlFld-ContribAuthor ">Yue  Yu</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">TBAI or KI-Promoted Oxidative Coupling of Enamines and
              N
              -Tosylhydrazine: An Unconventional Method toward 1,5- and 1,4,5-Substituted 1,2,3-Triazoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2018,</strong> <em>360 </em>
                                    (16)
                                     , 3117-3123. <a href="https://doi.org/10.1002/adsc.201800487" title="DOI URL">https://doi.org/10.1002/adsc.201800487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201800487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201800487%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DTBAI%252Bor%252BKI-Promoted%252BOxidative%252BCoupling%252Bof%252BEnamines%252Band%252BN%252B-Tosylhydrazine%25253A%252BAn%252BUnconventional%252BMethod%252Btoward%252B1%25252C5-%252Band%252B1%25252C4%25252C5-Substituted%252B1%25252C2%25252C3-Triazoles%26aulast%3DHuang%26aufirst%3DWei%26date%3D2018%26date%3D2018%26volume%3D360%26issue%3D16%26spage%3D3117%26epage%3D3123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Jin</span>, <span class="hlFld-ContribAuthor ">Rizhen  Huang</span>, <span class="hlFld-ContribAuthor ">Xiaochao  Huang</span>, <span class="hlFld-ContribAuthor ">Bin  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>, <span class="hlFld-ContribAuthor ">Hengshan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (8)
                                     , 1759-1775. <a href="https://doi.org/10.1016/j.bmc.2018.02.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.02.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.02.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B18%2525CE%2525B2-glycyrrhetinic%252Bacid%252Bconjugated%252Baminobenzothiazole%252Bderivatives%252Bas%252BHsp90-Cdc37%252Binteraction%252Bdisruptors%252Bthat%252Binhibit%252Bcell%252Bmigration%252Band%252Breverse%252Bdrug%252Bresistance%26aulast%3DJin%26aufirst%3DLe%26date%3D2018%26volume%3D26%26issue%3D8%26spage%3D1759%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Manish  Kumar</span>, <span class="hlFld-ContribAuthor ">Vipin K.  Maikhuri</span>, <span class="hlFld-ContribAuthor ">Navneet  Manav</span>, <span class="hlFld-ContribAuthor ">Ashok K.  Prasad</span>, <span class="hlFld-ContribAuthor ">Divya  Mathur</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Chemistry of Tri-substituted Triazole via [3 + 2] Cycloaddition of Azide and Double Bond: An Overview. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 119-129. <a href="https://doi.org/10.1007/978-981-10-8390-7_12" title="DOI URL">https://doi.org/10.1007/978-981-10-8390-7_12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-10-8390-7_12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-10-8390-7_12%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BChemistry%252Bof%252BTri-substituted%252BTriazole%252Bvia%252B%25255B3%2525E2%252580%252589%25252B%2525E2%252580%2525892%25255D%252BCycloaddition%252Bof%252BAzide%252Band%252BDouble%252BBond%25253A%252BAn%252BOverview%26aulast%3DKumar%26aufirst%3DRajesh%26date%3D2018%26date%3D2018%26spage%3D119%26epage%3D129%26pub%3DSpringer%2520Singapore%26atitle%3DGreen%252BChemistry%252Bin%252BEnvironmental%252BSustainability%252Band%252BChemical%252BEducation%26aulast%3DParmar%26aufirst%3DVirinder%2BS.%26date%3D2018%26volume%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mizuki  Yamada</span>, <span class="hlFld-ContribAuthor ">Tsutomu  Takahashi</span>, <span class="hlFld-ContribAuthor ">Mai  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Mio  Matsumura</span>, <span class="hlFld-ContribAuthor ">Kanna  Ono</span>, <span class="hlFld-ContribAuthor ">Ryota  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Yuki  Kitamura</span>, <span class="hlFld-ContribAuthor ">Yuki  Murata</span>, <span class="hlFld-ContribAuthor ">Naoki  Kakusawa</span>, <span class="hlFld-ContribAuthor ">Motohiro  Tanaka</span>, <span class="hlFld-ContribAuthor ">Tohru  Obata</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Fujiwara</span>, <span class="hlFld-ContribAuthor ">Shuji  Yasuike</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, antitumor activity, and cytotoxicity of 4-substituted 1-benzyl-5-diphenylstibano-1H-1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (2)
                                     , 152-154. <a href="https://doi.org/10.1016/j.bmcl.2017.11.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bantitumor%252Bactivity%25252C%252Band%252Bcytotoxicity%252Bof%252B4-substituted%252B1-benzyl-5-diphenylstibano-1H-1%25252C2%25252C3-triazoles%26aulast%3DYamada%26aufirst%3DMizuki%26date%3D2018%26volume%3D28%26issue%3D2%26spage%3D152%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuele  Mauri</span>, <span class="hlFld-ContribAuthor ">Alessandro  Sacchetti</span>, <span class="hlFld-ContribAuthor ">Nunzio  Vicario</span>, <span class="hlFld-ContribAuthor ">Luca  Peruzzotti-Jametti</span>, <span class="hlFld-ContribAuthor ">Filippo  Rossi</span>, <span class="hlFld-ContribAuthor ">Stefano  Pluchino</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of RGD functionalization in hybrid hydrogels as 3D neural stem cell culture systems. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials Science</span><span> <strong>2018,</strong> <em>6 </em>
                                    (3)
                                     , 501-510. <a href="https://doi.org/10.1039/C7BM01056G" title="DOI URL">https://doi.org/10.1039/C7BM01056G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7BM01056G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7BM01056G%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%2520Science%26atitle%3DEvaluation%252Bof%252BRGD%252Bfunctionalization%252Bin%252Bhybrid%252Bhydrogels%252Bas%252B3D%252Bneural%252Bstem%252Bcell%252Bculture%252Bsystems%26aulast%3DMauri%26aufirst%3DEmanuele%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D3%26spage%3D501%26epage%3D510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Jun  Wang</span>, <span class="hlFld-ContribAuthor ">Chuan-Long  Guo</span>, <span class="hlFld-ContribAuthor ">Xiang-Qian  Li</span>, <span class="hlFld-ContribAuthor ">Shuai-Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>, <span class="hlFld-ContribAuthor ">Yue  Zhao</span>, <span class="hlFld-ContribAuthor ">Jiao  Luo</span>, <span class="hlFld-ContribAuthor ">Kuo  Xu</span>, <span class="hlFld-ContribAuthor ">Hua  Liu</span>, <span class="hlFld-ContribAuthor ">Shu-Ju  Guo</span>, <span class="hlFld-ContribAuthor ">Ning  Wu</span>, <span class="hlFld-ContribAuthor ">Da-Yong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Bromophenol Hybrids as Potential Anticancer Agents through the Ros-Mediated Apoptotic Pathway: Design, Synthesis and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2017,</strong> <em>15 </em>
                                    (11)
                                     , 343. <a href="https://doi.org/10.3390/md15110343" title="DOI URL">https://doi.org/10.3390/md15110343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md15110343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd15110343%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DDiscovery%252Bof%252BNovel%252BBromophenol%252BHybrids%252Bas%252BPotential%252BAnticancer%252BAgents%252Bthrough%252Bthe%252BRos-Mediated%252BApoptotic%252BPathway%25253A%252BDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%26aulast%3DWang%26aufirst%3DLi-Jun%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D11%26spage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anu  Mishra</span>, <span class="hlFld-ContribAuthor ">Pratibha  Rai</span>, <span class="hlFld-ContribAuthor ">Madhulika  Srivastava</span>, <span class="hlFld-ContribAuthor ">Bhartendu Pati  Tripathi</span>, <span class="hlFld-ContribAuthor ">Snehlata  Yadav</span>, <span class="hlFld-ContribAuthor ">Jaya  Singh</span>, <span class="hlFld-ContribAuthor ">Jagdamba  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">A Peerless Aproach: Organophotoredox/Cu(I) Catalyzed, Regioselective, Visible Light Facilitated, Click Synthesis of 1,2,3-Triazoles via Azide–Alkyne [3 + 2] Cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Letters</span><span> <strong>2017,</strong> <em>147 </em>
                                    (10)
                                     , 2600-2611. <a href="https://doi.org/10.1007/s10562-017-2156-8" title="DOI URL">https://doi.org/10.1007/s10562-017-2156-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10562-017-2156-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10562-017-2156-8%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Letters%26atitle%3DA%252BPeerless%252BAproach%25253A%252BOrganophotoredox%25252FCu%252528I%252529%252BCatalyzed%25252C%252BRegioselective%25252C%252BVisible%252BLight%252BFacilitated%25252C%252BClick%252BSynthesis%252Bof%252B1%25252C2%25252C3-Triazoles%252Bvia%252BAzide%2525E2%252580%252593Alkyne%252B%25255B3%2525E2%252580%252589%25252B%2525E2%252580%2525892%25255D%252BCycloaddition%26aulast%3DMishra%26aufirst%3DAnu%26date%3D2017%26date%3D2017%26volume%3D147%26issue%3D10%26spage%3D2600%26epage%3D2611" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Bakka</span>, <span class="hlFld-ContribAuthor ">Morten B.  Strøm</span>, <span class="hlFld-ContribAuthor ">Jeanette H.  Andersen</span>, <span class="hlFld-ContribAuthor ">Odd R.  Gautun</span>. </span><span class="cited-content_cbyCitation_article-title">Methyl propiolate and 3-butynone: Starting points for synthesis of amphiphilic 1,2,3-triazole peptidomimetics for antimicrobial evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (20)
                                     , 5380-5395. <a href="https://doi.org/10.1016/j.bmc.2017.07.060" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.07.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.07.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.07.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DMethyl%252Bpropiolate%252Band%252B3-butynone%25253A%252BStarting%252Bpoints%252Bfor%252Bsynthesis%252Bof%252Bamphiphilic%252B1%25252C2%25252C3-triazole%252Bpeptidomimetics%252Bfor%252Bantimicrobial%252Bevaluation%26aulast%3DBakka%26aufirst%3DThomas%2BA.%26date%3D2017%26volume%3D25%26issue%3D20%26spage%3D5380%26epage%3D5395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Lin  Zhao</span>, <span class="hlFld-ContribAuthor ">Wanli  Xing</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zong</span>, <span class="hlFld-ContribAuthor ">Shuai  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of ethyl 3-hydroxy-5-methyl-2-(4-(m-tolyl)-1H-1,2,3-triazol-1-yl)-[1,1′-biphenyl]-4- carboxylate, C25H24N3O3. </span><span class="cited-content_cbyCitation_journal-name">Zeitschrift für Kristallographie - New Crystal Structures</span><span> <strong>2017,</strong> <em>232 </em>
                                    (5)
                                     , 827-829. <a href="https://doi.org/10.1515/ncrs-2017-0065" title="DOI URL">https://doi.org/10.1515/ncrs-2017-0065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/ncrs-2017-0065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fncrs-2017-0065%26sid%3Dliteratum%253Aachs%26jtitle%3DZeitschrift%2520f%25C3%25BCr%2520Kristallographie%2520-%2520New%2520Crystal%2520Structures%26atitle%3DCrystal%252Bstructure%252Bof%252Bethyl%252B3-hydroxy-5-methyl-2-%2525284-%252528m-tolyl%252529-1H-1%25252C2%25252C3-triazol-1-yl%252529-%25255B1%25252C1%2525E2%252580%2525B2-biphenyl%25255D-4-%252Bcarboxylate%25252C%252BC25H24N3O3%26aulast%3DWang%26aufirst%3DQiang%26date%3D2017%26volume%3D232%26issue%3D5%26spage%3D827%26epage%3D829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyed Ghorban  Hosseini</span>, <span class="hlFld-ContribAuthor ">Keyvan  Moeini</span>, <span class="hlFld-ContribAuthor ">Mohammed S.M.  Abdelbaky</span>, <span class="hlFld-ContribAuthor ">Santiago  García-Granda</span>. </span><span class="cited-content_cbyCitation_article-title">A coordination polymer of mercury(II) formed by triazole-based and chloride linkers. </span><span class="cited-content_cbyCitation_journal-name">Zeitschrift für Naturforschung B</span><span> <strong>2017,</strong> <em>72 </em>
                                    (8)
                                     , 573-577. <a href="https://doi.org/10.1515/znb-2017-0052" title="DOI URL">https://doi.org/10.1515/znb-2017-0052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/znb-2017-0052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fznb-2017-0052%26sid%3Dliteratum%253Aachs%26jtitle%3DZeitschrift%2520f%25C3%25BCr%2520Naturforschung%2520B%26atitle%3DA%252Bcoordination%252Bpolymer%252Bof%252Bmercury%252528II%252529%252Bformed%252Bby%252Btriazole-based%252Band%252Bchloride%252Blinkers%26aulast%3DHosseini%26aufirst%3DSeyed%2BGhorban%26date%3D2017%26date%3D2017%26volume%3D72%26issue%3D8%26spage%3D573%26epage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mizuki  Yamada</span>, <span class="hlFld-ContribAuthor ">Mio  Matsumura</span>, <span class="hlFld-ContribAuthor ">Masatoshi  Kawahata</span>, <span class="hlFld-ContribAuthor ">Yuki  Murata</span>, <span class="hlFld-ContribAuthor ">Naoki  Kakusawa</span>, <span class="hlFld-ContribAuthor ">Kentaro  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Shuji  Yasuike</span>. </span><span class="cited-content_cbyCitation_article-title">Antimony–lithium exchange reaction: Synthesis of 1,4,5-trisubstituted-1,2,3-triazoles by triazolyllithium with electrophiles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Organometallic Chemistry</span><span> <strong>2017,</strong> <em>834 </em>, 83-87. <a href="https://doi.org/10.1016/j.jorganchem.2017.02.019" title="DOI URL">https://doi.org/10.1016/j.jorganchem.2017.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jorganchem.2017.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jorganchem.2017.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Organometallic%2520Chemistry%26atitle%3DAntimony%2525E2%252580%252593lithium%252Bexchange%252Breaction%25253A%252BSynthesis%252Bof%252B1%25252C4%25252C5-trisubstituted-1%25252C2%25252C3-triazoles%252Bby%252Btriazolyllithium%252Bwith%252Belectrophiles%26aulast%3DYamada%26aufirst%3DMizuki%26date%3D2017%26volume%3D834%26spage%3D83%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas A.  Bakka</span>, <span class="hlFld-ContribAuthor ">Morten B.  Strøm</span>, <span class="hlFld-ContribAuthor ">Jeanette H.  Andersen</span>, <span class="hlFld-ContribAuthor ">Odd R.  Gautun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antimicrobial evaluation of cationic low molecular weight amphipathic 1,2,3-triazoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (5)
                                     , 1119-1123. <a href="https://doi.org/10.1016/j.bmcl.2017.01.092" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.092%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bantimicrobial%252Bevaluation%252Bof%252Bcationic%252Blow%252Bmolecular%252Bweight%252Bamphipathic%252B1%25252C2%25252C3-triazoles%26aulast%3DBakka%26aufirst%3DThomas%2BA.%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D1119%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaonan  Shi</span>, <span class="hlFld-ContribAuthor ">Xinying  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuesen  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">A convenient synthesis of 1-aryl-1H-1,2,3-triazoles from aliphatic substrates. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2017,</strong> <em>15 </em>
                                    (40)
                                     , 8529-8534. <a href="https://doi.org/10.1039/C7OB02035J" title="DOI URL">https://doi.org/10.1039/C7OB02035J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB02035J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB02035J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DA%252Bconvenient%252Bsynthesis%252Bof%252B1-aryl-1H-1%25252C2%25252C3-triazoles%252Bfrom%252Baliphatic%252Bsubstrates%26aulast%3DWang%26aufirst%3DQiang%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D40%26spage%3D8529%26epage%3D8534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balasubramanian  Gopalan</span>, <span class="hlFld-ContribAuthor ">Kalpattu Kuppusamy  Balasubramanian</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of Click Chemistry in Drug Discovery and Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 25-76. <a href="https://doi.org/10.1002/9783527694174.ch2" title="DOI URL">https://doi.org/10.1002/9783527694174.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527694174.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527694174.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DApplications%252Bof%252BClick%252BChemistry%252Bin%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DGopalan%26aufirst%3DBalasubramanian%26date%3D2016%26date%3D2016%26spage%3D25%26epage%3D76%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DClick%252BReactions%252Bin%252BOrganic%252BSynthesis%26aulast%3DChandrasekaran%26aufirst%3DSrinivasan%26date%3D2016%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Rohilla</span>, <span class="hlFld-ContribAuthor ">Shyam Sunder  Patel</span>, <span class="hlFld-ContribAuthor ">Nidhi  Jain</span>. </span><span class="cited-content_cbyCitation_article-title">Copper Acetate Catalyzed Regio­selective Synthesis of Substituted 1,2,3-Triazoles: A Versatile Azide-Alk­ene Cycloaddition/Oxidation Approach. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (4)
                                     , 847-854. <a href="https://doi.org/10.1002/ejoc.201501301" title="DOI URL">https://doi.org/10.1002/ejoc.201501301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201501301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201501301%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCopper%252BAcetate%252BCatalyzed%252BRegio%2525C2%2525ADselective%252BSynthesis%252Bof%252BSubstituted%252B1%25252C2%25252C3-Triazoles%25253A%252BA%252BVersatile%252BAzide-Alk%2525C2%2525ADene%252BCycloaddition%25252FOxidation%252BApproach%26aulast%3DRohilla%26aufirst%3DSandeep%26date%3D2016%26date%3D2015%26volume%3D2016%26issue%3D4%26spage%3D847%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Yi  Xu</span>, <span class="hlFld-ContribAuthor ">Ni-Na  Xue</span>, <span class="hlFld-ContribAuthor ">Di  Liu</span>, <span class="hlFld-ContribAuthor ">Yu-Mei  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Yong-Qiang  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Guang  Chen</span>, <span class="hlFld-ContribAuthor ">Xiao-Ming  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">4,5,6,7-Tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine as a new scaffold for heat shock protein 90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2016,</strong> <em>27 </em>
                                    (1)
                                     , 11-15. <a href="https://doi.org/10.1016/j.cclet.2015.09.024" title="DOI URL">https://doi.org/10.1016/j.cclet.2015.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2015.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2015.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3D4%25252C5%25252C6%25252C7-Tetrahydro-%25255B1%25252C2%25252C3%25255Dtriazolo%25255B1%25252C5-a%25255Dpyrazine%252Bas%252Ba%252Bnew%252Bscaffold%252Bfor%252Bheat%252Bshock%252Bprotein%252B90%252Binhibitors%26aulast%3DXu%26aufirst%3DMeng-Yi%26date%3D2016%26volume%3D27%26issue%3D1%26spage%3D11%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Loana  Musso</span>, <span class="hlFld-ContribAuthor ">Raffaella  Cincinelli</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>, <span class="hlFld-ContribAuthor ">Sabrina  Dallavalle</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 5,6-dihydro-4
              H
              -benzo[
              d
              ]isoxazol-7-one and 5,6-dihydro-4
              H
              -isoxazolo[5,4-
              c
              ]pyridin-7-one Derivatives as Potential Hsp90 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2015,</strong> <em>86 </em>
                                    (5)
                                     , 1030-1035. <a href="https://doi.org/10.1111/cbdd.12570" title="DOI URL">https://doi.org/10.1111/cbdd.12570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12570%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Bof%252B5%25252C6-dihydro-4%252BH%252B-benzo%25255B%252Bd%252B%25255Disoxazol-7-one%252Band%252B5%25252C6-dihydro-4%252BH%252B-isoxazolo%25255B5%25252C4-%252Bc%252B%25255Dpyridin-7-one%252BDerivatives%252Bas%252BPotential%252BHsp90%252BInhibitors%26aulast%3DMusso%26aufirst%3DLoana%26date%3D2015%26date%3D2015%26volume%3D86%26issue%3D5%26spage%3D1030%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Sattin</span>, <span class="hlFld-ContribAuthor ">Jiahui  Tao</span>, <span class="hlFld-ContribAuthor ">Gerolamo  Vettoretti</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Moroni</span>, <span class="hlFld-ContribAuthor ">Marzia  Pennati</span>, <span class="hlFld-ContribAuthor ">Alessia  Lopergolo</span>, <span class="hlFld-ContribAuthor ">Laura  Morelli</span>, <span class="hlFld-ContribAuthor ">Antonella  Bugatti</span>, <span class="hlFld-ContribAuthor ">Abbey  Zuehlke</span>, <span class="hlFld-ContribAuthor ">Mike  Moses</span>, <span class="hlFld-ContribAuthor ">Thomas  Prince</span>, <span class="hlFld-ContribAuthor ">Toshiki  Kijima</span>, <span class="hlFld-ContribAuthor ">Kristin  Beebe</span>, <span class="hlFld-ContribAuthor ">Marco  Rusnati</span>, <span class="hlFld-ContribAuthor ">Len  Neckers</span>, <span class="hlFld-ContribAuthor ">Nadia  Zaffaroni</span>, <span class="hlFld-ContribAuthor ">David A.  Agard</span>, <span class="hlFld-ContribAuthor ">Anna  Bernardi</span>, <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (39)
                                     , 13598-13608. <a href="https://doi.org/10.1002/chem.201502211" title="DOI URL">https://doi.org/10.1002/chem.201502211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201502211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201502211%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DActivation%252Bof%252BHsp90%252BEnzymatic%252BActivity%252Band%252BConformational%252BDynamics%252Bthrough%252BRationally%252BDesigned%252BAllosteric%252BLigands%26aulast%3DSattin%26aufirst%3DSara%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D39%26spage%3D13598%26epage%3D13608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  Matysiak</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Juszczak</span>, <span class="hlFld-ContribAuthor ">Monika M.  Karpińska</span>, <span class="hlFld-ContribAuthor ">Ewa  Langner</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Walczak</span>, <span class="hlFld-ContribAuthor ">Marta  Lemieszek</span>, <span class="hlFld-ContribAuthor ">Alicja  Skrzypek</span>, <span class="hlFld-ContribAuthor ">Wojciech  Rzeski</span>, <span class="hlFld-ContribAuthor ">Andrzej  Niewiadomy</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization, and pharmacological evaluation of novel azolo- and azinothiazinones containing 2,4-dihydroxyphenyl substituent as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2015,</strong> <em>146 </em>
                                    (8)
                                     , 1315-1327. <a href="https://doi.org/10.1007/s00706-015-1453-4" title="DOI URL">https://doi.org/10.1007/s00706-015-1453-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-015-1453-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-015-1453-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSynthesis%25252C%252Bcharacterization%25252C%252Band%252Bpharmacological%252Bevaluation%252Bof%252Bnovel%252Bazolo-%252Band%252Bazinothiazinones%252Bcontaining%252B2%25252C4-dihydroxyphenyl%252Bsubstituent%252Bas%252Banticancer%252Bagents%26aulast%3DMatysiak%26aufirst%3DJoanna%26date%3D2015%26date%3D2015%26volume%3D146%26issue%3D8%26spage%3D1315%26epage%3D1327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Cai  Lin</span>, <span class="hlFld-ContribAuthor ">Xiaochu  Qin</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Dong</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Fei  Tang</span>, <span class="hlFld-ContribAuthor ">Chaonan  Chen</span>, <span class="hlFld-ContribAuthor ">Jiancun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 3,5-disubstituted-4-alkynylisoxozales as a novel class of HSP90 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (16)
                                     , 3129-3134. <a href="https://doi.org/10.1016/j.bmcl.2015.06.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B3%25252C5-disubstituted-4-alkynylisoxozales%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252BHSP90%252Binhibitors%26aulast%3DSun%26aufirst%3DJian%26date%3D2015%26volume%3D25%26issue%3D16%26spage%3D3129%26epage%3D3134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Giannini</span>, <span class="hlFld-ContribAuthor ">Gianfranco  Battistuzzi</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring in vitro and in vivo Hsp90 inhibitors activity against human protozoan parasites. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (3)
                                     , 462-465. <a href="https://doi.org/10.1016/j.bmcl.2014.12.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.12.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.12.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.12.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DExploring%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252BHsp90%252Binhibitors%252Bactivity%252Bagainst%252Bhuman%252Bprotozoan%252Bparasites%26aulast%3DGiannini%26aufirst%3DGiuseppe%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D462%26epage%3D465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Davir  González-Calderón</span>, <span class="hlFld-ContribAuthor ">Itzel  Santillán-Iniesta</span>, <span class="hlFld-ContribAuthor ">Carlos A.  González-González</span>, <span class="hlFld-ContribAuthor ">Aydeé  Fuentes-Benítes</span>, <span class="hlFld-ContribAuthor ">Carlos  González-Romero</span>. </span><span class="cited-content_cbyCitation_article-title">A novel and facile synthesis of 1,4,5-trisubstituted 1,2,3-triazoles from benzylic alcohols through a one-pot, three-component system. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (3)
                                     , 514-516. <a href="https://doi.org/10.1016/j.tetlet.2014.12.019" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DA%252Bnovel%252Band%252Bfacile%252Bsynthesis%252Bof%252B1%25252C4%25252C5-trisubstituted%252B1%25252C2%25252C3-triazoles%252Bfrom%252Bbenzylic%252Balcohols%252Bthrough%252Ba%252Bone-pot%25252C%252Bthree-component%252Bsystem%26aulast%3DGonz%25C3%25A1lez-Calder%25C3%25B3n%26aufirst%3DDavir%26date%3D2015%26volume%3D56%26issue%3D3%26spage%3D514%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adluri B.  Shashank</span>, <span class="hlFld-ContribAuthor ">S.  Karthik</span>, <span class="hlFld-ContribAuthor ">R.  Madhavachary</span>, <span class="hlFld-ContribAuthor ">Dhevalapally B.  Ramachary</span>. </span><span class="cited-content_cbyCitation_article-title">An Enolate-Mediated Organocatalytic Azide-Ketone [3+2]-Cycloaddition Reaction: Regioselective High-Yielding Synthesis of Fully Decorated 1,2,3-Triazoles. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2014,</strong> <em>20 </em>
                                    (51)
                                     , 16877-16881. <a href="https://doi.org/10.1002/chem.201405501" title="DOI URL">https://doi.org/10.1002/chem.201405501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201405501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201405501%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DAn%252BEnolate-Mediated%252BOrganocatalytic%252BAzide-Ketone%252B%25255B3%25252B2%25255D-Cycloaddition%252BReaction%25253A%252BRegioselective%252BHigh-Yielding%252BSynthesis%252Bof%252BFully%252BDecorated%252B1%25252C2%25252C3-Triazoles%26aulast%3DShashank%26aufirst%3DAdluri%2BB.%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D51%26spage%3D16877%26epage%3D16881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Some selective Hsp90 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN followed by MePPh<sub>3</sub>Br, BuLi, THF; see ref  <a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">19</a>. (b) H<sub>2</sub> (1 atm), Pd/C, EtOH, rt, 6 h followed by BnBr, K<sub>2</sub>CO<sub>3</sub>, MeCN reflux, 3 h (94% overall). (c) HNO<sub>3</sub> conc, AcOH, 70 °C, 30 min, (35%). (d) (i) SnCl<sub>2</sub>, HCl, EtOH, 80 °C, 3 h; (ii) <i>t</i>-BuONO, Me<sub>3</sub>SiN<sub>3</sub>, MeCN, rt, 12 h (75% over two steps).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) CuSO<sub>4</sub>, Na ascorbate, DMF, rt, 12 h (55%). (b) (Cp*RuCl)<sub>4</sub>, DMF, rt, 3 h (72%). (c) (i) MsCl, TEA, DCM, rt, 2–4 h; (ii) amine, DMF, Et<sub>3</sub>N, rt, 12 h. (d) BCl<sub>3</sub>, DCM, 0° C to rt, 2 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) TBDMSCl, imidazole, DMF, rt, 12 h. (b) LiHDMS, MeOCOCl, THF, −78 °C (76% over two steps). (c) (Cp*RuCl)<sub>4</sub> DMF, rt, 12 h, (68%). (d) TBAF, THF, rt, 2 h (80%). (e) CBr<sub>4</sub>, PPh<sub>3</sub>, DCM, rt, 3 h (87%). (f) MsCl, Et<sub>3</sub>N, DCM, 0 °C, then rt for 12 h (90% crude). (g) Secondary amine, Et<sub>3</sub>N, DMF, rt. (h) Ethylamine, MeOH 80 °C, 48 h. (i) H<sub>2</sub> (1 atm), Pd(OH)<sub>2</sub> cat., 4 h, rt. (j) Primary amine Et<sub>3</sub>N, DMF, rt.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) MsCl, Et<sub>3</sub>N, DCM, 0 °C then rt for 12 h. (b) Morpholine, Et<sub>3</sub>N, DMF, rt, 12 h (75% over two steps). (c) (i) LiOH in THF H<sub>2</sub>O; (ii) (COCl)<sub>2</sub>; (iii) primary or secondary amine; (iv) BCl<sub>3</sub> in DCM, 0°C to rt (31% over three steps).</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stereographical representation of the complex between Hsp90 and <b>18</b> (ball and stick notation) as derived from molecular docking calculations and energy minimization (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI">2VCI</a>, 2.0 Å resolution). The triazole core and the resorcinol hydroxyl groups are involved in an extended network of water-bridged hydrogen bonds. The morpholine solubilizing group is exposed to the solvent and is able to block a water molecule. For the sake of clarity, only few amino acids are displayed and labeled, together with several water molecules (W). Hydrogen bond contacts are depicted as black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analysis of Hsp90 client protein levels (EGFR, Akt, CDK-4) and Hsp70 in A431 tumor cells treated with compound <b>19</b> vs17-DMAG and NVP-AUY922. Total cellular extracts were obtained 24 h after treatment. Actin is shown as a control for protein loading. A representative blot is shown. Results of densitometry analysis were reported as normalized (to β-actin) ratios. Western blot experiments were performed at least twice resulting in similar results.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Western blot analysis of Hsp90 client protein levels in A431 tumor cells treated with the lead compound <b>18</b> vs its diacetyl prodrug (<b>44</b>). Analysis was performed as described in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antitumor efficacy of compounds <b>18</b> and <b>19</b> delivered intraperitoneally in comparison with NVP-AUY922 against A431 epidermoid carcinoma (overexpressing EGF receptor) (A, B) and GTL-16 gastric carcinoma (overepressing c-Met) (C), xenografted sc in nude mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/medium/jm-2013-01536b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Analysis of Hsp90 client protein levels (EGFR, Akt, CDK-4, c-Met) and Hsp70 in A431 (A) and GTL-16 (B) tumor xenografts, following treatment with <b>18</b> and <b>19</b>, with respect to the reference compound (NVP-AUY922). Total proteins were purified 2 h (in the case of A431 tumors) or 6 h (in the case of GTL-16 tumors) after the last treatment. Actin is shown as a control for protein loading. Representative blots of two tumor samples/group are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm401536b/production/images/large/jm-2013-01536b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401536b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i71">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sreedhar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csermely, P.</span><span> </span><span class="NLM_article-title">Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy: a comprehensive review</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1016%2Fj.pharmthera.2003.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=15031001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitFeitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=227-257&author=A.+S.+Sreedharauthor=P.+Csermely&title=Heat+shock+proteins+in+the+regulation+of+apoptosis%3A+new+strategies+in+tumor+therapy%3A+a+comprehensive+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock proteins in the regulation of apoptosis: new strategies in tumor therapy. A comprehensive review</span></div><div class="casAuthors">Sreedhar, Amere Subbarao; Csermely, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-257</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Heat shock proteins (Hsp) form the most ancient defense system in all living organisms on earth.  These proteins act as mol. chaperones by helping in the refolding of misfolded proteins and assisting in their elimination if they become irreversibly damaged.  Hsp interact with a no. of cellular systems and form efficient cytoprotective mechanisms.  However, in some cases, wherein it is better if the cell dies, there is no reason for any further defense.  Programmed cell death is a widely conserved general phenomenon helping in many processes involving the reconstruction of multicellular organisms, as well as in the elimination of old or damaged cells.  Here, we review some novel elements of the apoptotic process, such as its interrelationship with cellular senescence and necrosis, as well as bacterial apoptosis.  We also give a survey of the most important elements of the apoptotic machinery and show the various modes of how Hsp interact with the apoptotic events in detail.  We review caspase-independent apoptotic pathways and anoikis as well.  Finally, we show the emerging variety of pharmacol. interventions inhibiting or, just conversely, inducing Hsp and review the emergence of Hsp as novel therapeutic targets in anticancer protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsa9XUmpeTJbVg90H21EOLACvtfcHk0ljHDDW8ku9iGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitFeitbs%253D&md5=f06c05fedd52f2b2a960177072f09f5d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2003.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2003.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DSreedhar%26aufirst%3DA.%2BS.%26aulast%3DCsermely%26aufirst%3DP.%26atitle%3DHeat%2520shock%2520proteins%2520in%2520the%2520regulation%2520of%2520apoptosis%253A%2520new%2520strategies%2520in%2520tumor%2520therapy%253A%2520a%2520comprehensive%2520review%26jtitle%3DPharmacol.%2520Ther.%26date%3D2004%26volume%3D101%26spage%3D227%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Stravopodis, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margaritis, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voutsinas, G. E.</span><span> </span><span class="NLM_article-title">Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3122</span><span class="NLM_x">–</span> <span class="NLM_lpage">3138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.2174%2F092986707782793925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=18220746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=3122-3138&author=D.+J.+Stravopodisauthor=L.+H.+Margaritisauthor=G.+E.+Voutsinas&title=Drug-mediated+targeted+disruption+of+multiple+protein+activities+through+functional+inhibition+of+the+Hsp90+chaperone+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex</span></div><div class="casAuthors">Stravopodis, Dimitrios J.; Margaritis, Lukas H.; Voutsinas, Gerassimos E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">3122-3138</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Hsp90 is an evolutionarily conserved and ubiquitously expressed mol. chaperone that mainly modulates, along with a group of co-chaperones, the general platform of protein folding and prevents the nonspecific aggregation of misfolded or unfolded proteins.  In the voluminous Hsp90 clientele, a large variety of important regulatory proteins can be identified, including many whose deregulation may lead to cancer initiation and progression, such as the oncogenic clients pp60v-src, Bcr-Abl, mutated p53, ErbB2 (Her-2), Akt, Flt3, HIF-1α and B-Raf.  Therefore, inhibition of Hsp90 function offers the prospect of simultaneously disrupting multiple signaling pathways directly implicated in the development of malignant phenotypes.  During the last few years, there has been a major focus on the development of Hsp90 specific inhibitors.  This started with the discovery that certain natural products could specifically disrupt Hsp90 chaperone activities.  The benzoquinone ansamycin antibiotic geldanamycin and its less toxic deriv. 17-AAG have been shown to possess strong anti-proliferative and apoptotic activity in cancer cells, whereas 17-AAG has demonstrated potent anti-tumor activity in several human xenograft models, including breast, prostate and colon cancer.  In an effort to overcome difficulties with drug toxicity and soly., a no. of novel bioengineered 17-AAG analogs, such as 17-DMAG and IPI-504, and small-mol. inhibitors, including purine and pyrazole derivs., have emerged from rational drug design followed by high-throughput screening approaches.  17-AAG was the leader inhibitor to enter and successfully complete phase I clin. trials, thus demonstrating that Hsp90 constitutes a valid drug target for cancer therapy.  This review includes information on the current model of ternary interactions between Hsp90, client proteins and a vast array of co-chaperones followed by a list of characteristic inhibitors and ongoing clin. trials reported thus far.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMIOuCiSvkbLVg90H21EOLACvtfcHk0ljHDDW8ku9iGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrsLg%253D&md5=d3c9b6ec73e1250e37fef98512b8aac3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F092986707782793925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782793925%26sid%3Dliteratum%253Aachs%26aulast%3DStravopodis%26aufirst%3DD.%2BJ.%26aulast%3DMargaritis%26aufirst%3DL.%2BH.%26aulast%3DVoutsinas%26aufirst%3DG.%2BE.%26atitle%3DDrug-mediated%2520targeted%2520disruption%2520of%2520multiple%2520protein%2520activities%2520through%2520functional%2520inhibition%2520of%2520the%2520Hsp90%2520chaperone%2520complex%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D3122%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Banerji, U.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 as a drug target: some like it hot</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1158%2F1078-0432.CCR-08-0132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=9-14&author=U.+Banerji&title=Heat+shock+protein+90+as+a+drug+target%3A+some+like+it+hot"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0132%26sid%3Dliteratum%253Aachs%26aulast%3DBanerji%26aufirst%3DU.%26atitle%3DHeat%2520shock%2520protein%252090%2520as%2520a%2520drug%2520target%253A%2520some%2520like%2520it%2520hot%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D1%26spage%3D9%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Neckers, L.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: the cancer chaperone</span> <span class="citation_source-journal">J Biosci .</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1007%2Fs12038-007-0051-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=17536171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=517-530&author=L.+Neckers&title=Heat+shock+protein+90%3A+the+cancer+chaperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Heat shock protein 90: the cancer chaperone</span></div><div class="casAuthors">Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biosciences (Bangalore, India)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-530</span>CODEN:
                <span class="NLM_cas:coden">JOBSDN</span>;
        ISSN:<span class="NLM_cas:issn">0250-5991</span>.
    
            (<span class="NLM_cas:orgname">Indian Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Heat shock protein 90 (Hsp90) is a mol. chaperone required for the stability and function of a no. of conditionally activated and/or expressed signaling proteins, as well as multiple mutated, chimeric, and/or overexpressed signaling proteins, that promote cancer cell growth and/or survival.  Hsp90 inhibitors are unique in that, although they are directed towards a specific mol. target, they simultaneously inhibit multiple cellular signaling pathways.  By inhibiting nodal points in multiple overlapping survival pathways utilized by cancer cells, combination of an Hsp90 inhibitor with std. chemotherapeutic agents may dramatically increase the in vivo efficacy of the std. agent.  Hsp90 inhibitors may circumvent the characteristic genetic plasticity that has allowed cancer cells to eventually evade the toxic effects of most molecularly targeted agents.  The mechanism-based use of Hsp90 inhibitors, both alone and in combination with other drugs, should be effective toward multiple forms of cancer.  Further, because Hsp90 inhibitors also induce Hsf-1-dependent expression of Hsp70, and because certain mutated Hsp90 client proteins are neurotoxic, these drugs display ameliorative properties in several neurodegenerative disease models, suggesting a novel role for Hsp90 inhibitors in treating multiple pathologies involving neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorZSMvQPzup7Vg90H21EOLACvtfcHk0ljHDDW8ku9iGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFamu7k%253D&md5=ffc9fd7cba8e3b9e03b2da9c29bc275f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs12038-007-0051-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12038-007-0051-y%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520the%2520cancer%2520chaperone%26jtitle%3DJ%2520Biosci%2520.%26date%3D2007%26volume%3D32%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ho, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Heat shock protein 90 and role of its chemical inhibitors in treatment of hematologic malignancies</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">801</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=779-801&author=N.+Hoauthor=A.+Liauthor=S.+Liauthor=H.+Zhang&title=Heat+shock+protein+90+and+role+of+its+chemical+inhibitors+in+treatment+of+hematologic+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DHeat%2520shock%2520protein%252090%2520and%2520role%2520of%2520its%2520chemical%2520inhibitors%2520in%2520treatment%2520of%2520hematologic%2520malignancies%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D779%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Taldone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zatorska, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moulick, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of small molecule Hsp90 probes</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2603</span><span class="NLM_x">–</span> <span class="NLM_lpage">2614</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2603-2614&author=T.+Taldoneauthor=D.+Zatorskaauthor=P.+D.+Patelauthor=H.+Zongauthor=A.+Rodinaauthor=J.+H.+Ahnauthor=K.+Moulickauthor=M.+L.+Guzmanauthor=G.+Chiosis&title=Design%2C+synthesis%2C+and+evaluation+of+small+molecule+Hsp90+probes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaldone%26aufirst%3DT.%26aulast%3DZatorska%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DP.%2BD.%26aulast%3DZong%26aufirst%3DH.%26aulast%3DRodina%26aufirst%3DA.%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DMoulick%26aufirst%3DK.%26aulast%3DGuzman%26aufirst%3DM.%2BL.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520small%2520molecule%2520Hsp90%2520probes%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2603%26epage%3D2614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R.</span><span> </span><span class="NLM_article-title">Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">482</span><span class="NLM_x">, </span> <span class="NLM_fpage">246</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=482&publication_year=2012&pages=246-250&author=G.+Chenauthor=W.+D.+Bradfordauthor=C.+W.+Seidelauthor=R.+Li&title=Hsp90+stress+potentiates+rapid+cellular+adaptation+through+induction+of+aneuploidy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DBradford%26aufirst%3DW.%2BD.%26aulast%3DSeidel%26aufirst%3DC.%2BW.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DHsp90%2520stress%2520potentiates%2520rapid%2520cellular%2520adaptation%2520through%2520induction%2520of%2520aneuploidy%26jtitle%3DNature%26date%3D2012%26volume%3D482%26spage%3D246%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruden, M. D.</span><span> </span><span class="NLM_article-title">Hsp90 Inhibitors and the reduction of anti-cancer drug resistance by non-genetic and genetic mechanisms</span> <span class="citation_source-journal">Pharmaceuticals</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">890</span><span class="NLM_x">–</span> <span class="NLM_lpage">898</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=890-898&author=X.+Luauthor=L.+Wangauthor=M.+D.+Ruden&title=Hsp90+Inhibitors+and+the+reduction+of+anti-cancer+drug+resistance+by+non-genetic+and+genetic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRuden%26aufirst%3DM.%2BD.%26atitle%3DHsp90%2520Inhibitors%2520and%2520the%2520reduction%2520of%2520anti-cancer%2520drug%2520resistance%2520by%2520non-genetic%2520and%2520genetic%2520mechanisms%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D890%26epage%3D898" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Turbyville, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kithsiri Wijeratne, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seliga, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luevano, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeth, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitesell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunatilaka, A. A. L.</span><span> </span><span class="NLM_article-title">Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/doi/10.1021/np058095b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVajs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=178-184&author=T.+J.+Turbyvilleauthor=E.+M.+Kithsiri+Wijeratneauthor=M.+X.+Liuauthor=A.+M.+Burnsauthor=C.+J.+Seligaauthor=L.+A.+Luevanoauthor=C.+L.+Davidauthor=S.+H.+Faethauthor=L.+Whitesellauthor=A.+A.+L.+Gunatilaka&title=Search+for+Hsp90+inhibitors+with+potential+anticancer+activity%3A+isolation+and+SAR+studies+of+radicicol+and+monocillin+I+from+two+plant-associated+fungi+of+the+Sonoran+desert"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Search for Hsp90 Inhibitors with Potential Anticancer Activity: Isolation and SAR Studies of Radicicol and Monocillin I from Two Plant-Associated Fungi of the Sonoran Desert</span></div><div class="casAuthors">Turbyville, Thomas J.; Wijeratne, E. M. Kithsiri; Liu, Manping X.; Burns, Anna M.; Seliga, Christopher J.; Luevano, Libia A.; David, Cynthia L.; Faeth, Stanley H.; Whitesell, Luke; Gunatilaka, A. A. Leslie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">178-184</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">In an effort to discover small mol. inhibitors of Hsp90, we have screened over 500 EtOAc exts. of Sonoran desert plant-assocd. fungi using a two-stage strategy consisting of a primary cell-based heat shock induction assay (HSIA) followed by a secondary biochem. luciferase refolding assay (LRA).  Bioassay-guided fractionation of exts. active in these assays derived from Chaetomium chiversii and Paraphaeosphaeria quadriseptata furnished the Hsp90 inhibitors radicicol (1) and monocillin I (2), resp.  In SAR studies, 1, 2, and their analogs, 3-16, were evaluated in these assays, and the antiproliferative activity of compds. active in both assays was detd. using the breast cancer cell line MCF-7.  Radicicol and monocillin I were also evaluated in a solid-phase competition assay for their ability to bind Hsp90 and to deplete cellular levels of two known Hsp90 client proteins with relevance to breast cancer, estrogen receptor (ER), and the type 1 insulin-like growth factor receptor (IGF-1R).  Some inferences on SAR were made considering the crystal structure of the N-terminus of yeast Hsp90 bound to 1 and the obsd. biol. activities of 1-16.  Isolation of radicicol and monocillin I in this study provides evidence that we have developed an effective strategy for discovering natural product-based Hsp90 inhibitors with potential anticancer activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps5fEK1mAeWLVg90H21EOLACvtfcHk0lj7pAKPBXV-eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVajs74%253D&md5=b46997bda895934e2287f9eb3093bf18</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fnp058095b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp058095b%26sid%3Dliteratum%253Aachs%26aulast%3DTurbyville%26aufirst%3DT.%2BJ.%26aulast%3DKithsiri%2BWijeratne%26aufirst%3DE.%2BM.%26aulast%3DLiu%26aufirst%3DM.%2BX.%26aulast%3DBurns%26aufirst%3DA.%2BM.%26aulast%3DSeliga%26aufirst%3DC.%2BJ.%26aulast%3DLuevano%26aufirst%3DL.%2BA.%26aulast%3DDavid%26aufirst%3DC.%2BL.%26aulast%3DFaeth%26aufirst%3DS.%2BH.%26aulast%3DWhitesell%26aufirst%3DL.%26aulast%3DGunatilaka%26aufirst%3DA.%2BA.%2BL.%26atitle%3DSearch%2520for%2520Hsp90%2520inhibitors%2520with%2520potential%2520anticancer%2520activity%253A%2520isolation%2520and%2520SAR%2520studies%2520of%2520radicicol%2520and%2520monocillin%2520I%2520from%2520two%2520plant-associated%2520fungi%2520of%2520the%2520Sonoran%2520desert%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2006%26volume%3D69%26spage%3D178%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Neckers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Hsp90 molecular chaperone inhibitors: Are we there yet?</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">64</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1158%2F1078-0432.CCR-11-1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=22215907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=64-76&author=L.+Neckersauthor=P.+Workman&title=Hsp90+molecular+chaperone+inhibitors%3A+Are+we+there+yet%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?</span></div><div class="casAuthors">Neckers, Len; Workman, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-76</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone that is exploited by malignant cells to support activated oncoproteins, including many cancer-assocd. kinases and transcription factors, and it is essential for oncogenic transformation.  Originally viewed with skepticism, Hsp90 inhibitors are now being actively pursued by the pharmaceutical industry, with 17 agents having entered clin. trials.  Investigators established Hsp90's druggability using the natural products geldanamycin and radicicol, which mimic the unusual ATP structure adopted in the chaperone's N-terminal nucleotide-binding pocket and cause potent and selective blockade of ATP binding/hydrolysis, inhibit chaperone function, deplete oncogenic clients, and show antitumor activity.  Preclin. data obtained with these natural products have heightened interest in Hsp90 as a drug target, and 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) has shown clin. activity (as defined by Response Evaluation Criteria in Solid Tumors) in HER2+ breast cancer.  Many optimized synthetic, small-mol. Hsp90 inhibitors from diverse chemotypes are now in clin. trials.  Here, we review the discovery and development of Hsp90 inhibitors and assess their potential.  There has been significant learning from studies of the basic biol. of Hsp90, as well as translational drug development involving this chaperone, enhanced by the use of Hsp90 inhibitors as chem. probes.  Success will likely lie in treating cancers that are addicted to particular driver oncogene products (e.g., HER2, ALK, EGFR, and BRAF) that are sensitive Hsp90 clients, as well as malignancies (esp. multiple myeloma) in which buffering of proteotoxic stress is crit. for survival.  We discuss approaches for enhancing the effectiveness of Hsp90 inhibitors and highlight new chaperone and stress-response pathway targets, including HSF1 and Hsp70.  Clin Cancer Res; 18(1); 64-76.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfICmNu1IWFbVg90H21EOLACvtfcHk0lj7pAKPBXV-eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFWmsw%253D%253D&md5=f67c3c11b5847e3866c91af2a16a63b8</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-1000%26sid%3Dliteratum%253Aachs%26aulast%3DNeckers%26aufirst%3DL.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DHsp90%2520molecular%2520chaperone%2520inhibitors%253A%2520Are%2520we%2520there%2520yet%253F%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D64%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Patki, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawar, S. S.</span><span> </span><span class="NLM_article-title">Hsp90: chaperone-me-not</span> <span class="citation_source-journal">Pathol. Oncol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1007%2Fs12253-013-9675-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=23900891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=631-640&author=J.+M.+Patkiauthor=S.+S.+Pawar&title=Hsp90%3A+chaperone-me-not"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">HSP90: Chaperone-me-not</span></div><div class="casAuthors">Patki, J. M.; Pawar, S. S.</div><div class="citationInfo"><span class="NLM_cas:title">Pathology & Oncology Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">631-640</span>CODEN:
                <span class="NLM_cas:coden">POREFR</span>;
        ISSN:<span class="NLM_cas:issn">1219-4956</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  With increasing understanding of the mol. basis of carcinogenesis, its progression and metastasis, the cancer therapy has shifted from empirical approaches to targeting specific mols. that regulate the complex network of signalling pathways for cell survival and proliferation.  These include key players in malignant transformation like protein kinases, transcription factors, steroid hormone receptors, cell cycle regulators, signal transduction proteins and regulators of apoptosis.  Almost all these proteins depend upon the mol. chaperone Hsp90 for their proper folding, stability and function and thus are a part of the Hsp90 clientele.  Dependence of these proteins on Hsp90 makes this chaperone an appealing target for cancer therapeutics.  Inhibition of Hsp90 can affect multiple oncogenic pathways simultaneously.  Moreover Hsp90 inhibitors selectively kill cancer cells compared to normal cells and cancer cells have greater dependence on Hsp90 for the maintenance of intracellular protein homeostasis.  All this has led to a rapid pace discovery of Hsp90 clients as well as chem. inhibitors of Hsp90.  The role of hsp90 in cancer, tumor selectivity of Hsp90 inhibitors and the current status of Hsp90 inhibitors are discussed in the present review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-L7_keMms8rVg90H21EOLACvtfcHk0liXWR-M-KP04Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFWntrfM&md5=31ad299d632f57170a06a6d00dc79c4b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs12253-013-9675-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12253-013-9675-4%26sid%3Dliteratum%253Aachs%26aulast%3DPatki%26aufirst%3DJ.%2BM.%26aulast%3DPawar%26aufirst%3DS.%2BS.%26atitle%3DHsp90%253A%2520chaperone-me-not%26jtitle%3DPathol.%2520Oncol.%2520Res.%26date%3D2013%26volume%3D19%26spage%3D631%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chang, D.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K-s.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, W.-G.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (Hsp90) inhibitors targeting proliferation and angiogenesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">10863</span><span class="NLM_x">–</span> <span class="NLM_lpage">10884</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301488q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10863-10884&author=D.-J.+Changauthor=H.+Anauthor=K-s.+Kimauthor=H.+H.+Kimauthor=J.+Jungauthor=M.+L.+Leeauthor=N.-J.+Kimauthor=Y.+T.+Hanauthor=H.+Yunauthor=S.+Leeauthor=G.+Leeauthor=S.+Leeauthor=J.+S.+Leeauthor=J.-H.+Chaauthor=J.-H.+Parkauthor=J.+W.+Parkauthor=S.-C.+Leeauthor=S.+G.+Kimauthor=J.+H.+Kimauthor=H.+Y.+Leeauthor=K.-W.+Kimauthor=W.-G.+Suh&title=Design%2C+synthesis%2C+and+biological+evaluation+of+novel+deguelin-based+heat+shock+protein+90+%28Hsp90%29+inhibitors+targeting+proliferation+and+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm301488q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301488q%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DD.-J.%26aulast%3DAn%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DK-s.%26aulast%3DKim%26aufirst%3DH.%2BH.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BL.%26aulast%3DKim%26aufirst%3DN.-J.%26aulast%3DHan%26aufirst%3DY.%2BT.%26aulast%3DYun%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DCha%26aufirst%3DJ.-H.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DS.-C.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DKim%26aufirst%3DK.-W.%26aulast%3DSuh%26aufirst%3DW.-G.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520deguelin-based%2520heat%2520shock%2520protein%252090%2520%2528Hsp90%2529%2520inhibitors%2520targeting%2520proliferation%2520and%2520angiogenesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D10863%26epage%3D10884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Soga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akinaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiotsu, Y.</span><span> </span><span class="NLM_article-title">Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.2174%2F138161213804143617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=22920907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFeqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=366-376&author=S.+Sogaauthor=S.+Akinagaauthor=Y.+Shiotsu&title=Hsp90+inhibitors+as+anti-cancer+agents%2C+from+basic+discoveries+to+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 inhibitors as anti-cancer agents, from basic discoveries to clinical development</span></div><div class="casAuthors">Soga, Shiro; Akinaga, Shiro; Shiotsu, Yukimasa</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">366-376</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Heat shock protein (Hsp) 90 is an ATP-dependent mol. chaperone which stabilizes various oncogenic kinases, including HER2, EGFR, BCR-ABL, B-Raf and EML4-ALK, which are essential for tumor growth.  Several monoclonal antibodies and small mol. kinase inhibitors which target these kinases have been identified as potential new mol. target therapeutics.  Previous reports have shown that many oncogenic proteins essential for cancer transformation are chaperoned by the Hsp90 complex, and some of these client proteins have been discovered by using Hsp90 inhibitors, such as geldanamycin (GA) and radicicol (RD).  Thus far more than 200 client proteins have been identified.  In past derivs. of these natural products have been evaluated in clin. trials, but none of the 1st generation of Hsp90 inhibitors has been approved yet because of their limitations in physico-chem. properties and/or safety profiles.  However, recent reports have indicated that more than 10 new agents, 2nd generation of Hsp90 inhibitors with different chemotypes from GA and RD, have entered clin. trials and some of them showed clin. efficacy.  In this review article, we describe the discoveries of major Hsp90 client proteins in the cancer field by RD derivs., the history of KW-2478 discovery and development by Kyowa Hakko Kirin, and gave an update on the current status of new Hsp90 inhibitors in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6siL38h_pnbVg90H21EOLACvtfcHk0liXWR-M-KP04Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFeqsLw%253D&md5=6b8012a64a3cb1b3ef19d646d90dc109</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138161213804143617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161213804143617%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DS.%26aulast%3DAkinaga%26aufirst%3DS.%26aulast%3DShiotsu%26aufirst%3DY.%26atitle%3DHsp90%2520inhibitors%2520as%2520anti-cancer%2520agents%252C%2520from%2520basic%2520discoveries%2520to%2520clinical%2520development%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D366%26epage%3D376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Biamonte, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Water, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arndt, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W.-C.</span><span> </span><span class="NLM_article-title">Heat shock protein 90: inhibitors in clinical trials</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9004708" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3-17&author=M.+A.+Biamonteauthor=R.+Van+de+Waterauthor=J.+W.+Arndtauthor=R.+H.+Scannevinauthor=D.+Perretauthor=W.-C.+Lee&title=Heat+shock+protein+90%3A+inhibitors+in+clinical+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Heat Shock Protein 90: Inhibitors in Clinical Trials</span></div><div class="casAuthors">Biamonte, Marco A.; Van de Water, Ryan; Arndt, Joseph W.; Scannevin, Robert H.; Perret, Daniel; Lee, Wen-Cherng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-17</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  HSP90 is the 90 kDa member of the family and exists as two isoforms: HSP90 is an inducible form overexpressed in cancer cells, while HSP90 is the constitutive form.  Since inhibition of HSP90 can lead to the degrdn. of a large no. of oncogenic proteins, HSP90 has become a target of interest for oncol.  A major advantage of HSP90 inhibitors is that they simultaneously attack several pathways necessary for cancer development, reducing the likelihood of the tumor acquiring resistance to any single therapeutic pathway.  It has also been proposed that HSP90 occurs in an activated form in cancer cells, whereas in normal somatic cells only the latent form is found.  This has given rise to the hypothesis that HSP90 inhibitors could be designed to selectively target the activated form and thus more specifically target cancer cells, but this assertion has been challenged.  Cancer cells seem to have a higher HSP90 activity than normal cells, and oncogenes are more dependent on HSP90 than house-keeping proteins.  In cell cultures, HSP90 inhibitors kill tumor cells at concns. much lower than those required to kill normal cells.  In mice, efficacy can be obsd. at nontoxic doses, and in humans, the first signs of clin. benefit are emerging.  It remains to be verified, however, if HSP90 inhibitors will truly provide a sufficient safety margin in the clinic.  Nononcol. indications may also emerge; besides cancer, the prevalent conditions mentioned in the literature with respect to HSP90 are Parkinson's disease, Alzheimer's disease, and fungal infections.  For the time being, however, the focus is oncol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYseMVVt55b7Vg90H21EOLACvtfcHk0liXWR-M-KP04Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFCjt7vJ&md5=14eee1036fc22e45da13b49cc93ed845</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm9004708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9004708%26sid%3Dliteratum%253Aachs%26aulast%3DBiamonte%26aufirst%3DM.%2BA.%26aulast%3DVan%2Bde%2BWater%26aufirst%3DR.%26aulast%3DArndt%26aufirst%3DJ.%2BW.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DPerret%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DW.-C.%26atitle%3DHeat%2520shock%2520protein%252090%253A%2520inhibitors%2520in%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Richter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soroka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skalniak, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leskovar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, J.</span><span> </span><span class="NLM_article-title">Conserved conformational changes in the ATPase cycle of human Hsp90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">17757</span><span class="NLM_x">–</span> <span class="NLM_lpage">17765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=17757-17765&author=K.+Richterauthor=J.+Sorokaauthor=L.+Skalniakauthor=A.+Leskovarauthor=M.+Hesslingauthor=J.+Reinsteinauthor=J.+Buchner&title=Conserved+conformational+changes+in+the+ATPase+cycle+of+human+Hsp90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichter%26aufirst%3DK.%26aulast%3DSoroka%26aufirst%3DJ.%26aulast%3DSkalniak%26aufirst%3DL.%26aulast%3DLeskovar%26aufirst%3DA.%26aulast%3DHessling%26aufirst%3DM.%26aulast%3DReinstein%26aufirst%3DJ.%26aulast%3DBuchner%26aufirst%3DJ.%26atitle%3DConserved%2520conformational%2520changes%2520in%2520the%2520ATPase%2520cycle%2520of%2520human%2520Hsp90%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D17757%26epage%3D17765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hanessian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auzzas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span> </span><span class="NLM_article-title">Vorinostat-like molecules as structural, stereochemical, and pharmacological tools</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100028g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=70-74&author=S.+Hanessianauthor=L.+Auzzasauthor=A.+Larssonauthor=J.+Zhangauthor=G.+Gianniniauthor=G.+Galloauthor=A.+Ciacciauthor=W.+Cabri&title=Vorinostat-like+molecules+as+structural%2C+stereochemical%2C+and+pharmacological+tools"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml100028g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100028g%26sid%3Dliteratum%253Aachs%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DAuzzas%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DCiacci%26aufirst%3DA.%26aulast%3DCabri%26aufirst%3DW.%26atitle%3DVorinostat-like%2520molecules%2520as%2520structural%252C%2520stereochemical%252C%2520and%2520pharmacological%2520tools%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D70%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Botta, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cesare, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fattorusso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondinelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriquez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taddei, M.</span><span> </span><span class="NLM_article-title">Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2165</span><span class="NLM_x">–</span> <span class="NLM_lpage">2182</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101373a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2165-2182&author=C.+B.+Bottaauthor=W.+Cabriauthor=E.+Ciniauthor=L.+De+Cesareauthor=C.+Fattorussoauthor=G.+Gianniniauthor=M.+Persicoauthor=A.+Petrellaauthor=F.+Rondinelliauthor=M.+Rodriquezauthor=A.+Russoauthor=M.+Taddei&title=Oxime+amides+as+a+novel+zinc+binding+group+in+histone+deacetylase+inhibitors%3A+synthesis%2C+biological+activity%2C+and+computational+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm101373a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101373a%26sid%3Dliteratum%253Aachs%26aulast%3DBotta%26aufirst%3DC.%2BB.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DCini%26aufirst%3DE.%26aulast%3DDe%2BCesare%26aufirst%3DL.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DPersico%26aufirst%3DM.%26aulast%3DPetrella%26aufirst%3DA.%26aulast%3DRondinelli%26aufirst%3DF.%26aulast%3DRodriquez%26aufirst%3DM.%26aulast%3DRusso%26aufirst%3DA.%26aulast%3DTaddei%26aufirst%3DM.%26atitle%3DOxime%2520amides%2520as%2520a%2520novel%2520zinc%2520binding%2520group%2520in%2520histone%2520deacetylase%2520inhibitors%253A%2520synthesis%252C%2520biological%2520activity%252C%2520and%2520computational%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2165%26epage%3D2182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Baruchello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisolia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbato, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rondanin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangiola, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alloatti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milazzo, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervoni, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guglielmi, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbarino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foderà, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span> </span><span class="NLM_article-title">Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8592</span><span class="NLM_x">–</span> <span class="NLM_lpage">8604</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201155e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8592-8604&author=R.+Baruchelloauthor=D.+Simoniauthor=G.+Grisoliaauthor=G.+Barbatoauthor=P.+Marchettiauthor=R.+Rondaninauthor=S.+Mangiolaauthor=G.+Gianniniauthor=T.+Brunettiauthor=D.+Alloattiauthor=G.+Galloauthor=A.+Ciacciauthor=L.+Vesciauthor=M.+Castorinaauthor=F.+M.+Milazzoauthor=M.+L.+Cervoniauthor=M.+B.+Guglielmiauthor=M.+Barbarinoauthor=R.+Foder%C3%A0author=C.+Pisanoauthor=W.+Cabri&title=Novel+3%2C4-isoxazolediamides+as+potent+inhibitors+of+chaperone+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201155e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201155e%26sid%3Dliteratum%253Aachs%26aulast%3DBaruchello%26aufirst%3DR.%26aulast%3DSimoni%26aufirst%3DD.%26aulast%3DGrisolia%26aufirst%3DG.%26aulast%3DBarbato%26aufirst%3DG.%26aulast%3DMarchetti%26aufirst%3DP.%26aulast%3DRondanin%26aufirst%3DR.%26aulast%3DMangiola%26aufirst%3DS.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DBrunetti%26aufirst%3DT.%26aulast%3DAlloatti%26aufirst%3DD.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DCiacci%26aufirst%3DA.%26aulast%3DVesci%26aufirst%3DL.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DMilazzo%26aufirst%3DF.%2BM.%26aulast%3DCervoni%26aufirst%3DM.%2BL.%26aulast%3DGuglielmi%26aufirst%3DM.%2BB.%26aulast%3DBarbarino%26aufirst%3DM.%26aulast%3DFoder%25C3%25A0%26aufirst%3DR.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DCabri%26aufirst%3DW.%26atitle%3DNovel%25203%252C4-isoxazolediamides%2520as%2520potent%2520inhibitors%2520of%2520chaperone%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8592%26epage%3D8604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Brough, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barril, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgognoni, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cansfield, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, N. G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drysdale, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martins, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Northfield, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodromou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roughley, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L.</span><span> </span><span class="NLM_article-title">4,5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">196</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701018h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=196-218&author=P.+A.+Broughauthor=W.+Aherneauthor=X.+Barrilauthor=J.+Borgognoniauthor=K.+Boxallauthor=J.+E.+Cansfieldauthor=K.-M.+J.+Cheungauthor=I.+Collinsauthor=N.+G.+M.+Daviesauthor=M.+J.+Drysdaleauthor=B.+Dymockauthor=S.+E.+Ecclesauthor=H.+Finchauthor=A.+Finkauthor=A.+Hayesauthor=R.+Howesauthor=R.+E.+Hubbardauthor=K.+Jamesauthor=A.+M.+Jordanauthor=A.+Lockieauthor=V.+Martinsauthor=A.+Masseyauthor=T.+P.+Matthewsauthor=E.+McDonaldauthor=C.+J.+Northfieldauthor=L.+H.+Pearlauthor=C.+Prodromouauthor=S.+Rayauthor=F.+I.+Raynaudauthor=S.+D.+Roughleyauthor=S.+Y.+Sharpauthor=A.+Surgenorauthor=D.+L.+Walmsleyauthor=P.+Webbauthor=M.+Woodauthor=P.+Workmanauthor=L.+Wright&title=4%2C5-Diarylisoxazole+Hsp90+chaperone+inhibitors%3A+potential+therapeutic+agents+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm701018h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701018h%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DP.%2BA.%26aulast%3DAherne%26aufirst%3DW.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DBorgognoni%26aufirst%3DJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCansfield%26aufirst%3DJ.%2BE.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DDavies%26aufirst%3DN.%2BG.%2BM.%26aulast%3DDrysdale%26aufirst%3DM.%2BJ.%26aulast%3DDymock%26aufirst%3DB.%26aulast%3DEccles%26aufirst%3DS.%2BE.%26aulast%3DFinch%26aufirst%3DH.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJames%26aufirst%3DK.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLockie%26aufirst%3DA.%26aulast%3DMartins%26aufirst%3DV.%26aulast%3DMassey%26aufirst%3DA.%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcDonald%26aufirst%3DE.%26aulast%3DNorthfield%26aufirst%3DC.%2BJ.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DProdromou%26aufirst%3DC.%26aulast%3DRay%26aufirst%3DS.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRoughley%26aufirst%3DS.%2BD.%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DSurgenor%26aufirst%3DA.%26aulast%3DWalmsley%26aufirst%3DD.%2BL.%26aulast%3DWebb%26aufirst%3DP.%26aulast%3DWood%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DWright%26aufirst%3DL.%26atitle%3D4%252C5-Diarylisoxazole%2520Hsp90%2520chaperone%2520inhibitors%253A%2520potential%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D196%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Cikotiene, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazlauskas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matuliene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michailoviene, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torresan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jachno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matulis, D.</span><span> </span><span class="NLM_article-title">5-Aryl-4-(5-substituted-2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1092</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1089-1092&author=I.+Cikotieneauthor=E.+Kazlauskasauthor=J.+Matulieneauthor=V.+Michailovieneauthor=J.+Torresanauthor=J.+Jachnoauthor=D.+Matulis&title=5-Aryl-4-%285-substituted-2%2C4-dihydroxyphenyl%29-1%2C2%2C3-thiadiazoles+as+inhibitors+of+Hsp90+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCikotiene%26aufirst%3DI.%26aulast%3DKazlauskas%26aufirst%3DE.%26aulast%3DMatuliene%26aufirst%3DJ.%26aulast%3DMichailoviene%26aufirst%3DV.%26aulast%3DTorresan%26aufirst%3DJ.%26aulast%3DJachno%26aufirst%3DJ.%26aulast%3DMatulis%26aufirst%3DD.%26atitle%3D5-Aryl-4-%25285-substituted-2%252C4-dihydroxyphenyl%2529-1%252C2%252C3-thiadiazoles%2520as%2520inhibitors%2520of%2520Hsp90%2520chaperone%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1089%26epage%3D1092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hong, T.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, J.-S.</span><span> </span><span class="NLM_article-title">Identification of new Hsp90 inhibitors by structure-based virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4839</span><span class="NLM_x">–</span> <span class="NLM_lpage">4842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4839-4842&author=T.-J.+Hongauthor=H.+Parkauthor=Y.-J.+Kimauthor=J.-H.+Jeongauthor=J.-S.+Hahn&title=Identification+of+new+Hsp90+inhibitors+by+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DT.-J.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DY.-J.%26aulast%3DJeong%26aufirst%3DJ.-H.%26aulast%3DHahn%26aufirst%3DJ.-S.%26atitle%3DIdentification%2520of%2520new%2520Hsp90%2520inhibitors%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4839%26epage%3D4842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">McCleese, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fossey, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalek, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, C. A.</span><span> </span><span class="NLM_article-title">The novel Hsp90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines</span> <span class="citation_source-journal">Int. J. Cancer.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">2792</span><span class="NLM_x">–</span> <span class="NLM_lpage">2801</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1002%2Fijc.24660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=19544563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2009&pages=2792-2801&author=J.+K.+McCleeseauthor=M.+D.+Bearauthor=S.+L.+Fosseyauthor=R.+M.+Mihalekauthor=K.+P.+Foleyauthor=W.+Yingauthor=J.+Barsoumauthor=C.+A.+London&title=The+novel+Hsp90+inhibitor+STA-1474+exhibits+biologic+activity+against+osteosarcoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines</span></div><div class="casAuthors">McCleese, Jennifer K.; Bear, Misty D.; Fossey, Stacey L.; Mihalek, Robert M.; Foley, Kevin P.; Ying, Weiwen; Barsoum, James; London, Cheryl A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2792-2801</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Osteosarcoma (OSA), the most common malignant bone tumor in dogs and children, exhibits a similar clin. presentation and mol. biol. in both species.  Unfortunately, 30-40% of children and 90% of dogs still die of disease despite aggressive therapy.  The purpose of this study was to test the biol. activity of a novel heat shock protein 90 (HSP90) inhibitor, STA-1474, against OSA.  Canine and human OSA cell lines and normal canine osteoblasts were treated with STA-1474 and evaluated for effects on proliferation (CyQuant), apoptosis (Annexin V, PARP cleavage, caspase 3/7 activation) and known HSP90 client proteins.  HSP90 was immunopptd. from normal and malignant osteoblasts and Western blotting for co-chaperones was performed.  Mice bearing canine OSA xenografts were treated with STA-1474, and tumors samples were evaluated for caspase-3 activation and loss of p-Akt/Akt.  Treatment with STA-1474 promoted loss of cell viability, inhibition of cell proliferation and induction of apoptosis in OSA cell lines.  STA-1474 and its active metabolite STA-9090 also demonstrated increased potency compared to 17-AAG.  STA-1474 exhibited selectivity for OSA cells vs. normal canine osteoblasts, and HSP90 co-pptd. with co-chaperones p23 and Hop in canine OSA cells but not in normal canine osteoblasts.  Furthermore, STA-1474 downregulated the expression of p-Met/Met, p-Akt/Akt and p-STAT3.  Finally, STA-1474 induced tumor regression, caspase-3 activation and downregulation of p-Met/Met and p-Akt/Akt in OSA xenografts.  Together, these data suggest that HSP90 represents a relevant target for therapeutic intervention in OSA. © 2009 UICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6OY9Zp2J7BLVg90H21EOLACvtfcHk0lgUHoTABhrB4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsLjM&md5=fb4fdefb903eed2f78ecf5ac96afaa50</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1002%2Fijc.24660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.24660%26sid%3Dliteratum%253Aachs%26aulast%3DMcCleese%26aufirst%3DJ.%2BK.%26aulast%3DBear%26aufirst%3DM.%2BD.%26aulast%3DFossey%26aufirst%3DS.%2BL.%26aulast%3DMihalek%26aufirst%3DR.%2BM.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DLondon%26aufirst%3DC.%2BA.%26atitle%3DThe%2520novel%2520Hsp90%2520inhibitor%2520STA-1474%2520exhibits%2520biologic%2520activity%2520against%2520osteosarcoma%2520cell%2520lines%26jtitle%3DInt.%2520J.%2520Cancer.%26date%3D2009%26volume%3D125%26spage%3D2792%26epage%3D2801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chimmanamada, D.; Burlinson, J. A.; Ying, W.; Sun, L.; Schweizer, S. M.; Zhang, S.; Demko, Z.; James, D.; Prezwloka, T.</span><span> </span><span class="NLM_article-title">Triazole compounds that modulate Hsp90 activity</span>. US2011105483 (A1),<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+Chimmanamada&author=J.+A.+Burlinson&author=W.+Ying&author=L.+Sun&author=S.+M.+Schweizer&author=S.+Zhang&author=Z.+Demko&author=D.+James&author=T.+Prezwloka&title=Triazole+compounds+that+modulate+Hsp90+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChimmanamada%26aufirst%3DD.%26atitle%3DTriazole%2520compounds%2520that%2520modulate%2520Hsp90%2520activity%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Majireck, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, S. M.</span><span> </span><span class="NLM_article-title">A Study of the scope and regioselectivity of the ruthenium-catalyzed [3 + 2]-cycloaddition of azides with internal alkynes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">8680</span><span class="NLM_x">–</span> <span class="NLM_lpage">8683</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo061688m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVaqs7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2006&pages=8680-8683&author=M.+M.+Majireckauthor=S.+M.+Weinreb&title=A+Study+of+the+scope+and+regioselectivity+of+the+ruthenium-catalyzed+%5B3+%2B+2%5D-cycloaddition+of+azides+with+internal+alkynes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A Study of the Scope and Regioselectivity of the Ruthenium-Catalyzed [3 + 2]-Cycloaddition of Azides with Internal Alkynes</span></div><div class="casAuthors">Majireck, Max M.; Weinreb, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8680-8683</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">[3 + 2]-Cycloaddns. of alkyl azides with various unsym. internal alkynes in the presence of Cp*RuCl(PPh3)2 as catalyst in refluxing benzene have been examd., leading to 1,4,5-trisubstituted-1,2,3-triazoles, e.g., I.  Whereas alkyl Ph and dialkyl acetylenes undergo cycloaddns. to afford mixts. of regioisomeric 1,2,3-triazoles, acyl-substituted internal alkynes react with complete regioselectivity.  In addn., propargyl alcs. and propargyl amines were found to react with azides to afford single regioisomeric products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFceK7OGLHwrVg90H21EOLACvtfcHk0lgUHoTABhrB4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVaqs7bN&md5=93ea6404f7e2a5219b799b0db84e29ca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjo061688m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo061688m%26sid%3Dliteratum%253Aachs%26aulast%3DMajireck%26aufirst%3DM.%2BM.%26aulast%3DWeinreb%26aufirst%3DS.%2BM.%26atitle%3DA%2520Study%2520of%2520the%2520scope%2520and%2520regioselectivity%2520of%2520the%2520ruthenium-catalyzed%2520%255B3%2520%252B%25202%255D-cycloaddition%2520of%2520azides%2520with%2520internal%2520alkynes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2006%26volume%3D71%26spage%3D8680%26epage%3D8683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Spiteri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, J. E.</span><span> </span><span class="NLM_article-title">Copper-catalyzed azide–alkyne cycloaddition: regioselective synthesis of 1,4,5-trisubstituted 1,2,3-triazoles</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=31-33&author=C.+Spiteriauthor=J.+E.+Moses&title=Copper-catalyzed+azide%E2%80%93alkyne+cycloaddition%3A+regioselective+synthesis+of+1%2C4%2C5-trisubstituted+1%2C2%2C3-triazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpiteri%26aufirst%3DC.%26aulast%3DMoses%26aufirst%3DJ.%2BE.%26atitle%3DCopper-catalyzed%2520azide%25E2%2580%2593alkyne%2520cycloaddition%253A%2520regioselective%2520synthesis%2520of%25201%252C4%252C5-trisubstituted%25201%252C2%252C3-triazoles%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2010%26volume%3D49%26spage%3D31%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">Because of detection limits of the assay, the most active compounds were reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> as having IC<sub>50</sub> < 5 nM. However, curve fitting using the GraphPad Prism software program suggested a binding lower than 3.0 nM for compounds <b>18</b>, <b>21</b>, <b>25</b>, <b>26</b>, <b>27</b>, while the best IC<sub>50</sub> value was found for pyrrolidine derivative <b>21</b> (IC<sub>50</sub> = 1 nM). For the limits of the assay see the following:</p></div><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llauger, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huezo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiosis, G.</span><span> </span><span class="NLM_article-title">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1177%2F1087057104265995" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=15296636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=375-381&author=J.+Kimauthor=S.+Feltsauthor=L.+Llaugerauthor=H.+Heauthor=H.+Huezoauthor=N.+Rosenauthor=G.+Chiosis&title=Development+of+a+fluorescence+polarization+assay+for+the+molecular+chaperone+Hsp90"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a fluorescence polarization assay for the molecular chaperone Hsp90</span></div><div class="casAuthors">Kim, Joungnam; Felts, Sara; Llauger, Laura; He, Huazhong; Huezo, Henri; Rosen, Neal; Chiosis, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">375-381</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Heat shock protein 90 (Hsp90) is a mol. chaperone with essential functions in maintaining transformation, and there is increasing interest in developing Hsp90 inhibitors as cancer therapeutics.  In this study, the authors describe the development and optimization of a novel assay for the identification of Hsp90 inhibitors using fluorescence polarization.  The assay is based on the competition of fluorescently (BODIPY) labeled geldanamycin (GM) for binding to purified recombinant Hsp90α (GM is a natural product that binds to the ATP/ADP pocket in the amino terminal of Hsp90).  The authors show that GM-BODIPY binds Hsp90α with high affinity.  Even at low Hsp90α concns. (30 nM), the measured polarization value is close to the max. assay range of 160 mP, making measurements very sensitive.  Its performance, as judged by signal-to-noise ratios (> 10) and Z and Z' values (> 0.5), suggests that this is a robust and reliable assay.  GM, PU24FCl, ADP, and ATP, all known to bind to the Hsp90 pocket, compete with GM-BODIPY for binding to Hsp90α with EC50s in agreement with reported values.  These data demonstrate that the Hsp90-FP-based assay can be used for high-throughput screening in aiding the identification of novel Hsp90 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTTKuW5DgFIbVg90H21EOLACvtfcHk0lja5FWS85RXGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsVagt70%253D&md5=e6e13d80237b2b5c65a78d20d2f3c4bc</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F1087057104265995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057104265995%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DFelts%26aufirst%3DS.%26aulast%3DLlauger%26aufirst%3DL.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHuezo%26aufirst%3DH.%26aulast%3DRosen%26aufirst%3DN.%26aulast%3DChiosis%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520fluorescence%2520polarization%2520assay%2520for%2520the%2520molecular%2520chaperone%2520Hsp90%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2004%26volume%3D9%26spage%3D375%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><div class="note"><p class="first last">LC/MS analysis showed that compound <b>44</b> is stable under conditions employed in the FP assay. For resorcinol esterification in order to get an effective pro-drug see the following:</p></div><span class="NLM_contrib-group">London, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bear, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paalangara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span> </span><span class="NLM_article-title">Phase I evaluation of STA-1474, a prodrug of the novel Hsp90 inhibitor ganetespib, in dogs with spontaneous cancer</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e2701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e2701&author=C.+A.+Londonauthor=M.+D.+Bearauthor=J.+McCleeseauthor=K.+P.+Foleyauthor=R.+Paalangaraauthor=T.+Inoueauthor=W.+Yingauthor=J.+Barsoum&title=Phase+I+evaluation+of+STA-1474%2C+a+prodrug+of+the+novel+Hsp90+inhibitor+ganetespib%2C+in+dogs+with+spontaneous+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DC.%2BA.%26aulast%3DBear%26aufirst%3DM.%2BD.%26aulast%3DMcCleese%26aufirst%3DJ.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DPaalangara%26aufirst%3DR.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26atitle%3DPhase%2520I%2520evaluation%2520of%2520STA-1474%252C%2520a%2520prodrug%2520of%2520the%2520novel%2520Hsp90%2520inhibitor%2520ganetespib%252C%2520in%2520dogs%2520with%2520spontaneous%2520cancer%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26spage%3De2701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">Compound <b>18</b> and NVP-AUY922 bind Hsp90 comparably with the diverse STA-9090 (ganatesib):</p></div><span class="NLM_contrib-group">Shimamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carretero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgman, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barsoum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Ganetespib (STA-9090), a nongeldanamycin Hsp90 inhibitor, has potent antitumor activity in vitro and in vivo models of non-small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4973</span><span class="NLM_x">–</span> <span class="NLM_lpage">4982</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm401536b&amp;key=10.1158%2F1078-0432.CCR-11-2967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=22806877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4973-4982&author=T.+Shimamuraauthor=S.+A.+Pereraauthor=K.+P.+Foleyauthor=J.+Sangauthor=S.+J.+Rodigauthor=T.+Inoueauthor=L.+Chenauthor=D.+Liauthor=J.+Carreteroauthor=Y.-C.+Liauthor=P.+Sinhaauthor=C.+D.+Careyauthor=C.+L.+Borgmanauthor=J.-P.+Jimenezauthor=M.+Meyersonauthor=W.+Yingauthor=J.+Barsoumauthor=K.-K.+Wongauthor=G.+I.+Shapiro&title=Ganetespib+%28STA-9090%29%2C+a+nongeldanamycin+Hsp90+inhibitor%2C+has+potent+antitumor+activity+in+vitro+and+in+vivo+models+of+non-small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Ganetespib (STA-9090), a Nongeldanamycin HSP90 Inhibitor, Has Potent Antitumor Activity in In Vitro and In Vivo Models of Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Shimamura, Takeshi; Perera, Samanthi A.; Foley, Kevin P.; Sang, Jim; Rodig, Scott J.; Inoue, Takayo; Chen, Liang; Li, Danan; Carretero, Julian; Li, Yu-Chen; Sinha, Papiya; Carey, Christopher D.; Borgman, Christa L.; Jimenez, John-Paul; Meyerson, Matthew; Ying, Weiwen; Barsoum, James; Wong, Kwok-Kin; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4973-4985</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: We describe the anticancer activity of ganetespib, a novel non-geldanamycin heat shock protein 90 (HSP90) inhibitor, in non-small cell lung cancer (NSCLC) models.  Exptl. Design: The activity of ganetespib was compared with that of the geldanamycin 17-AAG in biochem. assays, cell lines, and xenografts, and evaluated in an ERBB2 YVMA-driven mouse lung adenocarcinoma model.  Results: Ganetespib blocked the ability of HSP90 to bind to biotinylated geldanamycin and disrupted the assocn. of HSP90 with its cochaperone, p23, more potently than 17-AAG.  In genomically defined NSCLC cell lines, ganetespib caused depletion of receptor tyrosine kinases, extinguishing of downstream signaling, inhibition of proliferation and induction of apoptosis with IC50 values ranging 2 to 30 nmol/L, substantially lower than those required for 17-AAG (20-3,500 nmol/L).  Ganetespib was also approx. 20-fold more potent in isogenic Ba/F3 pro-B cells rendered IL-3 independent by expression of EGFR and ERBB2 mutants.  In mice bearing NCI-H1975 (EGFR L858R/T790M) xenografts, ganetespib was rapidly eliminated from plasma and normal tissues but was maintained in tumor with t1/2 58.3 h, supporting once-weekly dosing expts., in which ganetespib produced greater tumor growth inhibition than 17-AAG.  However, after a single dose, reexpression of mutant EGFR occurred by 72 h, correlating with reversal of antiproliferative and proapoptotic effects.  Consecutive day dosing resulted in xenograft regressions, accompanied by more sustained pharmacodynamic effects.  Ganetespib also showed activity against mouse lung adenocarcinomas driven by oncogenic ERBB2 YVMA.  Conclusions: Ganetespib has greater potency than 17-AAG and potential efficacy against several NSCLC subsets, including those harboring EGFR or ERBB2 mutation.  Clin Cancer Res; 18(18); 4973-85. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoOaAHBIqU6bVg90H21EOLACvtfcHk0lja5FWS85RXGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lt7zJ&md5=92bb99dd7de0f7d4fc4f1d1a897605ea</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-11-2967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-11-2967%26sid%3Dliteratum%253Aachs%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DPerera%26aufirst%3DS.%2BA.%26aulast%3DFoley%26aufirst%3DK.%2BP.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCarretero%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.-C.%26aulast%3DSinha%26aufirst%3DP.%26aulast%3DCarey%26aufirst%3DC.%2BD.%26aulast%3DBorgman%26aufirst%3DC.%2BL.%26aulast%3DJimenez%26aufirst%3DJ.-P.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DYing%26aufirst%3DW.%26aulast%3DBarsoum%26aufirst%3DJ.%26aulast%3DWong%26aufirst%3DK.-K.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DGanetespib%2520%2528STA-9090%2529%252C%2520a%2520nongeldanamycin%2520Hsp90%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%2520models%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D4973%26epage%3D4982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Koga, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neckers, L. M.</span><span> </span><span class="NLM_article-title">Low dose geldanamycin inhibits hepatocyte growth factor and hypoxia-stimulated invasion of cancer cells</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1393</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=1393-402&author=F.+Kogaauthor=S.+Tsutsumiauthor=L.+M.+Neckers&title=Low+dose+geldanamycin+inhibits+hepatocyte+growth+factor+and+hypoxia-stimulated+invasion+of+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DF.%26aulast%3DTsutsumi%26aufirst%3DS.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DLow%2520dose%2520geldanamycin%2520inhibits%2520hepatocyte%2520growth%2520factor%2520and%2520hypoxia-stimulated%2520invasion%2520of%2520cancer%2520cells%26jtitle%3DCell%2520Cycle%26date%3D2007%26volume%3D6%26spage%3D1393%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Maulik, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kijima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghosh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tibaldi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salgia, R.</span><span> </span><span class="NLM_article-title">Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm401536b&amp;key=11839685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFens7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=620-7&author=G.+Maulikauthor=T.+Kijimaauthor=P.+C.+Maauthor=S.+K.+Ghoshauthor=J.+Linauthor=G.+I.+Shapiroauthor=E.+Schaeferauthor=E.+Tibaldiauthor=B.+E.+Johnsonauthor=R.+Salgia&title=Modulation+of+the+c-Met%2Fhepatocyte+growth+factor+pathway+in+small+cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer</span></div><div class="casAuthors">Maulik, Gautam; Kijima, Takashi; Ma, Patrick C.; Ghosh, Sudip K.; Lin, Jeffrey; Shapiro, Geoffrey I.; Schaefer, Erik; Tibaldi, Elena; Johnson, Bruce E.; Salgia, Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">620-627</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand HGF (hepatocyte growth factor) have been shown to be involved in angiogenesis, cellular motility, growth, invasion, and differentiation.  The role of c-Met/HGF axis in small cell lung cancer (SCLC) has not been reported previously.  We have detd. the expression of p170c-Met precursor and p140c-Met β-chain in seven SCLC cell lines by immunoblotting.  We used the SCLC cell line H69, which expressed an abundant amt. of c-Met to study the function and downstream effects of c-Met activation.  Stimulation of H69 cells with HGF (40 ng/mL, 6-h stimulation) significantly altered cell motility of the SCLC cells with increased formation of filopodia and membrane ruffling, characterized as membrane blebbing, as well as increased migration of the cellular clusters were seen.  We have further studied the signal transduction pathways of HGF/c-Met in the H69 cell line.  The stimulation of H69 with HGF (40 ng/mL, >24 h, maximal at 1 h) increased the amt. of reactive oxygen species formed by 34%.  HGF stimulation (40 ng/mL, 7.5-min stimulation) of H69 cells showed increased tyrosine phosphorylated bands identified at Mr 68,000, 120,000-140,000, and 200,000.  Some of these tyrosine-phosphorylated bands were identified as the focal adhesion proteins paxillin, FAK, PYK2, and the c-Met receptor itself.  Phospho-specific antibodies show that tyrosines at amino acid (a.a.) 31 of paxillin, and autophosphorylation sites at a.a. 397 of p125FAK, and a.a. 402 of PYK2 are phosphorylated in response to HGF/c-Met signaling.  We also demonstrate that the Hsp90 inhibitor geldanamycin, which also affects c-Met, reduced the growth and viability of four of four SCLC cell lines by 25% to 85%, over a 72-h time period.  Geldanamycin caused apoptosis of SCLC cells, as well as led to increased levels of Hsp70 but not Hsp90.  These results demonstrate that c-Met/HGF pathway is functional in SCLC, and it would be useful to target this pathway toward novel therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_d-kEyrq5bVg90H21EOLACvtfcHk0lj0BXz5ZyDTAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFens7w%253D&md5=528b03929eccc62a21f6fcbfb8e3e237</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaulik%26aufirst%3DG.%26aulast%3DKijima%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DP.%2BC.%26aulast%3DGhosh%26aufirst%3DS.%2BK.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DSchaefer%26aufirst%3DE.%26aulast%3DTibaldi%26aufirst%3DE.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DSalgia%26aufirst%3DR.%26atitle%3DModulation%2520of%2520the%2520c-Met%252Fhepatocyte%2520growth%2520factor%2520pathway%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D620%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">Compounds <b>18</b> and <b>19</b> were dosed differently and according to different schedules because the experimental conditions were chosen upon a series of preliminary experiments to identify the best tolerability and efficacy.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><div class="note"><p class="first last">Screening was performed by Reaction Biology Corp., Malvern, PA. See the following:</p></div><span class="NLM_contrib-group">Auzzas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschênes-Simard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cabri, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battistuzzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanessian, S.</span><span> </span><span class="NLM_article-title">Non-natural macrocyclic inhibitors of histone deacetylases: design, synthesis, and activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8387</span><span class="NLM_x">–</span> <span class="NLM_lpage">8399</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101092u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm401536b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWrtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8387-8399&author=L.+Auzzasauthor=A.+Larssonauthor=R.+Materaauthor=A.+Baraldiauthor=B.+Desch%C3%AAnes-Simardauthor=G.+Gianniniauthor=W.+Cabriauthor=G.+Battistuzziauthor=G.+Galloauthor=A.+Ciacciauthor=L.+Vesciauthor=C.+Pisanoauthor=S.+Hanessian&title=Non-natural+macrocyclic+inhibitors+of+histone+deacetylases%3A+design%2C+synthesis%2C+and+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Non-Natural Macrocyclic Inhibitors of Histone Deacetylases: Design, Synthesis, and Activity</span></div><div class="casAuthors">Auzzas, Luciana; Larsson, Andreas; Matera, Riccardo; Baraldi, Annamaria; Deschenes-Simard, Benoit; Giannini, Giuseppe; Cabri, Walter; Battistuzzi, Gianfranco; Gallo, Grazia; Ciacci, Andrea; Vesci, Loredana; Pisano, Claudio; Hanessian, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8387-8399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nonpeptidic chiral macrocycles, e.g. I [X = (CH2)n, n = 1-3], were designed on the basis of an analog of suberoylanilide hydroxamic acid II (SAHA, vorinostat) and evaluated against 11 histone deacetylase (HDAC) isoforms.  The identification of crit. amino acid residues highly conserved in the cap region of HDACs guided the design of the suberoyl-based macrocycles, which were expected to bear a max. common substructure required to target the whole HDAC panel.  A nanomolar HDAC inhibitory profile was obsd. for several compds., which was comparable, if not superior, to that of II.  A promising cytotoxic activity was found for selected macrocycles against lung and colon cancer cell lines.  Further elaboration of selected candidates led to compds. with an improved selectivity against HDAC6 over the other isoenzymes.  Pair-fitting anal. was used to compare one of the best candidates with the natural tetrapeptide apicidin, in an effort to define a general pharmacophore that might be useful in the design of surrogates of peptidic macrocycles as potent and isoform-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJOcBz2w8SRLVg90H21EOLACvtfcHk0lj0BXz5ZyDTAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWrtb%252FI&md5=061fb93af453824141ca9c0fdb09a701</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm101092u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101092u%26sid%3Dliteratum%253Aachs%26aulast%3DAuzzas%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DA.%26aulast%3DMatera%26aufirst%3DR.%26aulast%3DBaraldi%26aufirst%3DA.%26aulast%3DDesch%25C3%25AAnes-Simard%26aufirst%3DB.%26aulast%3DGiannini%26aufirst%3DG.%26aulast%3DCabri%26aufirst%3DW.%26aulast%3DBattistuzzi%26aufirst%3DG.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DCiacci%26aufirst%3DA.%26aulast%3DVesci%26aufirst%3DL.%26aulast%3DPisano%26aufirst%3DC.%26aulast%3DHanessian%26aufirst%3DS.%26atitle%3DNon-natural%2520macrocyclic%2520inhibitors%2520of%2520histone%2520deacetylases%253A%2520design%252C%2520synthesis%252C%2520and%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8387%26epage%3D8399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kekatpure, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannenberg, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subbaramaiah, K.</span><span> </span><span class="NLM_article-title">HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">7436</span><span class="NLM_x">–</span> <span class="NLM_lpage">7445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=7436-7445&author=V.+D.+Kekatpureauthor=A.+J.+Dannenbergauthor=K.+Subbaramaiah&title=HDAC6+modulates+Hsp90+chaperone+activity+and+regulates+activation+of+aryl+hydrocarbon+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKekatpure%26aufirst%3DV.%2BD.%26aulast%3DDannenberg%26aufirst%3DA.%2BJ.%26aulast%3DSubbaramaiah%26aufirst%3DK.%26atitle%3DHDAC6%2520modulates%2520Hsp90%2520chaperone%2520activity%2520and%2520regulates%2520activation%2520of%2520aryl%2520hydrocarbon%2520receptor%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D7436%26epage%3D7445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bali, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pranpar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balasis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocha, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaraswamy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyapalle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span> </span><span class="NLM_article-title">Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">26729</span><span class="NLM_x">–</span> <span class="NLM_lpage">26734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=26729-26734&author=P.+Baliauthor=M.+Pranparauthor=J.+Bradnerauthor=M.+Balasisauthor=W.+Fiskusauthor=F.+Guoauthor=K.+Rochaauthor=S.+Kumaraswamyauthor=S.+Boyapalleauthor=P.+Atadjaauthor=E.+Setoauthor=K.+Bhalla&title=Inhibition+of+histone+deacetylase+6+acetylates+and+disrupts+the+chaperone+function+of+heat+shock+protein+90"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBali%26aufirst%3DP.%26aulast%3DPranpar%26aufirst%3DM.%26aulast%3DBradner%26aufirst%3DJ.%26aulast%3DBalasis%26aufirst%3DM.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DRocha%26aufirst%3DK.%26aulast%3DKumaraswamy%26aufirst%3DS.%26aulast%3DBoyapalle%26aufirst%3DS.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DSeto%26aufirst%3DE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DInhibition%2520of%2520histone%2520deacetylase%25206%2520acetylates%2520and%2520disrupts%2520the%2520chaperone%2520function%2520of%2520heat%2520shock%2520protein%252090%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D26729%26epage%3D26734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiskus, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandawat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atadja, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradner, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalla, K.</span><span> </span><span class="NLM_article-title">HDAC6 inhibition enhances 17-AAG mediated abrogation of Hsp90 chaperone function in human leukemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">1886</span><span class="NLM_x">–</span> <span class="NLM_lpage">1893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2008&pages=1886-1893&author=R.+Raoauthor=W.+Fiskusauthor=Y.+Yangauthor=P.+Leeauthor=R.+Joshiauthor=P.+Fernandezauthor=A.+Mandawatauthor=P.+Atadjaauthor=J.+E.+Bradnerauthor=K.+Bhalla&title=HDAC6+inhibition+enhances+17-AAG+mediated+abrogation+of+Hsp90+chaperone+function+in+human+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%26aulast%3DFiskus%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DR.%26aulast%3DFernandez%26aufirst%3DP.%26aulast%3DMandawat%26aufirst%3DA.%26aulast%3DAtadja%26aufirst%3DP.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DBhalla%26aufirst%3DK.%26atitle%3DHDAC6%2520inhibition%2520enhances%252017-AAG%2520mediated%2520abrogation%2520of%2520Hsp90%2520chaperone%2520function%2520in%2520human%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D2008%26volume%3D112%26spage%3D1886%26epage%3D1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2VCI','PDB','2VCI'); return false;">PDB: 2VCI</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i66"><a href="/doi/suppl/10.1021/jm401536b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37306"></div></div></div></div></div><hr /></hr><p class="last">Synthetic scheme of compound <b>43</b>, analysis of Hsp90 client protein levels, and the antiproliferative activity of all 1,2,3-triazoles on a panel of tumor cell lines. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401536b/suppl_file/jm401536b_si_001.pdf">jm401536b_si_001.pdf (282.33 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401536b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-6%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm401536b%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401536b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a83706cc03dbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
